title,link,published,summary
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML,http://classic.clinicaltrials.gov/ct2/show/NCT06105658?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Acute Myelocytic Leukemia<br /><b>Interventions</b>:    Biological: Unrelated umbilical cord blood;   Drug: Chemotherapy drugs including Venetoclax, Decetabine and Azacitidine<br /><b>Sponsor</b>:    Anhui Provincial Hospital<br /><b>Recruiting</b>"
Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy,http://classic.clinicaltrials.gov/ct2/show/NCT06105645?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Epilepsy<br /><b>Intervention</b>:    Device: Micro-Macro Depth electrodes<br /><b>Sponsor</b>:    University Hospital, Toulouse<br /><b>Not yet recruiting</b>"
"A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment",http://classic.clinicaltrials.gov/ct2/show/NCT06105632?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Advanced or Metastatic Breast Cancer<br /><b>Interventions</b>:    Drug: PF-07220060;   Drug: Fulvestrant;   Drug: Everolimus;   Drug: Exemestane<br /><b>Sponsor</b>:    Pfizer<br /><b>Not yet recruiting</b>
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene.,http://classic.clinicaltrials.gov/ct2/show/NCT06105619?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Glioblastoma<br /><b>Interventions</b>:    Drug: PLB1001;   Drug: Temozolomide;   Drug: Cisplatin combined with etoposide<br /><b>Sponsor</b>:    Beijing Pearl Biotechnology Limited Liability Company<br /><b>Active, not recruiting</b>"
Feasibility of the AveCure Microwave Ablation Technology for the Bronchoscopic Treatment of Malignant Central Airway Obstructions,http://classic.clinicaltrials.gov/ct2/show/NCT06105606?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Airway Obstruction;   Central Airway Obstruction<br /><b>Intervention</b>:    Device: AveCure Flexible Microwave Ablation Probe<br /><b>Sponsors</b>:    Beth Israel Deaconess Medical Center;   MedWaves, Inc<br /><b>Not yet recruiting</b>"
Effect of Balneotherapy and Physiotherapy Treatment in Female Infertility: a Retrospective Study,http://classic.clinicaltrials.gov/ct2/show/NCT06105593?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Infertility, Female<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Harkány Thermal Rehabilitation Centre<br /><b>Enrolling by invitation</b>"
"Conduction System Pacing vs Biventricular Pacing in Systolic Dysfunction and Wide QRS: Mortality, Heart Failure Hospitalization or Cardiac Transplant",http://classic.clinicaltrials.gov/ct2/show/NCT06105580?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cardiac Resynchronization Therapy;   Heart Failure<br /><b>Interventions</b>:    Procedure: Conduction system pacing;   Procedure: Biventricular pacing<br /><b>Sponsors</b>:    Hospital Clinic of Barcelona;   Institut d'Investigacions Biomèdiques August Pi i Sunyer<br /><b>Not yet recruiting</b>
"The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress",http://classic.clinicaltrials.gov/ct2/show/NCT06105567?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Premenstrual Syndrome;   Emotional Disorder;   Perceived Stress<br /><b>Intervention</b>:    Behavioral: Training given according to the health promotion model by applying the Philips 66 technique<br /><b>Sponsor</b>:    Kafkas University<br /><b>Not yet recruiting</b>
"Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma",http://classic.clinicaltrials.gov/ct2/show/NCT06105554?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Multiple Myeloma<br /><b>Intervention</b>:    Drug: Belumosudil mesylate<br /><b>Sponsors</b>:    M.D. Anderson Cancer Center;   Sanofi US Services, Inc<br /><b>Not yet recruiting</b>"
Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation,http://classic.clinicaltrials.gov/ct2/show/NCT06105541?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Hypermobile Ehlers-Danlos Syndrome;   Hypermobile Spectrum Disorder;   Ehlers-Danlos Syndrome<br /><b>Intervention</b>:    Device: Transcutaneous Auricular Neurostimulation<br /><b>Sponsor</b>:    Medical University of South Carolina<br /><b>Recruiting</b>
A Phase 1 Study of PMN310 In Healthy Volunteers,http://classic.clinicaltrials.gov/ct2/show/NCT06105528?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Healthy Participants<br /><b>Interventions</b>:    Drug: PMN310;   Drug: Placebo<br /><b>Sponsor</b>:    ProMis Neurosciences, Inc<br /><b>Not yet recruiting</b>"
Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06105515?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Gastric Cancer<br /><b>Intervention</b>:    Procedure: Laparoscopic and Endoscopic Collaborative Surgery (LECS)<br /><b>Sponsor</b>:    Region Stockholm<br /><b>Not yet recruiting</b>
"Systematic Evaluation of Psychotherapy Training: Supervision, Student Learning, and Patient Outcomes",http://classic.clinicaltrials.gov/ct2/show/NCT06105502?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Student Education<br /><b>Intervention</b>:    Behavioral: Psychotherapy education<br /><b>Sponsors</b>:    Region Stockholm;   Karolinska Institutet<br /><b>Not yet recruiting</b>
"""Tunnel"" Flap vs Trapezoidal Flap for Lateral Sinus Lift",http://classic.clinicaltrials.gov/ct2/show/NCT06105489?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Severe Atrophy of the Edentulous Maxilla<br /><b>Interventions</b>:    Procedure: Lateral Sinus Lift using tunnel flap technique;   Procedure: Lateral Sinus Lift using crestal incision flap<br /><b>Sponsor</b>:    Studio Dentistico Associato Sivolella<br /><b>Recruiting</b>
Effect of Protein and Retinol on Alcohol-induced FGF21,http://classic.clinicaltrials.gov/ct2/show/NCT06105476?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Other: Alcohol;   Other: Alcohol+protein;   Other: Alcohol+retinol;   Other: Retinol<br /><b>Sponsor</b>:    University of Copenhagen<br /><b>Not yet recruiting</b>
"Multiple Sclerosis, Menstrual Cycle and Physical Acivity",http://classic.clinicaltrials.gov/ct2/show/NCT06105463?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: Strength training sessions and High-interval intensity training sessions<br /><b>Sponsor</b>:    Universidad de Almeria<br /><b>Recruiting</b>
Respiratory Muscle Assesment in COVID-patients Without Hospitalization,http://classic.clinicaltrials.gov/ct2/show/NCT06105450?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Covid19;   Diaphragm Injury<br /><b>Intervention</b>:    Diagnostic Test: Comprehensive assessment of respiratory muscle function.<br /><b>Sponsor</b>:    RWTH Aachen University<br /><b>Not yet recruiting</b>
Implementation of a Multifactorial Falls Prevention Intervention in Older Community-dWElling peRsons,http://classic.clinicaltrials.gov/ct2/show/NCT06105437?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Falls Prevention;   Implementation;   Older People<br /><b>Intervention</b>:    Other: BE-EMPOWERed program<br /><b>Sponsors</b>:    KU Leuven;   Flemish Agency for Care and Health<br /><b>Recruiting</b>
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability,http://classic.clinicaltrials.gov/ct2/show/NCT06105424?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Tobacco Use;   Smoking;   Smoking, Tobacco<br /><b>Intervention</b>:    Procedure: Lung Permeability Assessment<br /><b>Sponsor</b>:    RAI Services Company<br /><b>Completed</b>"
Siderophore-labelled Position Emission Tomography for Correlating Invasive Fungal InfeCtions,http://classic.clinicaltrials.gov/ct2/show/NCT06105411?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Invasive Fungal Infections<br /><b>Intervention</b>:    Diagnostic Test: 68Ga-labelled TAFC PET/CT scan<br /><b>Sponsor</b>:    Peter MacCallum Cancer Centre, Australia<br /><b>Not yet recruiting</b>"
the Effect of Core Stability on Hand Functions,http://classic.clinicaltrials.gov/ct2/show/NCT06105398?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Rotator Cuff Tear Arthropathy<br /><b>Intervention</b>:    Other: clinical evaluation<br /><b>Sponsor</b>:    Gülçe İrem Yalçınkaya<br /><b>Active, not recruiting</b>"
Suboccipital Myofascial Release Technique in Young Adults,http://classic.clinicaltrials.gov/ct2/show/NCT06105385?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Myofascial Release<br /><b>Intervention</b>:    Other: Suboccipital Myofascial Release Technique<br /><b>Sponsor</b>:    Pamukkale University<br /><b>Recruiting</b>
"Ramadan Fasting, Microbiota and FABP4",http://classic.clinicaltrials.gov/ct2/show/NCT06105372?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Intermittent Fasting<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Okan University<br /><b>Enrolling by invitation</b>
The Effect of Dignity Therapy Applied to Cancer Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06105359?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cancer;   Dignity<br /><b>Interventions</b>:    Behavioral: Dignity therapy;   Other: standardize care<br /><b>Sponsor</b>:    Necmettin Erbakan University<br /><b>Not yet recruiting</b>
Prevalence of ENT Diseseas,http://classic.clinicaltrials.gov/ct2/show/NCT06105346?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Conscripts;   Military Induction Board;   ENT Disease;   Rhinosinusitis Chronic;   Rhinosinusitis;   HPV Infection;   HPV Vaccine;   Long COVID;   ENT Surgery<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Medical University of Graz<br /><b>Not yet recruiting</b>
Fidgety Movements of Preterm Neonates Included in COSGOD III,http://classic.clinicaltrials.gov/ct2/show/NCT06105333?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Preterm;   General Movements;   Fidgety Movements;   Near Infrared Spectroscopy;   Neurological Outcome<br /><b>Intervention</b>:    Procedure: standard care plus cerebral oxygen saturation monitoring with a dedicated treatment guideline<br /><b>Sponsor</b>:    Medical University of Graz<br /><b>Recruiting</b>
COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study,http://classic.clinicaltrials.gov/ct2/show/NCT06105320?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Prodromal Alzheimer's Disease;   Alzheimer Disease;   Mild Cognitive Impairment;   Neurocognitive Disorders<br /><b>Interventions</b>:    Other: LCHF;   Other: HCLF<br /><b>Sponsors</b>:    Karolinska University Hospital;   Fingers Brain Health Institute;   Karolinska Institutet;   af Jochnick Foundation<br /><b>Recruiting</b>
Using Cognitive-Behavioral Change and Mobile Technology to Improve RN Sleep and Fatigue,http://classic.clinicaltrials.gov/ct2/show/NCT06105307?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Occupational Health;   Sleep;   Fatigue;   Nurse<br /><b>Interventions</b>:    Behavioral: RN-SLEEP;   Behavioral: Healthy Habit - Educational Control<br /><b>Sponsors</b>:    University of Cincinnati;   Washington State University<br /><b>Not yet recruiting</b>
Time-Restricted Eating and Bipolar Disorder,http://classic.clinicaltrials.gov/ct2/show/NCT06105294?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Bipolar Disorder<br /><b>Intervention</b>:    Behavioral: time-restricted eating<br /><b>Sponsor</b>:    University of California, Berkeley<br /><b>Terminated</b>"
Nurse Specialist Intervention Promoting Altered Coping and Treatment for Chronic Pain,http://classic.clinicaltrials.gov/ct2/show/NCT06105281?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Chronic Pain<br /><b>Intervention</b>:    Behavioral: The consultation with a pain specialist nurse<br /><b>Sponsors</b>:    Universiteit Antwerpen;   Vitaz<br /><b>Recruiting</b>
Management of Shoulder Dystocia in Flipped Learning,http://classic.clinicaltrials.gov/ct2/show/NCT06105268?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Shoulder Dystocia - Delivered<br /><b>Intervention</b>:    Other: flipped learning training group<br /><b>Sponsor</b>:    Karabuk University<br /><b>Recruiting</b>
"A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553",http://classic.clinicaltrials.gov/ct2/show/NCT06105255?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Healthy Male<br /><b>Intervention</b>:    Drug: D-1553<br /><b>Sponsor</b>:    InventisBio Co., Ltd<br /><b>Active, not recruiting</b>"
Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe),http://classic.clinicaltrials.gov/ct2/show/NCT06105242?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    CTEPH<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Intermountain Health Care, Inc.<br /><b>Recruiting</b>"
Clinical Value of Plasma Humanin in Acute Kidney Injury,http://classic.clinicaltrials.gov/ct2/show/NCT06105229?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Acute Kidney Injury<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Guangdong Provincial People's Hospital<br /><b>Recruiting</b>
The Effect of Crossword and Word Search Puzzles on Nursing Students' Parenteral Medication Administration Knowledge,http://classic.clinicaltrials.gov/ct2/show/NCT06105216?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Nursing Education;   Medicatioon Administration Knowledge;   Puzzle<br /><b>Intervention</b>:    Other: Crossword and word search puzzles<br /><b>Sponsor</b>:    Evrim Eyikara<br /><b>Completed</b>
RATME vs LATME in Middle and Low Rectal Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06105203?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Total Mesorectal Excision;   Rectal Neoplasms;   Robotic Surgical Procedures;   Laparoscopy<br /><b>Interventions</b>:    Procedure: Robotic-assisted total mesorectal excision;   Procedure: laparoscopic-assisted total mesorectal excision<br /><b>Sponsors</b>:    The First Hospital of Jilin University;   Jilin Provincial Tumor Hospital;   Daping Hospital and the Research Institute of Surgery of the Third Military Medical University;   The Second Affiliated Hospital of Dalian Medical University;   The Second Affiliated Hospital of Harbin Medical University<br /><b>Not yet recruiting</b>
Clinical Study to Evaluate Clinical Outcomes of LuxSmart IOL as Compared With LuxGood IOL,http://classic.clinicaltrials.gov/ct2/show/NCT06105190?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Cataract;   Lens Opacities<br /><b>Interventions</b>:    Device: Implantation of premium monofocal IOL, LuxSmart (device under investigation);   Device: Implantation of monofocal IOL, LuxGood (control device)<br /><b>Sponsors</b>:    Cutting Edge SAS;   targomedGmbH<br /><b>Recruiting</b>"
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study,http://classic.clinicaltrials.gov/ct2/show/NCT06105177?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Lung Cancer<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Catharina Ziekenhuis Eindhoven;   Eindhoven University of Technology;   Roche BV Netherlands;   Maxima Medical Center;   Zuyderland Medisch Centrum;   Maastricht University Medical Center;   St. Anna Ziekenhuis, Geldrop, Netherlands;   The Netherlands Cancer Institute<br /><b>Not yet recruiting</b>"
Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans,http://classic.clinicaltrials.gov/ct2/show/NCT06105164?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Appetitive Behavior;   Obesity<br /><b>Interventions</b>:    Device: Repetitive Transcranial Magnetic Stimulation (rTMS);   Device: Sham repetitive Transcranial Magnetic Stimulation (rTMS)<br /><b>Sponsors</b>:    Brigham and Women's Hospital;   Mclean Hospital;   Beth Israel Deaconess Medical Center<br /><b>Not yet recruiting</b>
"Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers",http://classic.clinicaltrials.gov/ct2/show/NCT06105151?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Schizophrenia<br /><b>Interventions</b>:    Drug: VV119(SAD);   Drug: VV119 Placebo(SAD);   Drug: VV119(FE)<br /><b>Sponsor</b>:    Vigonvita Life Sciences<br /><b>Not yet recruiting</b>
Cannabidiol Effects on Blood Alcohol Level and Intoxication,http://classic.clinicaltrials.gov/ct2/show/NCT06105138?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Alcohol Use Disorder<br /><b>Interventions</b>:    Dietary Supplement: 200mg Cannabidiol oral solution;   Dietary Supplement: 30mg Cannabidiol oral solution;   Dietary Supplement: Placebo<br /><b>Sponsor</b>:    Colorado State University<br /><b>Completed</b>
Autologous Micrografts From the Palatal Mucosa for Periodontal Regeneration,http://classic.clinicaltrials.gov/ct2/show/NCT06105125?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Periodontitis<br /><b>Interventions</b>:    Device: Rigenera + bone substitute;   Device: Bone substitute alone<br /><b>Sponsor</b>:    University of Turin, Italy<br /><b>Not yet recruiting</b>"
Periodontal Regeneration With Hyaluronic Acid or Enamel Matrix Derivatives,http://classic.clinicaltrials.gov/ct2/show/NCT06105112?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Periodontitis<br /><b>Interventions</b>:    Device: Hyaluronic acid;   Device: Enamel matrix derivatives<br /><b>Sponsor</b>:    University of Turin, Italy<br /><b>Recruiting</b>"
Effect of Performance-specific Cleft Speech Intervention and Long-term Learning in Children With a Cleft Palate,http://classic.clinicaltrials.gov/ct2/show/NCT06105099?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cleft Palate Children;   Speech Disorders in Children;   Cleft Lip and Palate;   Speech Therapy<br /><b>Interventions</b>:    Behavioral: Motor-phonetic intervention;   Behavioral: Phonological intervention;   Behavioral: Combined phonetic-phonological intervention<br /><b>Sponsors</b>:    University Ghent;   Research Foundation Flanders<br /><b>Recruiting</b>
Risk Analysis Interview IVDR 2023,http://classic.clinicaltrials.gov/ct2/show/NCT06105086?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Risk Variables<br /><b>Intervention</b>:    Other: Semi-structured interview<br /><b>Sponsors</b>:    Universitair Ziekenhuis Brussel;   Vrije Universiteit Brussel<br /><b>Not yet recruiting</b>
"""Pulmonary Rehabilitation Program in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis""",http://classic.clinicaltrials.gov/ct2/show/NCT06105073?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Systemic Sclerosis Associated Interstitial Lung Disease<br /><b>Intervention</b>:    Procedure: Pulmonary Rehabilitation Program<br /><b>Sponsor</b>:    Coordinación de Investigación en Salud, Mexico<br /><b>Recruiting</b>"
Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis,http://classic.clinicaltrials.gov/ct2/show/NCT06105060?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Non-alcoholic Steatohepatitis<br /><b>Interventions</b>:    Drug: Rosuvastatin 20mg;   Drug: N-acetyl cysteine;   Drug: Rosuvastatin and N-acetyl cysteine;   Drug: Vita-E<br /><b>Sponsor</b>:    Beni-Suef University<br /><b>Not yet recruiting</b>
Validation of a Remediation Method for Memory Disorders Using Motor and Emotional Encoding in Patients With Alzheimer's Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06105047?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Alzheimer Disease<br /><b>Intervention</b>:    Behavioral: Cognitive tests<br /><b>Sponsor</b>:    Centre Hospitalier Universitaire de Saint Etienne<br /><b>Not yet recruiting</b>
Placenta Accreta Spectrum Disorder Conservative Managment Versus Hysterectomy Prospective Analysis,http://classic.clinicaltrials.gov/ct2/show/NCT06105034?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Placenta Accreta<br /><b>Intervention</b>:    Procedure: interventional techniques, the severity of placental invasion, and various placental positions and suture techniques<br /><b>Sponsor</b>:    Nourhan Elsadany<br /><b>Completed</b>"
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor,http://classic.clinicaltrials.gov/ct2/show/NCT06105021?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Pancreatic Ductal Adenocarcinoma;   Non-Small Cell Lung Cancer;   Colorectal Cancer;   Solid Tumor;   KRAS G12V<br /><b>Intervention</b>:    Drug: AFNT-211<br /><b>Sponsor</b>:    Affini-T Therapeutics, Inc.<br /><b>Not yet recruiting</b>"
"Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer",http://classic.clinicaltrials.gov/ct2/show/NCT06105008?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Breast Neoplasms<br /><b>Interventions</b>:    Drug: Disitamab Vedotin;   Drug: Toripalimab<br /><b>Sponsor</b>:    RemeGen Co., Ltd.<br /><b>Not yet recruiting</b>"
Back Beliefs Among the General Population,http://classic.clinicaltrials.gov/ct2/show/NCT06104995?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Low Back Pain<br /><b>Interventions</b>:    Other: Interventional video;   Other: Control video<br /><b>Sponsors</b>:    Bern University of Applied Sciences;   Haute Ecole de Santé Vaud<br /><b>Not yet recruiting</b>
"The Effect of Superimposed Electrical Stimulation on Sitting Balance, Respiratory Functions, and Abdominal Muscle Thickness in Complete Spinal Cord Injury",http://classic.clinicaltrials.gov/ct2/show/NCT06104982?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Spinal Cord Injury Thoracic<br /><b>Interventions</b>:    Device: NeuroTrac MyoPlus Pro single-channel electromyography biofeedback electrotherapy devices;   Other: Isometric strengthening exercises<br /><b>Sponsor</b>:    Ankara City Hospital Bilkent<br /><b>Completed</b>
DFC 004 Biomarkers for Active Diabetic Foot Ulcers,http://classic.clinicaltrials.gov/ct2/show/NCT06104969?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Diabetic Foot Ulcer;   Diabetic Foot;   Diabetes<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    University of Michigan;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br /><b>Recruiting</b>
Weaning Protocol for High-flow Nasal Oxygen Therapy in Intensive Care,http://classic.clinicaltrials.gov/ct2/show/NCT06104956?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Acute Hypoxemic Respiratory Failure;   High-flow Nasal Oxygen Therapy<br /><b>Interventions</b>:    Drug: HFNO weaning protocol;   Drug: Standard of care<br /><b>Sponsor</b>:    University Hospital, Tours<br /><b>Not yet recruiting</b>"
Stockholm hyperTRIglyceridemia REGister (STRIREG) Study,http://classic.clinicaltrials.gov/ct2/show/NCT06104943?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Familial Hypertriglyceridemia<br /><b>Interventions</b>:    Other: Heredity for cardiovascular disease;   Other: Heredity for pancreatitis;   Other: Heredity for type 2 diabetes;   Other: Heredity for hypertriglyceridemia<br /><b>Sponsor</b>:    Region Stockholm<br /><b>Active, not recruiting</b>"
Plasma Extracellular Vesicles in Meningioma Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06104930?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Meningioma<br /><b>Intervention</b>:    Other: Explorative biomarker study<br /><b>Sponsor</b>:    University Hospital Heidelberg<br /><b>Not yet recruiting</b>
Effect of Maolactin on Gastrointestinal Tract (GIT) Health,http://classic.clinicaltrials.gov/ct2/show/NCT06104917?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Gastrointestinal Dysfunction<br /><b>Interventions</b>:    Drug: High Dose Maolactin;   Drug: Low Dose Maolactin;   Drug: Maltodextrin<br /><b>Sponsor</b>:    RDC Clinical Pty Ltd<br /><b>Not yet recruiting</b>
Managing Anxiety in Pediatric Primary Care (MAPP),http://classic.clinicaltrials.gov/ct2/show/NCT06104904?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Anxiety;   Anxiety Disorders<br /><b>Intervention</b>:    Behavioral: MAPP<br /><b>Sponsors</b>:    UConn Health;   National Institutes of Health (NIH);   National Institute of Mental Health (NIMH)<br /><b>Recruiting</b>
Radicle Recharge: A Study of Health and Wellness Products on Energy Levels and Other Health Outcomes,http://classic.clinicaltrials.gov/ct2/show/NCT06104891?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Energy;   Fatigue<br /><b>Interventions</b>:    Dietary Supplement: Recharge Placebo Control 1;   Dietary Supplement: Recharge Active Study Product 1;   Dietary Supplement: Recharge Active Study Product 2;   Dietary Supplement: Recharge Active Study Product 3<br /><b>Sponsor</b>:    Radicle Science<br /><b>Not yet recruiting</b>
A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone,http://classic.clinicaltrials.gov/ct2/show/NCT06104878?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hodgkin Lymphoma<br /><b>Intervention</b>:    Other: No Intervention<br /><b>Sponsor</b>:    Takeda<br /><b>Not yet recruiting</b>
Tinnitus Sound Therapy Using Mobile Application.,http://classic.clinicaltrials.gov/ct2/show/NCT06104865?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Sount Therapy for Tinnitus Using Mobile Phone Aplication<br /><b>Intervention</b>:    Behavioral: Tinnitus Sound Therapy using (Resound Tinnitus relief) mobile application<br /><b>Sponsors</b>:    Dr. Basel Samman;   Primary Health Care Corporation, Qatar<br /><b>Not yet recruiting</b>"
Triage Survey for Neurology Research Eligibility,http://classic.clinicaltrials.gov/ct2/show/NCT06104852?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Alzheimer Disease<br /><b>Interventions</b>:    Other: Survey;   Other: Optional Medication Washout<br /><b>Sponsor</b>:    Adams Clinical<br /><b>Recruiting</b>
Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata,http://classic.clinicaltrials.gov/ct2/show/NCT06104839?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Alopecia Areata<br /><b>Interventions</b>:    Drug: NXC736;   Drug: Placebo<br /><b>Sponsor</b>:    NEXTGEN Bioscience<br /><b>Not yet recruiting</b>
Health-Related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on Emicizumab,http://classic.clinicaltrials.gov/ct2/show/NCT06104826?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Hemophilia A<br /><b>Intervention</b>:    Drug: Emicizumab<br /><b>Sponsors</b>:    Newark Beth Israel Medical Center;   Genentech, Inc.<br /><b>Not yet recruiting</b>"
Evaluation of Deaf Men's Knowledge About Sexual Health,http://classic.clinicaltrials.gov/ct2/show/NCT06104813?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Deafness;   Sexual Satisfaction;   Sexually Transmitted Diseases;   Sexual Violence;   Educational Problems<br /><b>Intervention</b>:    Other: Interviews<br /><b>Sponsor</b>:    Central Hospital, Nancy, France<br /><b>Completed</b>"
Effect of Weight Loss on Hepcidin Levels and Iron Status in Subjects With Obesity.,http://classic.clinicaltrials.gov/ct2/show/NCT06104800?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Obesity;   Iron Deficiency Anemia<br /><b>Interventions</b>:    Other: Calorie-restricted diet with red meat;   Other: Calorie-restricted diet without red meat<br /><b>Sponsor</b>:    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran<br /><b>Not yet recruiting</b>
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome,http://classic.clinicaltrials.gov/ct2/show/NCT06104787?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Interstitial Cystitis;   Painful Bladder Syndrome (PBS)<br /><b>Interventions</b>:    Drug: Clarix Flo;   Drug: Placebo<br /><b>Sponsor</b>:    Case Western Reserve University<br /><b>Not yet recruiting</b>
The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06104774?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Thoracic Neoplasms<br /><b>Intervention</b>:    Behavioral: Tai Chi Exercise<br /><b>Sponsor</b>:    China Medical University Hospital<br /><b>Not yet recruiting</b>
The Effect of Instrument- Assisted Soft Tissue Mobilization on Upper Crossed Syndrome,http://classic.clinicaltrials.gov/ct2/show/NCT06104761?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Upper Cross Syndrome<br /><b>Interventions</b>:    Other: Release group;   Other: strength exercises and stretching for upper crossed syndrome<br /><b>Sponsor</b>:    Cairo University<br /><b>Not yet recruiting</b>
A Cohort of Severe Placental Fetal Growth Restriction (CoSFGR),http://classic.clinicaltrials.gov/ct2/show/NCT06104748?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Fetal Growth Restriction<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Shanghai First Maternity and Infant Hospital<br /><b>Recruiting</b>
Finding the Best Combination of Brain and Spinal Cord Stimulation With Hand Training After Spinal Cord Injury,http://classic.clinicaltrials.gov/ct2/show/NCT06104735?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Spinal Cord Injuries<br /><b>Interventions</b>:    Procedure: Synaptic Pairing Interval;   Procedure: Frequency;   Procedure: Bouts;   Procedure: Spacing;   Procedure: Exercise;   Procedure: SCAP plus Exercise<br /><b>Sponsors</b>:    Bronx VA Medical Center;   Bronx Veterans Medical Research Foundation, Inc;   New York State Department of Health<br /><b>Not yet recruiting</b>"
Comparison of the Effect of Copenhagen Adduction Exercises Performed at Different Load-intensity,http://classic.clinicaltrials.gov/ct2/show/NCT06104722?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Groin Injury<br /><b>Interventions</b>:    Other: High-intensity Copenhagen adduction exercise;   Other: Low-intensity Copenhagen adduction exercise<br /><b>Sponsor</b>:    Hacettepe University<br /><b>Not yet recruiting</b>
Local and Peripheral Immune Responsive Landscape Induced by Local Cryoablation in Patients With Lung Adenocarcinoma,http://classic.clinicaltrials.gov/ct2/show/NCT06104709?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Lung Adenocarcinoma;   Local Cryoablation<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    China-Japan Friendship Hospital<br /><b>Not yet recruiting</b>
Comprehensive Geriatric Assessment in Kidney Transplantation,http://classic.clinicaltrials.gov/ct2/show/NCT06104696?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Kidney Transplant; Complications;   Frailty Syndrome;   Depressive Syndrome<br /><b>Intervention</b>:    Procedure: Functional geriatric assessment<br /><b>Sponsor</b>:    Institute for Clinical and Experimental Medicine<br /><b>Recruiting</b>
A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis,http://classic.clinicaltrials.gov/ct2/show/NCT06104683?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Relapsing Multiple Sclerosis;   Multiple Sclerosis<br /><b>Interventions</b>:    Drug: Placebo;   Drug: Pirtobrutinib<br /><b>Sponsors</b>:    Loxo Oncology, Inc.;   Eli Lilly and Company<br /><b>Not yet recruiting</b>"
The Effect of Synaquell™ in Contact Sport Athletes,http://classic.clinicaltrials.gov/ct2/show/NCT06104670?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Dietary Supplement: Synaquell(TM);   Dietary Supplement: Placebo<br /><b>Sponsors</b>:    Mayo Clinic;   Sanford Health<br /><b>Not yet recruiting</b>
Qualitative Techniques to Define Meaningful Within-Patient Change in Symptoms of Advanced Cancer Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06104657?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Hematopoietic and Lymphoid System Neoplasm;   Malignant Solid Neoplasm<br /><b>Intervention</b>:    Other: Non-Interventional Study<br /><b>Sponsor</b>:    Mayo Clinic<br /><b>Recruiting</b>
A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany (DELPHIN),http://classic.clinicaltrials.gov/ct2/show/NCT06104644?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Plaque Psoriasis<br /><b>Intervention</b>:    Drug: Deucravacitinib<br /><b>Sponsor</b>:    Bristol-Myers Squibb<br /><b>Recruiting</b>
A Prospective Trial in Patients With Crohn's Disease in Remission and Having Irritable Bowel Syndrome-like Symptoms,http://classic.clinicaltrials.gov/ct2/show/NCT06104631?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Irritable Bowel Syndrome-like Symptoms;   Crohn Disease Remission<br /><b>Interventions</b>:    Other: BK003;   Other: Placebo<br /><b>Sponsor</b>:    Biokuris s.a.<br /><b>Not yet recruiting</b>
Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis,http://classic.clinicaltrials.gov/ct2/show/NCT06104618?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Metastatic Penile Squamous Cell Carcinoma;   Stage III Penile Cancer AJCC v8;   Stage IV Penile Cancer AJCC v8;   Unresectable Penile Squamous Cell Carcinoma<br /><b>Intervention</b>:    Drug: Enfortumab Vedotin<br /><b>Sponsor</b>:    Mayo Clinic<br /><b>Not yet recruiting</b>
Improving Access to Chiropractic Care in Community Health Centers,http://classic.clinicaltrials.gov/ct2/show/NCT06104605?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Lower Back Pain<br /><b>Interventions</b>:    Other: Institutional interventions;   Other: PCPs interventions;   Other: Patient interventions<br /><b>Sponsors</b>:    Boston Medical Center;   National Center for Complementary and Integrative Health (NCCIH)<br /><b>Not yet recruiting</b>
Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL,http://classic.clinicaltrials.gov/ct2/show/NCT06104592?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Large B-cell Lymphoma;   Relapsed Non-Hodgkin Lymphoma<br /><b>Interventions</b>:    Radiation: Comprehensive Ablative Bridging Irradiation (CABI);   Biological: Chimeric Antigen Receptor T-Cell Therapy<br /><b>Sponsors</b>:    H. Lee Moffitt Cancer Center and Research Institute;   Kite, A Gilead Company<br /><b>Recruiting</b>"
Concordance Between Monitoring Systems for Organ/Space Surgical Site Infections in Rectal Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06104579?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Rectal Cancer;   Organ-Space Surgical Site Infection<br /><b>Intervention</b>:    Other: Person-level linkage of both databases looking for concordance in the diagnosis of organ-space surgical site infection<br /><b>Sponsor</b>:    Hospital de Granollers<br /><b>Completed</b>
Global Trial in APG2575 for Patients With CLL/SLL,http://classic.clinicaltrials.gov/ct2/show/NCT06104566?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    CLL/SLL<br /><b>Interventions</b>:    Drug: lisaftoclax +BTK inhibitor;   Drug: BTK inhibitor<br /><b>Sponsor</b>:    Ascentage Pharma Group Inc.<br /><b>Not yet recruiting</b>
A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma,http://classic.clinicaltrials.gov/ct2/show/NCT06104553?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    B-cell Non-Hodgkin's Lymphoma<br /><b>Intervention</b>:    Drug: SHR-A1912; R-Chemo<br /><b>Sponsor</b>:    Shanghai Hengrui Pharmaceutical Co., Ltd.<br /><b>Not yet recruiting</b>"
Comparison of the Effects of Liquid Vaseline and Olive Oil on Itching and Scarring in Scald Burns,http://classic.clinicaltrials.gov/ct2/show/NCT06104540?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Scald Burn;   Itching;   Hypertrophic Scarring<br /><b>Intervention</b>:    Other: extra virgin olive oil groups and liquid vaseline groups and control groups<br /><b>Sponsor</b>:    Ankara Yildirim Beyazıt University<br /><b>Not yet recruiting</b>
Indicator Amino Acid Oxidation in ICU Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06104527?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Critical Illness;   Muscle Wasting<br /><b>Interventions</b>:    Combination Product: Standard protein enteral nutrition with enteral tracer;   Combination Product: High protein enteral nutrition with enteral tracer<br /><b>Sponsors</b>:    Maastricht University;   Maastricht University Medical Center<br /><b>Not yet recruiting</b>
Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids,http://classic.clinicaltrials.gov/ct2/show/NCT06104514?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Rhytides;   Wrinkle<br /><b>Intervention</b>:    Device: Sofwave<br /><b>Sponsor</b>:    Sofwave Medical LTD<br /><b>Enrolling by invitation</b>
Validation of the Blood Pressure Monitoring Function,http://classic.clinicaltrials.gov/ct2/show/NCT06104501?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Blood Pressure<br /><b>Intervention</b>:    Device: RadiHeart<br /><b>Sponsors</b>:    RadiRad Co., Ltd.;   Hualien Tzu Chi General Hospital<br /><b>Not yet recruiting</b>"
A Study of Avutometinib for People With Solid Tumor Cancers,http://classic.clinicaltrials.gov/ct2/show/NCT06104488?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Refractory Cancer;   CNS Tumors;   CNS Tumor, Adult;   CNS Tumor, Childhood;   MAP Kinase Family Gene Mutation;   NF1;   Plexiform Neurofibroma;   Low-grade Glioma;   Optic Pathway Gliomas;   Neuroblastoma;   Primary Brain Tumor;   Solid Tumor;   Solid Tumor, Adult;   Solid Carcinoma;   Central Nervous System Tumor<br /><b>Intervention</b>:    Drug: Avutometinib<br /><b>Sponsor</b>:    Memorial Sloan Kettering Cancer Center<br /><b>Recruiting</b>"
Diagnostic Performance of Chest Computed Tomography Scan in Patients Aged 65 and Over Presenting to Emergency Room With Acute Dyspnea,http://classic.clinicaltrials.gov/ct2/show/NCT06104475?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Dyspnea<br /><b>Intervention</b>:    Other: CT scan<br /><b>Sponsor</b>:    Assistance Publique - Hôpitaux de Paris<br /><b>Not yet recruiting</b>
Exploring the Cortical Hemodynamic Variability of Prefrontal iTBS: a Concurrent TBS/fNIRS Study,http://classic.clinicaltrials.gov/ct2/show/NCT06104462?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Intervention</b>:    Device: Intermittent theta burst stimulation (iTBS)<br /><b>Sponsor</b>:    The Hong Kong Polytechnic University<br /><b>Not yet recruiting</b>
A Study of MK-5684 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005),http://classic.clinicaltrials.gov/ct2/show/NCT06104449?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Prostatic Neoplasms;   Metastatic Castration-Resistant Prostate Cancer<br /><b>Interventions</b>:    Drug: MK-5684;   Drug: Dexamethasone;   Drug: Fludrocortisone acetate;   Drug: Hydrocortisone<br /><b>Sponsor</b>:    Merck Sharp & Dohme LLC<br /><b>Not yet recruiting</b>
Individualized Music Playlist Based on ISO Principle for De-escalation of Agitation in Dementia,http://classic.clinicaltrials.gov/ct2/show/NCT06104436?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Dementia<br /><b>Interventions</b>:    Behavioral: Individualized music playlist;   Behavioral: Preferred music;   Behavioral: Usual care<br /><b>Sponsor</b>:    The Hong Kong Polytechnic University<br /><b>Not yet recruiting</b>
"Open-label, Multicenter, multinAtionaL, inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients",http://classic.clinicaltrials.gov/ct2/show/NCT06104423?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hypertension<br /><b>Interventions</b>:    Drug: Nebivolol 5 mg;   Drug: Ramipril 2.5/5/10 mg<br /><b>Sponsor</b>:    Menarini International Operations Luxembourg SA<br /><b>Recruiting</b>
Optimization of Fractionation Schedules of Heel Spur Radiotherapy Prospective Randomized Open-label Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06104410?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Heel Spur<br /><b>Interventions</b>:    Radiation: Standard fractioned dose;   Radiation: Experimental single dose<br /><b>Sponsor</b>:    Masaryk Memorial Cancer Institute<br /><b>Recruiting</b>
Exercise Strategies in Parkinson's Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06104397?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Parkinson Disease<br /><b>Interventions</b>:    Other: Written exercise guidance by neurologist;   Other: Physical therapy<br /><b>Sponsors</b>:    Shirley Ryan AbilityLab;   University of Chicago;   Northwestern Lake Forest Hospital;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)<br /><b>Not yet recruiting</b>
Characteristics of Injury Claims by Chronic Pain Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06104384?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Social Functioning;   Chronic Pain;   Injuries;   Disabilities Multiple<br /><b>Intervention</b>:    Behavioral: Behavioral and supportive therapy<br /><b>Sponsor</b>:    Salem Anaesthesia Pain Clinic<br /><b>Recruiting</b>
Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy,http://classic.clinicaltrials.gov/ct2/show/NCT06104371?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Breast Cancer<br /><b>Intervention</b>:    Device: Magtrace<br /><b>Sponsors</b>:    Sahlgrenska University Hospital, Sweden;   Uppsala University;   Region Västmanland;   University Hospital, Linkoeping;   Baylor College of Medicine;   The University of Hong Kong-Shenzhen Hospital;   Royal Marsden NHS Foundation Trust;   University of Athens;   University College Dublin<br /><b>Not yet recruiting</b>"
"Ph 2a Study of the Effects of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes",http://classic.clinicaltrials.gov/ct2/show/NCT06104358?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Diabete Type 2;   Obesity<br /><b>Intervention</b>:    Drug: HU6<br /><b>Sponsor</b>:    Rivus Pharmaceuticals, Inc.<br /><b>Not yet recruiting</b>"
Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines,http://classic.clinicaltrials.gov/ct2/show/NCT06104345?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Vaccine-Preventable Diseases;   Typhoid Fever;   Cholera<br /><b>Interventions</b>:    Biological: Oral typhoid fever vaccine;   Biological: Oral cholera vaccine<br /><b>Sponsors</b>:    Helsinki University Central Hospital;   University of Helsinki<br /><b>Recruiting</b>
"PMCF to Assess Real-life Usage Effectiveness, Safety and Patient Satisfaction of a Range of Hypertonic Seawater-based Decongestant Nasal Sprays",http://classic.clinicaltrials.gov/ct2/show/NCT06104332?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Allergic Rhinitis;   URTI<br /><b>Interventions</b>:    Device: ProRhinel Naturel spray nasal/ Allergic rhinitis;   Device: ProRhinel EXTRA Eucalyptus spray nasal;   Device: RESPIMER Enfant;   Device: Phytosun Aroms spray nasal MAX;   Device: PHYSIOMER RHUME TRIPLE ACTION;   Device: Phytosun Aroms spray nasal decongestionnant;   Device: ProRhinel Naturel spray nasal/ URTI<br /><b>Sponsors</b>:    Laboratoire de la Mer;   Slb Pharma<br /><b>Not yet recruiting</b>
Dose Exploration Study of GSK4532990 in Participants With NASH or Suspected NASH,http://classic.clinicaltrials.gov/ct2/show/NCT06104319?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Non-alcoholic Fatty Liver Disease<br /><b>Intervention</b>:    Drug: GSK4532990<br /><b>Sponsor</b>:    GlaxoSmithKline<br /><b>Not yet recruiting</b>
Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER),http://classic.clinicaltrials.gov/ct2/show/NCT06104306?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    HIV-1-infection<br /><b>Intervention</b>:    Drug: B/F/TAF<br /><b>Sponsor</b>:    Gilead Sciences<br /><b>Not yet recruiting</b>
Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber,http://classic.clinicaltrials.gov/ct2/show/NCT06104293?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Allergic Rhinitis Due to Grass Pollen<br /><b>Intervention</b>:    Other: Grass Pollen Allergen Exposure<br /><b>Sponsor</b>:    Alyatec<br /><b>Completed</b>
"Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment",http://classic.clinicaltrials.gov/ct2/show/NCT06104280?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Opioid Use Disorder;   Sleep Disturbance<br /><b>Interventions</b>:    Other: Post-Illumination Pupillary Response (PIPR);   Other: Polysomnography;   Other: Multiple Sleep Latency Test<br /><b>Sponsors</b>:    University of Alabama at Birmingham;   National Institute on Drug Abuse (NIDA)<br /><b>Not yet recruiting</b>
Medical Tai Chi Exercise Healing in Treating mCRC Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06104267?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Colorectal Cancer<br /><b>Intervention</b>:    Behavioral: 7-Form of Medical Tai Chi Exercise Healing for Colon cancer patients<br /><b>Sponsors</b>:    The First Affiliated Hospital with Nanjing Medical University;   SIR RUNRUN Hospital<br /><b>Recruiting</b>
Determining the Effect of Preoperative Education on Orthopedic Surgery Patients on Pain Beliefs and Pain-Related Care Needs in the Postoperative Period,http://classic.clinicaltrials.gov/ct2/show/NCT06104254?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Orthopedic Disorder;   Post Operative Pain<br /><b>Intervention</b>:    Other: education<br /><b>Sponsor</b>:    Duzce University<br /><b>Not yet recruiting</b>
BGT007 Cells for the Treatment of Refractory Digestive System Tumors,http://classic.clinicaltrials.gov/ct2/show/NCT06104241?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Gastrointestinal Cancer<br /><b>Intervention</b>:    Biological: BGT007 Injection<br /><b>Sponsors</b>:    The Affiliated Hospital of Xuzhou Medical University;   Guangzhou Bioresette Biomedical Technology Co., Ltd.<br /><b>Recruiting</b>"
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH),http://classic.clinicaltrials.gov/ct2/show/NCT06104228?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Arterial Hypertension;   Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder);   Connective Tissue Diseases<br /><b>Intervention</b>:    Drug: 129Xe Hyperpolarized<br /><b>Sponsors</b>:    Bastiaan Driehuys;   American Heart Association<br /><b>Not yet recruiting</b>
BGT007H Cells for the Treatment of Refractory Digestive System Tumors,http://classic.clinicaltrials.gov/ct2/show/NCT06104215?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Digestive Tract Cancer<br /><b>Intervention</b>:    Biological: BGT007H Injection<br /><b>Sponsors</b>:    The Affiliated Hospital of Xuzhou Medical University;   Guangzhou Bioresette Biomedical Technology Co., Ltd.<br /><b>Recruiting</b>"
Early Maladaptive Schemas in French Health Care Professionals With Burn Out,http://classic.clinicaltrials.gov/ct2/show/NCT06104202?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Burn Out<br /><b>Intervention</b>:    Other: Early Maladaptive Schemas<br /><b>Sponsor</b>:    GCS Ramsay Santé pour l'Enseignement et la Recherche<br /><b>Not yet recruiting</b>
Prospective Ultrafast MRI Radiomics for Breast Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06104189?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Breast Cancer<br /><b>Intervention</b>:    Diagnostic Test: MRI<br /><b>Sponsor</b>:    Korea University Ansan Hospital<br /><b>Completed</b>
Effectiveness of Virtual Reality Therapy in Alcohol Use Disorder Study,http://classic.clinicaltrials.gov/ct2/show/NCT06104176?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Alcool Use Disorder<br /><b>Interventions</b>:    Behavioral: CBT in group;   Other: Virtual reality exposure;   Behavioral: individual CBT<br /><b>Sponsor</b>:    Assistance Publique - Hôpitaux de Paris<br /><b>Not yet recruiting</b>
"Impact of Cantilever Design on Clinical, Radiographic, and Volumetric Parameters: a Retrospective Study",http://classic.clinicaltrials.gov/ct2/show/NCT06104163?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Partial Edentulism<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    University of Catania<br /><b>Completed</b>
Erythrocyte Transport of Lactate During Exercise (TELE Project),http://classic.clinicaltrials.gov/ct2/show/NCT06104150?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Energy Metabolism<br /><b>Intervention</b>:    Other: Intervallic submaximal exercise test<br /><b>Sponsor</b>:    Technical University of Madrid<br /><b>Recruiting</b>
MOOC Applications Related to Shared Decision Making in Bariatric Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06104137?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Bariatric Surgery Candidate;   Shared Decision Making;   Informed Consent<br /><b>Interventions</b>:    Other: course (MOOC) patient education;   Other: standard patient consent process<br /><b>Sponsor</b>:    South Tyneside and Sunderland NHS Foundation Trust<br /><b>Not yet recruiting</b>
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity,http://classic.clinicaltrials.gov/ct2/show/NCT06104124?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sjogren's Syndrome<br /><b>Interventions</b>:    Drug: Dazodalibep;   Drug: Placebo<br /><b>Sponsor</b>:    Horizon Therapeutics Ireland DAC<br /><b>Not yet recruiting</b>
Epigenetic Memory of Vitamin D Supplementation,http://classic.clinicaltrials.gov/ct2/show/NCT06104111?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Immune System Diseases;   Infections;   Healthy Lifestyle<br /><b>Intervention</b>:    Dietary Supplement: Vitamin D3<br /><b>Sponsor</b>:    Polish Academy of Sciences<br /><b>Recruiting</b>
A User Study With Vernivia® for Bacterial Vaginosis.,http://classic.clinicaltrials.gov/ct2/show/NCT06104098?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Bacterial Vaginoses<br /><b>Intervention</b>:    Device: D005 vaginal mousse<br /><b>Sponsors</b>:    Pharmiva AB;   Key2Compliance;   Replior AB<br /><b>Completed</b>
99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06104085?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Breast Cancer<br /><b>Intervention</b>:    Diagnostic Test: 99mTc-MY6349 SPECT/CT scan<br /><b>Sponsor</b>:    Peking Union Medical College Hospital<br /><b>Recruiting</b>
Effect of Adding Computerized Cognitive Training on Balance and Gait in Parkinson's Disease (Follow-up Study),http://classic.clinicaltrials.gov/ct2/show/NCT06104072?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Parkinson Disease<br /><b>Interventions</b>:    Device: REHACOM Software;   Other: Designed Physical Therapy Program<br /><b>Sponsor</b>:    Engy Badreldin Saleh Moustafa, PhD<br /><b>Recruiting</b>"
NOL Guided Analgesia During Elective Laparoscopic Surgery Under General Anesthesia,http://classic.clinicaltrials.gov/ct2/show/NCT06104059?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Intraoperative Analgesia<br /><b>Interventions</b>:    Device: Nociception level index (NOL™);   Other: Fentanyl<br /><b>Sponsor</b>:    Attikon Hospital<br /><b>Recruiting</b>
Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis,http://classic.clinicaltrials.gov/ct2/show/NCT06104046?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hepatitis C Virus<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06104033?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Coronary Artery Disease;   Multi Vessel Coronary Artery Disease<br /><b>Interventions</b>:    Device: drug-coated balloon;   Device: drug-eluting stent<br /><b>Sponsors</b>:    Bon-Kwon Koo;   Seoul National University Hospital;   St Vincent's Hospital;   Uijeongbu St. Mary Hospital;   Gachon University Gil Medical Center;   Gangnam Severance Hospital;   Kyunghee University Medical Center;   Keimyung University Dongsan Medical Center;   Inje University Ilsan Paik Hospital;   Daegu Catholic University Medical Center;   Bucheon Sejong Hospital;   Seoul National University Bundang Hospital;   Soonchunhyang University Hospital;   Yeungnam University Hospital;   Wonju Severance Christian Hospital;   Ulsan University Hospital;   Ewha Womans University Mokdong Hospital;   Inje University;   Chonnam National University Hospital;   Chung-Ang University Gwangmyeong Hospital;   Chung-Ang University Hosptial, Chung-Ang University College of Medicine;   Ulsan Medical Center;   Hanyang University Seoul Hospital;   Jeju National University Hospital;   KangWon National University Hospital;   Uijeongbu Eulji Medical Center, Eulji University;   Seoul St. Mary's Hospital;   Gyeongsang National University Hospital;   Severance Hospital;   Chosun University Hospital;   Kyungpook National University Hospital;   Korea University Anam Hospital;   Kyung Hee University Hospital at Gangdong;   Ajou University School of Medicine<br /><b>Recruiting</b>"
Lung Ultrasound-Guided Intraoperative Fluid Management Strategies,http://classic.clinicaltrials.gov/ct2/show/NCT06104020?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Shoulder Arthropathy Associated With Other Conditions<br /><b>Intervention</b>:    Other: Intraoperative fluid management stratigies.<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
"Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study",http://classic.clinicaltrials.gov/ct2/show/NCT06104007?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Coronary Artery Disease;   In-stent Restenosis<br /><b>Intervention</b>:    Device: Genoss® DCB<br /><b>Sponsor</b>:    Seoul National University Hospital<br /><b>Recruiting</b>
Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination,http://classic.clinicaltrials.gov/ct2/show/NCT06103994?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Influenza<br /><b>Interventions</b>:    Dietary Supplement: Multistrain probiotic;   Other: Placebo<br /><b>Sponsors</b>:    The Archer-Daniels-Midland Company;   NEXT CRO<br /><b>Not yet recruiting</b>
Acute Liver Injury in Patients With Pneumonia,http://classic.clinicaltrials.gov/ct2/show/NCT06103981?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Acute Liver Injury;   Pneumonia<br /><b>Intervention</b>:    Other: Acute Liver Injury<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Influence of Gastric Tube Presence in Upholding the Correct Placement of LMA Blockbuster,http://classic.clinicaltrials.gov/ct2/show/NCT06103968?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Anesthesia<br /><b>Intervention</b>:    Device: LMA BLOCKBUSTER<br /><b>Sponsor</b>:    Aligarh Muslim University<br /><b>Not yet recruiting</b>
OptiMuscle - Improving Respiration by Optimising Muscle Function,http://classic.clinicaltrials.gov/ct2/show/NCT06103955?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Dysfunctional Breathing;   Breathing Pattern Disorder<br /><b>Intervention</b>:    Behavioral: Digital Breathing Biofeedback system<br /><b>Sponsor</b>:    University of Salford<br /><b>Not yet recruiting</b>
Automated Carbon Dioxide Angiography in Fenestrated/Branched Endovascular Abdominal Aortic Aneurysm Repair,http://classic.clinicaltrials.gov/ct2/show/NCT06103942?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Thoracoabdominal Aortic Aneurysm<br /><b>Intervention</b>:    Diagnostic Test: CO2 angiography<br /><b>Sponsor</b>:    Uppsala University<br /><b>Not yet recruiting</b>
Adult Eating Disorder Assessment Study,http://classic.clinicaltrials.gov/ct2/show/NCT06103929?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Eating Disorders<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    University of Leicester;   Leicestershire Partnership NHS Trust, UK;   City, University of London;   National Centre for Social Research, London, UK;   University of London<br /><b>Not yet recruiting</b>"
Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice,http://classic.clinicaltrials.gov/ct2/show/NCT06103916?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Ovarian Tumor;   Ovarian Cancer<br /><b>Intervention</b>:    Other: Observational study. Prospective registration of ultrasound data in patients with ovarian tumors for which an ultrasound in according with the IOTA definitions is performed.<br /><b>Sponsors</b>:    Maxima Medical Center;   Radboud University Medical Center;   The Netherlands Cancer Institute;   Catharina Ziekenhuis Eindhoven;   ZonMw: The Netherlands Organisation for Health Research and Development<br /><b>Recruiting</b>
Measure of Acceptance of chRonic Visible sKin conditionS,http://classic.clinicaltrials.gov/ct2/show/NCT06103903?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Acceptance of Visible Chronic Dermatological Disease;   Disease Acceptance;   Psychological Well-Being;   Social Segregation<br /><b>Intervention</b>:    Behavioral: Questionnaire<br /><b>Sponsors</b>:    University Hospital, Tours;   INSERM UMR 1246 SPHERE<br /><b>Recruiting</b>"
Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma,http://classic.clinicaltrials.gov/ct2/show/NCT06103890?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Esophageal Squamous Cell Carcinoma<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Hebei Medical University Fourth Hospital;   Handan Central Hospital;   Xingtai People's Hospital<br /><b>Recruiting</b>
A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers,http://classic.clinicaltrials.gov/ct2/show/NCT06103877?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy Volunteers<br /><b>Interventions</b>:    Biological: AZD1163;   Other: Placebo<br /><b>Sponsors</b>:    AstraZeneca;   Parexel<br /><b>Not yet recruiting</b>
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06103864?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Breast Cancer<br /><b>Interventions</b>:    Drug: Dato-DXd;   Drug: Durvalumab;   Drug: Paclitaxel;   Drug: Nab-paclitaxel;   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Pembrolizumab<br /><b>Sponsors</b>:    AstraZeneca;   Daiichi Sankyo, Inc.<br /><b>Not yet recruiting</b>"
Effect of Mask Use on Jaw Functionality,http://classic.clinicaltrials.gov/ct2/show/NCT06103851?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Temporomandibular Joint Disorders<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Istanbul Medipol University Hospital<br /><b>Active, not recruiting</b>"
18F-Fluciclovine PET/CT in Multiple Myeloma,http://classic.clinicaltrials.gov/ct2/show/NCT06103838?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Multiple Myeloma;   Newly Diagnosed Multiple Myeloma (NDMM);   Relapsed and/or Refractory Multiple Myeloma (RRMM)<br /><b>Interventions</b>:    Drug: 18F-fluciclovine injection;   Procedure: 18F-FDG PET/CT<br /><b>Sponsor</b>:    National Cancer Institute (NCI)<br /><b>Not yet recruiting</b>
"A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients With Obstructive Sleep Apnea (OSA)",http://classic.clinicaltrials.gov/ct2/show/NCT06103825?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea<br /><b>Interventions</b>:    Drug: Solriamfetol;   Drug: Placebo<br /><b>Sponsor</b>:    Ignis Therapeutics (Suzhou) Limited<br /><b>Recruiting</b>
Evaluate Performance and Safety of Hyalo4 Skin in Acute and Chronic Wounds,http://classic.clinicaltrials.gov/ct2/show/NCT06103812?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Wound Heal<br /><b>Intervention</b>:    Device: Hyalo4 Skin Gel<br /><b>Sponsor</b>:    Fidia Farmaceutici s.p.a.<br /><b>Recruiting</b>
Application of Information-Motivation-Behavioral Model-based Continuity of Care on the Peri-implantitis Recovery in Diabetic Implant Overdenture Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06103799?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Bone Resorption;   Diabetes<br /><b>Intervention</b>:    Behavioral: IMB model-based continuity of care<br /><b>Sponsor</b>:    The Dental Hospital of Zhejiang University School of Medicine<br /><b>Completed</b>
"Effects of High-Intensity Interval Training on Physical Fitness, Skills, and Tactical Performance, 12 Weeks High-Intensity Interval Training",http://classic.clinicaltrials.gov/ct2/show/NCT06103786?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Power, Personal<br /><b>Interventions</b>:    Behavioral: Assigned Interventions;   Behavioral: Random Interventions<br /><b>Sponsor</b>:    Universiti Putra Malaysia<br /><b>Recruiting</b>"
A Study of Single and Multiple Oral Doses of TollB-001,http://classic.clinicaltrials.gov/ct2/show/NCT06103773?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Rheumatoid Arthritis<br /><b>Interventions</b>:    Drug: TollB-001 tablets;   Drug: TollB-001 placebo<br /><b>Sponsor</b>:    Toll Biotech Co. Ltd. (Beijing)<br /><b>Recruiting</b>
Positioning of Esketamine Treatment in the Real-world Management of Depression,http://classic.clinicaltrials.gov/ct2/show/NCT06103760?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Major Depressive Disorder<br /><b>Intervention</b>:    Drug: Esketamine Nasal Spray [Spravato]<br /><b>Sponsors</b>:    Royal North Shore Hospital;   Janssen-Cilag Pty Ltd<br /><b>Not yet recruiting</b>
Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet®,http://classic.clinicaltrials.gov/ct2/show/NCT06103747?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Fed Conditions<br /><b>Interventions</b>:    Drug: Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg);   Drug: Galvumet® Film Coated Tablets (850 mg / 50 mg)<br /><b>Sponsors</b>:    Reseach Laboratory of Clinical and Experimental Pharmacology;   Société Arabe des Industries Pharmaceutiques SAIPH - Tunisia;   Centre National Chalbi Belkahia de Pharmacovigilance CNPV - Tunisia<br /><b>Completed</b>
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants,http://classic.clinicaltrials.gov/ct2/show/NCT06103734?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Migraine<br /><b>Interventions</b>:    Combination Product: Zavegepant 10 mg;   Combination Product: Placebo - Control 1;   Combination Product: Placebo - Control 2<br /><b>Sponsor</b>:    Pfizer<br /><b>Not yet recruiting</b>
Role of Nebulized Dexmedetomidine in Blunting the Effects of Direct Laryngoscopy and Endotracheal Tube on Heart Rate and Blood Pressure.,http://classic.clinicaltrials.gov/ct2/show/NCT06103721?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hemodynamic Instability<br /><b>Interventions</b>:    Drug: Dexmedetomidine Injection [Precedex];   Drug: Normal Saline<br /><b>Sponsors</b>:    Muhammad Haroon Anwar;   Pakistan Institute of Medical Sciences<br /><b>Not yet recruiting</b>
"Quantitative Perfusion Imaging of the Lower Limb in Peripheral Arterial Disease Using Contrast Enhanced Perfusion Ultrasound, Arterial Spin Labelling Magnetic Resonance Imaging and Perfusion Angiography",http://classic.clinicaltrials.gov/ct2/show/NCT06103708?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Vascular Diseases<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    University College, London<br /><b>Recruiting</b>"
Vtama in Psoriasis Patients Being Treated With Biologics.,http://classic.clinicaltrials.gov/ct2/show/NCT06103695?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Psoriasis<br /><b>Intervention</b>:    Drug: Tapinarof<br /><b>Sponsor</b>:    Psoriasis Treatment Center of Central New Jersey<br /><b>Completed</b>
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE),http://classic.clinicaltrials.gov/ct2/show/NCT06103682?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Non-small Cell Lung Cancer;   Oligoprogressive;   Small-cell Lung Cancer<br /><b>Intervention</b>:    Device: Ablative local therapy<br /><b>Sponsors</b>:    University of California, Davis;   National Cancer Institute (NCI)<br /><b>Recruiting</b>"
Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS),http://classic.clinicaltrials.gov/ct2/show/NCT06103669?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Breast Cancer;   Oligoprogressive;   Head and Neck Cancer;   Sarcoma;   Other Cancer<br /><b>Intervention</b>:    Device: Ablative local therapy<br /><b>Sponsors</b>:    University of California, Davis;   National Cancer Institute (NCI)<br /><b>Recruiting</b>"
"E-B-FAHF-2, Multi OIT and Xolair for Food Allergy",http://classic.clinicaltrials.gov/ct2/show/NCT06103656?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Food Allergy<br /><b>Interventions</b>:    Drug: Drug: Chinese Herbal Medication;   Drug: Drug: Placebo;   Drug: Drug: Omalizumab<br /><b>Sponsors</b>:    New York Medical College;   Icahn School of Medicine at Mount Sinai<br /><b>Completed</b>
Simulation Based Emergency Brex Birth Management Training,http://classic.clinicaltrials.gov/ct2/show/NCT06103643?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Birth<br /><b>Intervention</b>:    Other: Using High Reality Simulator<br /><b>Sponsor</b>:    Ondokuz Mayıs University<br /><b>Recruiting</b>
Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device,http://classic.clinicaltrials.gov/ct2/show/NCT06103630?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Obstructive Sleep Apnea of Adult<br /><b>Interventions</b>:    Other: Oropharyngeal Exercises;   Other: Mandibular advancement device<br /><b>Sponsor</b>:    National Cheng-Kung University Hospital<br /><b>Not yet recruiting</b>
Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06103617?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Head and Neck Cancer;   Recurrent Cancer<br /><b>Intervention</b>:    Drug: Penicillamine<br /><b>Sponsor</b>:    Nanfang Hospital, Southern Medical University<br /><b>Not yet recruiting</b>"
Tympanic Thermometers Accuracy,http://classic.clinicaltrials.gov/ct2/show/NCT06103604?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Fever<br /><b>Intervention</b>:    Diagnostic Test: latest generation tympanic thermometer<br /><b>Sponsor</b>:    Istituto Ortopedico Rizzoli<br /><b>Not yet recruiting</b>
Controlled Arterial Protection to Ultimately Remove Embolic Material,http://classic.clinicaltrials.gov/ct2/show/NCT06103591?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Aortic Valve Stenosis<br /><b>Intervention</b>:    Device: The EmStop Embolic Protection System (EmStop System)<br /><b>Sponsors</b>:    EmStop Inc;   Bright Research Partners<br /><b>Not yet recruiting</b>
"Evaluation of SOST, TWEAK, RANKL, OPG Levels in Smokers and Non-Smokers With Periodontitis",http://classic.clinicaltrials.gov/ct2/show/NCT06103578?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Periodontitis;   Smoking<br /><b>Intervention</b>:    Diagnostic Test: GCF and saliva analysis<br /><b>Sponsor</b>:    Gazi University<br /><b>Completed</b>
EHR Nudges to Improve Quality of Care in HF,http://classic.clinicaltrials.gov/ct2/show/NCT06103565?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Heart Failure With Reduced Ejection Fraction<br /><b>Intervention</b>:    Other: Clinical Decision Support Tool<br /><b>Sponsor</b>:    Northwestern University<br /><b>Not yet recruiting</b>
BLOOM Forward: Investigating Weight Loss Impact on TJAC Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06103552?sfpd_d=14&sel_rss=new14,"Fri, 27 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Obesity;   Knee Osteoarthritis;   Hip Osteoarthritis;   Arthroplasty Complications<br /><b>Intervention</b>:    Behavioral: Building Lifestyle Options for Orthopedic Mobility (BLOOM)<br /><b>Sponsors</b>:    Ottawa Hospital Research Institute;   LEAF Weight Loss Clinic;   The Ottawa Hospital<br /><b>Not yet recruiting</b>
Pacertool Early Feasibility Study - Safety and Performance,http://classic.clinicaltrials.gov/ct2/show/NCT06103539?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Heart Failure With Reduced Ejection Fraction;   Dyssynchrony;   Medical Device Performance<br /><b>Intervention</b>:    Device: Cardiac catheterization and evoked response to cardiac stimulation<br /><b>Sponsor</b>:    Pacertool AS<br /><b>Not yet recruiting</b>
Immunonutrition in ERAS Protocols in Gynecologic Oncology,http://classic.clinicaltrials.gov/ct2/show/NCT06103526?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Nutritional Deficiency;   Gynecologic Cancer;   ERAS<br /><b>Intervention</b>:    Dietary Supplement: Immunonutrition<br /><b>Sponsor</b>:    National and Kapodistrian University of Athens<br /><b>Recruiting</b>
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children,http://classic.clinicaltrials.gov/ct2/show/NCT06103513?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Growth Disorders;   Growth Failure;   Growth Hormone Treatment;   Growth<br /><b>Intervention</b>:    Drug: Somatropin<br /><b>Sponsor</b>:    Northwell Health<br /><b>Recruiting</b>
Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis,http://classic.clinicaltrials.gov/ct2/show/NCT06103500?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Sepsis;   Bacterial Infections;   Community-Acquired Infections;   Hospital Infection<br /><b>Intervention</b>:    Other: Clinical Decision Support Algorithm for Empiric Antibiotics in Sepsis<br /><b>Sponsors</b>:    Ottawa Hospital Research Institute;   Canadian Institutes of Health Research (CIHR)<br /><b>Not yet recruiting</b>
Long Term Follow-Up for RGX-111,http://classic.clinicaltrials.gov/ct2/show/NCT06103487?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Mucopolysaccharidosis I<br /><b>Intervention</b>:    Genetic: No Intervention<br /><b>Sponsor</b>:    REGENXBIO Inc.<br /><b>Enrolling by invitation</b>
Clinical Reporting to Alleviate the Nocebo Effect,http://classic.clinicaltrials.gov/ct2/show/NCT06103474?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Nocebo Effect<br /><b>Intervention</b>:    Diagnostic Test: Lumbar Magnetic Resonance Imaging (MRI)<br /><b>Sponsors</b>:    University of Alabama at Birmingham;   American Roentgen Ray Society<br /><b>Not yet recruiting</b>
Fat Grafting an Ideal Filler For Contour Deformities With Hyperpigmentation On Face,http://classic.clinicaltrials.gov/ct2/show/NCT06103461?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hyperpigmentation<br /><b>Intervention</b>:    Procedure: Autologous fat grafting<br /><b>Sponsor</b>:    King Edward Medical University<br /><b>Completed</b>
Prediction of the Risks of Cardiovascular Mortality,http://classic.clinicaltrials.gov/ct2/show/NCT06103448?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cardiovascular Diseases;   Cardiovascular Morbidity;   Stroke;   Embolism;   Cardiac Arrest<br /><b>Intervention</b>:    Device: Ankle-brachial index - system 100<br /><b>Sponsor</b>:    Jan Evangelista Purkyne University<br /><b>Not yet recruiting</b>
Multivisceral Resections for Locally Advanced Gastric Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06103435?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Gastric Cancer<br /><b>Intervention</b>:    Procedure: Extent od surgical resection<br /><b>Sponsor</b>:    Jagiellonian University<br /><b>Completed</b>
Change in Taste Sensation After Orthognathic Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06103422?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Orthognathic Surgery;   Altered Taste<br /><b>Interventions</b>:    Diagnostic Test: Whole mouth taste tests;   Diagnostic Test: Localized taste tests<br /><b>Sponsors</b>:    Yağmur Malkoc;   Istanbul Medipol University Hospital<br /><b>Completed</b>
MSCs for the Treatment of Burn Wounds,http://classic.clinicaltrials.gov/ct2/show/NCT06103409?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Burn Wound;   Second- or Third-degree Burn<br /><b>Intervention</b>:    Biological: Implantation of allogeneic MSCs on burn wounds<br /><b>Sponsors</b>:    Instituto Venezolano de Investigaciones Cientificas;   Unidad de Terapia Celular - IVIC;   Hospital Pediátrico Niño Jesús, San Felipe, Yaracuy;   Hospital Central Dr. Plácido D. Rodriguez Rivero, San Felipe, Yaracuy<br /><b>Enrolling by invitation</b>"
Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs),http://classic.clinicaltrials.gov/ct2/show/NCT06103396?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pseudoarthrosis of Bone;   Pseudarthrosis;   Non Union Fracture;   Nonunion Bone Fracture<br /><b>Interventions</b>:    Biological: Transplantation of autologous MSCs in nonunion fracture;   Biological: Transplantation of allogeneic MSCs in nonunion fracture<br /><b>Sponsors</b>:    Instituto Venezolano de Investigaciones Cientificas;   Hospital Central Dr. Plácido D. Rodriguez Rivero;   Instituto Autónomo Hospital Universitario de la Universidad de Los Andes<br /><b>Enrolling by invitation</b>
Second Phase of the Pilot Study for Obtaining Mature Oocytes by in Vitro Maturation in Oocyte-donor Women,http://classic.clinicaltrials.gov/ct2/show/NCT06103383?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Infertility, Female;   Oocyte Maturation<br /><b>Interventions</b>:    Drug: Controlled ovarian stimuation;   Procedure: Oocyte pick up;   Procedure: Oocyte in vitro maturation;   Procedure: Oocyte in vitro activation<br /><b>Sponsor</b>:    Instituto Valenciano de Infertilidad, IVI VALENCIA<br /><b>Recruiting</b>"
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation,http://classic.clinicaltrials.gov/ct2/show/NCT06103370?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    HIV Infections;   Substance Use Disorders;   Addiction;   Opioid Use;   Drug Use;   Intravenous Drug Usage<br /><b>Intervention</b>:    Behavioral: Peer-educator-based network<br /><b>Sponsors</b>:    Johns Hopkins University;   National Institute on Drug Abuse (NIDA);   Maryland Department of Health and Mental Hygiene<br /><b>Not yet recruiting</b>
Identification of Innovative Circulating and Cellular Biomarkers in Subjects With Acute and Chronic Coronary Syndrome: the PLAQUE Study,http://classic.clinicaltrials.gov/ct2/show/NCT06103357?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Coronary Syndrome<br /><b>Intervention</b>:    Other: blood sample collection<br /><b>Sponsors</b>:    Istituto Nazionale di Ricovero e Cura per Anziani;   Ministry of Health, Italy<br /><b>Recruiting</b>"
The Effect of 4-7-8 Breathing Exercise Training on Sleep Quality,http://classic.clinicaltrials.gov/ct2/show/NCT06103344?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Nursing Students<br /><b>Intervention</b>:    Behavioral: 4-7-8 Breathing Exercise Training<br /><b>Sponsor</b>:    Uğur Doğan<br /><b>Not yet recruiting</b>
Fungal Surveillance in Bangladesh,http://classic.clinicaltrials.gov/ct2/show/NCT06103331?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Invasive Fungal Infections<br /><b>Intervention</b>:    Other: Invasive Fungal disease surveillance<br /><b>Sponsors</b>:    International Centre for Diarrhoeal Disease Research, Bangladesh;   Centers for Disease Control and Prevention;   Institute of Epidemiology, Disease Control and Research<br /><b>Recruiting</b>"
eHealth Interventions for Breast Cancer Cognitive Impairment,http://classic.clinicaltrials.gov/ct2/show/NCT06103318?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Breast Cancer;   Cognitive Dysfunction<br /><b>Intervention</b>:    Behavioral: ICOgnition<br /><b>Sponsors</b>:    Institut Català d'Oncologia;   Institut d'Investigació Biomèdica de Bellvitge;   Carlos III Health Institute<br /><b>Not yet recruiting</b>
Risk Stratifications for Patients With Palpitations,http://classic.clinicaltrials.gov/ct2/show/NCT06103305?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Arrhythmias, Cardiac<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>"
Calcium Levels in Major Trauma,http://classic.clinicaltrials.gov/ct2/show/NCT06103292?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Major Trauma<br /><b>Intervention</b>:    Diagnostic Test: ionized calcium levels<br /><b>Sponsor</b>:    Hossam Abdel Rahman Ahmed Ismail<br /><b>Not yet recruiting</b>
Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin,http://classic.clinicaltrials.gov/ct2/show/NCT06103279?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cancer<br /><b>Intervention</b>:    Drug: Empagliflozin 10 MG<br /><b>Sponsor</b>:    Ain Shams University<br /><b>Not yet recruiting</b>
Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention,http://classic.clinicaltrials.gov/ct2/show/NCT06103266?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Atrial Fibrillation;   Coronary Artery Disease<br /><b>Intervention</b>:    Drug: Rivaroxaban<br /><b>Sponsor</b>:    J.P.S Henriques<br /><b>Not yet recruiting</b>
Effect of Probiotic on the Gut Microbiota of Healthy Volunteers,http://classic.clinicaltrials.gov/ct2/show/NCT06103253?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Healthy Adults<br /><b>Intervention</b>:    Dietary Supplement: a Bla80 group<br /><b>Sponsor</b>:    Wecare Probiotics Co., Ltd.<br /><b>Completed</b>"
A Probiotic That Improve Intestinal Flora,http://classic.clinicaltrials.gov/ct2/show/NCT06103240?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Intestinal Flora<br /><b>Intervention</b>:    Other: Lacticaseibacillus rhamnosus LRa05<br /><b>Sponsor</b>:    Wecare Probiotics Co., Ltd.<br /><b>Completed</b>"
The Effect of Low Doses of Intermediate Acting Corticosteroids on the Prolongation of Pregnancy in Threatened Preterm Birth,http://classic.clinicaltrials.gov/ct2/show/NCT06103227?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Preterm Birth<br /><b>Intervention</b>:    Drug: Prednisone 5Mg<br /><b>Sponsor</b>:    University of Mostar<br /><b>Not yet recruiting</b>
The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06103214?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ovarian Neoplasm Epithelial<br /><b>Interventions</b>:    Other: acute normovolemic hemodilution (ANH);   Other: acute hypervolemic hemodilution (AHH)<br /><b>Sponsor</b>:    Zhejiang Cancer Hospital<br /><b>Completed</b>
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury,http://classic.clinicaltrials.gov/ct2/show/NCT06103201?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Traumatic Brain Injury;   Subarachnoid Hemorrhage<br /><b>Intervention</b>:    Drug: Hyperpolarized 13C-Pyruvate<br /><b>Sponsor</b>:    University of Maryland, Baltimore<br /><b>Not yet recruiting</b>"
"Comparing the Effect of Melatonin, Diazepam, and Placebo on Decreasing the Level of Anxiety Preoperatively",http://classic.clinicaltrials.gov/ct2/show/NCT06103188?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Anxiety;   Preoperative Anxiety<br /><b>Interventions</b>:    Drug: Placebo;   Drug: Diazepam;   Drug: Melatonin<br /><b>Sponsor</b>:    University of Jordan<br /><b>Completed</b>
Observational and Prospective Study of Hepatic Steatosis and Related Risk Factors Using Ultrasound and Artificial Intelligence,http://classic.clinicaltrials.gov/ct2/show/NCT06103175?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Steatotic Liver Disease;   Artificial Intelligence;   Ultrasound<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    University of Bari;   Eurisko Technology srl;   Centro Radiologico Lucano<br /><b>Active, not recruiting</b>"
Comparison of Different Feeding Appliances for Cleft Palate Babies,http://classic.clinicaltrials.gov/ct2/show/NCT06103162?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cleft Palate<br /><b>Intervention</b>:    Device: flexible feeding plate<br /><b>Sponsor</b>:    Tanta University<br /><b>Completed</b>
The Role of Cognitive Flexibility in Mindfulness Intervention: a Functional Near-infrared Spectroscopy Study,http://classic.clinicaltrials.gov/ct2/show/NCT06103149?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Emotional Distress<br /><b>Intervention</b>:    Behavioral: Mindfulness Intervention for Emotional Distress(MIED)<br /><b>Sponsor</b>:    Xinghua Liu<br /><b>Not yet recruiting</b>
Maestro 1.0 Post-Market Registry,http://classic.clinicaltrials.gov/ct2/show/NCT06103136?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Surgery<br /><b>Intervention</b>:    Device: Laparoscopic surgery using the Maestro Platform<br /><b>Sponsor</b>:    Moon Surgical<br /><b>Recruiting</b>
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study,http://classic.clinicaltrials.gov/ct2/show/NCT06103123?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Myocarditis;   Myocarditis Acute;   Pericarditis;   Pericarditis Acute<br /><b>Interventions</b>:    Diagnostic Test: Stand of care ECG, Holter, MRI, ECHO, Quality of life questionnaire;   Other: Baseline Quality of Life questionnaire<br /><b>Sponsor</b>:    Cardiology Research UBC<br /><b>Recruiting</b>"
Effect of Order and Conjugation of Different Photobiomodulation Therapies and Anterior Repositioning Appliance in Management of TMD Cases,http://classic.clinicaltrials.gov/ct2/show/NCT06103110?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    TMJ Disorder<br /><b>Intervention</b>:    Device: Photobiomodulation<br /><b>Sponsor</b>:    Mansoura University<br /><b>Completed</b>
Histologic Evolution of Patients With Liver Transplantation,http://classic.clinicaltrials.gov/ct2/show/NCT06103097?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Liver Transplant Failure and Rejection;   Children, Only<br /><b>Intervention</b>:    Other: No interventions done (obervational)<br /><b>Sponsors</b>:    Hospital Vall d'Hebron;   Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition<br /><b>Recruiting</b>"
"Effectiveness of Local Food Solutions for the Prevention of Acute Malnutrition in Tigray, Northern Ethiopia (ELOFSAM)",http://classic.clinicaltrials.gov/ct2/show/NCT06103084?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Acute Malnutrition in Childhood<br /><b>Interventions</b>:    Dietary Supplement: Bahgina;   Dietary Supplement: SQLNS<br /><b>Sponsors</b>:    Mekelle University;   Tigray Development Association;   Mums for Mums;   Tigray Health Research Institute;   Tigray Health Bureau;   UNICEF Tigray Office<br /><b>Recruiting</b>
Role of Membrane Sweeping on Initiation of Labor and Vaginal Birth in Previous Cesarean Section,http://classic.clinicaltrials.gov/ct2/show/NCT06103071?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Vaginal Birth After Cesarean Section<br /><b>Intervention</b>:    Procedure: Sweeping of membranes<br /><b>Sponsor</b>:    HITEC-Institute of Medical Sciences<br /><b>Recruiting</b>
The Prevalence of Fibromyalgia in Adults at Al-Karak Jordan a Cross-sectional Study,http://classic.clinicaltrials.gov/ct2/show/NCT06103058?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Fibromyalgia;   Orthopedic Disorder<br /><b>Intervention</b>:    Other: Cross sectional<br /><b>Sponsor</b>:    Mutah University<br /><b>Recruiting</b>
The Effects of Unilateral and Bilateral Mirror Therapy on Upper Extremity Function of Stroke at Acute Stage.,http://classic.clinicaltrials.gov/ct2/show/NCT06103045?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Stroke, Acute<br /><b>Intervention</b>:    Other: unilateral and bilateral mirror therapy<br /><b>Sponsor</b>:    National Taiwan University Hospital Hsin-Chu Branch<br /><b>Recruiting</b>"
Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC,http://classic.clinicaltrials.gov/ct2/show/NCT06103032?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Breast Cancer<br /><b>Interventions</b>:    Procedure: Breast Conserving Surgery;   Procedure: Mastectomy<br /><b>Sponsor</b>:    Peking Union Medical College Hospital<br /><b>Completed</b>
Comparison of Patient Satisfaction and Chewing Efficiency Between Conventional and 3D Printed Complete Dentures.,http://classic.clinicaltrials.gov/ct2/show/NCT06103019?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Patient Satisfaction<br /><b>Interventions</b>:    Other: conventional complete denture;   Other: 3D complete denture<br /><b>Sponsor</b>:    Fatma mahanna<br /><b>Completed</b>
Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy,http://classic.clinicaltrials.gov/ct2/show/NCT06103006?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Duchenne Muscular Dystrophy<br /><b>Intervention</b>:    Other: Telerehabilitation<br /><b>Sponsor</b>:    Lokman Hekim Üniversitesi<br /><b>Completed</b>
"Ferroptosis in Patients With COPD COPD With/Without Risk of Cardiovascular Events. Pathophysiological Implications, Diagnostics and Prognoses. FerrEPOC Study.",http://classic.clinicaltrials.gov/ct2/show/NCT06102993?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    COPD Exacerbation<br /><b>Intervention</b>:    Other: Non-interventional study<br /><b>Sponsor</b>:    Hospital Universitario Marqués de Valdecilla<br /><b>Recruiting</b>
Endoscopic Ultrasound Shear Wave vs Transient Elastography for Liver Steatosis: The RUMIPAMBA Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06102980?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Liver Steatosis<br /><b>Interventions</b>:    Device: Transparietal ultrasound (US)-based shear wave elastography (SWE);   Device: Vibration-controlled transient elastography (VCTE);   Device: Endoscopic ultrasound (EUS)-guided shear wave elastography (SWE)<br /><b>Sponsor</b>:    Instituto Ecuatoriano de Enfermedades Digestivas<br /><b>Not yet recruiting</b>
EEG Characteristics and Postoperative Delirium,http://classic.clinicaltrials.gov/ct2/show/NCT06102967?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Postoperative Delirium;   Cognitive Function Abnormal;   PSI;   Frailty<br /><b>Intervention</b>:    Behavioral: delirium<br /><b>Sponsor</b>:    Zhuo Liu<br /><b>Not yet recruiting</b>
A Multi-domain and Multi-component Falls Intervention Program for Community- Dwelling Older Adults: SAFE-TECH,http://classic.clinicaltrials.gov/ct2/show/NCT06102954?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Fall Prevention;   Fall Injury<br /><b>Intervention</b>:    Other: Falls prevention intervention including exercise and educational components<br /><b>Sponsor</b>:    Duke-NUS Graduate Medical School<br /><b>Not yet recruiting</b>
Cognitive Control Targets for the Treatment of Obsessive Compulsive Disorder in Young Children,http://classic.clinicaltrials.gov/ct2/show/NCT06102941?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Obsessive-Compulsive Disorder in Children<br /><b>Intervention</b>:    Device: Cognitive Control Training (CT)<br /><b>Sponsors</b>:    Columbia University;   New York State Psychiatric Institute;   National Institute of Mental Health (NIMH)<br /><b>Not yet recruiting</b>
A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation,http://classic.clinicaltrials.gov/ct2/show/NCT06102928?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor<br /><b>Intervention</b>:    Drug: Combined therapy of anlotinib and aumolertinib<br /><b>Sponsor</b>:    Kunming Medical University<br /><b>Recruiting</b>
Rocuronium vs Cis-atracurium: Do Rocuronium Still 'ROCKS' In Coronary Artery Bypass Grafting - A Retrospective Cohort Study,http://classic.clinicaltrials.gov/ct2/show/NCT06102915?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Neuromuscular Blockade;   Postoperative Pulmonary Atelectasis;   Postoperative Pulmonary Complication;   Coronary Artery Disease;   Coronary Artery Bypass Grafting;   Hypothermic Cardiopulmonary Bypass<br /><b>Interventions</b>:    Drug: Rocuronium Bromide 10 MG/ML;   Drug: Nimbex 10 MG in 5 ML Injection<br /><b>Sponsor</b>:    Institut Jantung Negara<br /><b>Recruiting</b>
"Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer",http://classic.clinicaltrials.gov/ct2/show/NCT06102902?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Metastatic Colorectal Adenocarcinoma;   Refractory Colorectal Adenocarcinoma;   Stage IV Colorectal Cancer AJCC v8<br /><b>Interventions</b>:    Drug: BET Bromodomain Inhibitor ZEN-3694;   Procedure: Biopsy;   Procedure: Biospecimen Collection;   Biological: Cetuximab;   Procedure: Computed Tomography;   Drug: Encorafenib;   Procedure: Magnetic Resonance Imaging<br /><b>Sponsor</b>:    National Cancer Institute (NCI)<br /><b>Not yet recruiting</b>
GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES,http://classic.clinicaltrials.gov/ct2/show/NCT06102889?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pancreatic Adenocarcinoma<br /><b>Intervention</b>:    Diagnostic Test: liquid biopsy<br /><b>Sponsors</b>:    Karolinska University Hospital;   Universitätsklinikum Hamburg-Eppendorf;   Aarhus University Hospital;   Centre Hospitalier Universitaire de Nice;   Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III;   Medical University of Graz;   Centre Hospitalier Régional Universitaire Montpellier<br /><b>Enrolling by invitation</b>
Feasibility of Physical Activity in Older Adults With Haematological Malignancies: ACCES Study,http://classic.clinicaltrials.gov/ct2/show/NCT06102876?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Geriatric;   Haematologic Neoplasm<br /><b>Intervention</b>:    Other: Physical activity (PA) program<br /><b>Sponsor</b>:    University Hospital, Toulouse<br /><b>Not yet recruiting</b>"
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia,http://classic.clinicaltrials.gov/ct2/show/NCT06102863?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I<br /><b>Intervention</b>:    Drug: statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);<br /><b>Sponsor</b>:    Peking University People's Hospital<br /><b>Recruiting</b>
Adaptation of Critical Time Intervention for Young Adults With MH Challenges,http://classic.clinicaltrials.gov/ct2/show/NCT06102850?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Mental Disorder<br /><b>Intervention</b>:    Behavioral: Critical Time Intervention for Young Adults with Mental Health conditions<br /><b>Sponsor</b>:    University of Houston<br /><b>Recruiting</b>
Tumor Vaccines for Solid Tumors,http://classic.clinicaltrials.gov/ct2/show/NCT06102837?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Glioma;   Solid Tumor<br /><b>Interventions</b>:    Biological: tumor vaccine;   Radiation: Radiotherapy;   Drug: Chemotherapy;   Procedure: Surgery<br /><b>Sponsor</b>:    Huashan Hospital<br /><b>Recruiting</b>
Organoid-based Functional Precision Therapy for Advanced Breast Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06102824?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    HER2-negative Breast Cancer;   Advanced Breast Cancer<br /><b>Interventions</b>:    Drug: Organoid-guided treatment;   Drug: Taxane;   Drug: Capecitabine;   Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Eribulin<br /><b>Sponsors</b>:    Guangdong Provincial People's Hospital;   First Affiliated Hospital, Sun Yat-Sen University;   Sun Yat-sen University;   Shantou Central Hospital<br /><b>Not yet recruiting</b>"
Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty,http://classic.clinicaltrials.gov/ct2/show/NCT06102811?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Arthroplasty, Replacement, Hip<br /><b>Interventions</b>:    Other: Low Concentration Local Anesthetic Fascia Iliaca Compartment Block;   Other: High Concentration Local Anesthetic Fascia Iliaca Compartment Block<br /><b>Sponsor</b>:    University of Toronto<br /><b>Recruiting</b>"
Acupuncture for Lumbar Spinal Stenosis,http://classic.clinicaltrials.gov/ct2/show/NCT06102798?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Lumbar Spinal Stenosis<br /><b>Interventions</b>:    Device: Acunpuncture;   Device: Sham acupuncture<br /><b>Sponsor</b>:    Guang'anmen Hospital of China Academy of Chinese Medical Sciences<br /><b>Not yet recruiting</b>
Fruquintinib Combined With TAS102 for Advanced Gastric Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06102785?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Gastric Cancer<br /><b>Intervention</b>:    Drug: Fruquintinib, TAS102<br /><b>Sponsor</b>:    Tianjin Medical University Cancer Institute and Hospital<br /><b>Recruiting</b>"
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06102772?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Gastric Cancer<br /><b>Intervention</b>:    Drug: Adebrelimab，Fruquintinib<br /><b>Sponsor</b>:    Tianjin Medical University Cancer Institute and Hospital<br /><b>Recruiting</b>
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed,http://classic.clinicaltrials.gov/ct2/show/NCT06102759?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Gastric Cancer<br /><b>Intervention</b>:    Drug: Adebrelimab，Fruquintinib<br /><b>Sponsor</b>:    Tianjin Medical University Cancer Institute and Hospital<br /><b>Recruiting</b>
Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma,http://classic.clinicaltrials.gov/ct2/show/NCT06102746?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Gastric Neuroendocrine Carcinoma<br /><b>Intervention</b>:    Drug: Sintilimab，Surufatinib<br /><b>Sponsor</b>:    Tianjin Medical University Cancer Institute and Hospital<br /><b>Recruiting</b>
Chronic Pelvic Pain in Females and Males,http://classic.clinicaltrials.gov/ct2/show/NCT06102733?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pelvic Pain Syndrome;   Sacroiliac Disorder;   Piriformis Syndrome;   Sacrococcygeal Disorder;   Inguinal Hernia<br /><b>Intervention</b>:    Behavioral: Rehabilitation therapy<br /><b>Sponsor</b>:    Salem Anaesthesia Pain Clinic<br /><b>Recruiting</b>
"This Study is Two-center, Prospective, Randomized, Open-label, Controlled, Investigator-sponsored Study That Aims to Investigate the Efficacy of Low-dose Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Minor-to-moderate Ischemic Stroke During Hospitalization",http://classic.clinicaltrials.gov/ct2/show/NCT06102720?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ischemic Stroke<br /><b>Interventions</b>:    Drug: Colchicine;   Drug: Clopidogrel<br /><b>Sponsor</b>:    Mikhail Zykov<br /><b>Recruiting</b>
The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06102707?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ovarian Cancer Recurrent<br /><b>Intervention</b>:    Drug: Fluzopril Combined With Apatinib<br /><b>Sponsor</b>:    Qilu Hospital of Shandong University<br /><b>Not yet recruiting</b>
Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy,http://classic.clinicaltrials.gov/ct2/show/NCT06102694?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Thrombotic Microangiopathies;   Hematopoietic Stem Cell Transplantation<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Institute of Hematology & Blood Diseases Hospital, China<br /><b>Not yet recruiting</b>"
"Examination of the Effect of Early Mobilization on Postoperative Recovery, Pain, Quality of Life and Complication Development in Elective Minimally Invasive Spine Surgery",http://classic.clinicaltrials.gov/ct2/show/NCT06102681?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Spine Fusion;   Lumbar Disc Herniation;   Cervical Disc Disease<br /><b>Intervention</b>:    Other: intervention group<br /><b>Sponsor</b>:    Duzce University<br /><b>Not yet recruiting</b>
Survival and PN Dependence in SBS Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06102668?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Short Bowel Syndrome<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    The First Affiliated Hospital of University of Science and Technology of China;   Jinling Hospital, China<br /><b>Completed</b>"
Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics,http://classic.clinicaltrials.gov/ct2/show/NCT06102655?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Premature Ovarian Insufficiency;   Metabolomics;   Traditional Chinese Medicine;   Mechanism;   Clinical Syndrome<br /><b>Intervention</b>:    Drug: Jiajian Guishen Formulation<br /><b>Sponsor</b>:    Shi Yun<br /><b>Recruiting</b>
The Clinical Usage of a Free Gingival Graft Combined With Frenotomy in Patients With High Frenal Attachment,http://classic.clinicaltrials.gov/ct2/show/NCT06102642?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    High Frenum Attachment;   Free Gingival Graft<br /><b>Intervention</b>:    Biological: Combining free gingival graft with frenotomy procedure<br /><b>Sponsor</b>:    Cairo University<br /><b>Not yet recruiting</b>
Ovary Syndrome for Efficient Diagnosis and Targeted Therapy,http://classic.clinicaltrials.gov/ct2/show/NCT06102629?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Polycystic Ovary Syndrome<br /><b>Interventions</b>:    Procedure: laparoscopy / laparotomy;   Other: NO INTERVENTION<br /><b>Sponsor</b>:    Asian Institute of Gastroenterology, India<br /><b>Not yet recruiting</b>"
Osteocalcin Level in Gingival Clavicular Fluid During Canine Retraction in Periodontal Compromised Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06102616?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Osteocalsin Level in Periodontally Affected Tooth During Orthodontic Tooth Movement<br /><b>Intervention</b>:    Diagnostic Test: measure Osteocalcin level<br /><b>Sponsor</b>:    Faculty of Dental Medicine for Girls<br /><b>Completed</b>
Biobased Polyester Versus Synthetic Fiberglass Casts for Treating Stable Upper Limb Fractures in Children,http://classic.clinicaltrials.gov/ct2/show/NCT06102603?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Upper Limb Fracture<br /><b>Interventions</b>:    Other: the biobased polyester cast;   Other: the synthetic fiberglass cast<br /><b>Sponsor</b>:    Far Eastern Memorial Hospital<br /><b>Completed</b>
Oxygen Extraction-guided Transfusion,http://classic.clinicaltrials.gov/ct2/show/NCT06102590?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Blood Transfusion<br /><b>Interventions</b>:    Other: Individualized red blood cell transfusion strategy;   Other: European guidelines red blood cell transfusion strategy<br /><b>Sponsor</b>:    Università degli Studi di Ferrara<br /><b>Not yet recruiting</b>
Systemic Adverse Effects After Osteopathic Treatment and Vitamin C,http://classic.clinicaltrials.gov/ct2/show/NCT06102577?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Adverse Effects;   Ascorbic Acid;   Oxidative Stress<br /><b>Interventions</b>:    Dietary Supplement: 1gr. Vitamine C;   Other: 1gr Placebo;   Other: control group<br /><b>Sponsor</b>:    Centre Medicina Esportiva i Osteopatia, Spain<br /><b>Completed</b>"
GST-moms: Effects of Group-schematherapy on Mother-child Attachment Relations,http://classic.clinicaltrials.gov/ct2/show/NCT06102564?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cluster C Personality Disorder (Diagnosis);   Mother-Child Relations<br /><b>Intervention</b>:    Behavioral: Group schematherapy<br /><b>Sponsors</b>:    Maastricht University;   Psychologiepraktijk Esra<br /><b>Not yet recruiting</b>
A Retrospective Analysis of Incisional Hernia Repair's Postoperative Recurrence,http://classic.clinicaltrials.gov/ct2/show/NCT06102551?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Incisional Hernia;   Recurrent Hernia<br /><b>Intervention</b>:    Behavioral: Recurrence after surgery<br /><b>Sponsor</b>:    Fudan University<br /><b>Completed</b>
"""Hachi Barie"" Project - A Multidisciplinary Program to Accompany Severely Obese Teenagers in the Weight Loss Process for the Benefit of Their Recruitment Into the Israel Defense Forces",http://classic.clinicaltrials.gov/ct2/show/NCT06102538?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Morbid Obesity<br /><b>Intervention</b>:    Behavioral: # The importance of service in the IDF # Physical activity # Healthy nutrition # Psychological support<br /><b>Sponsor</b>:    Sheba Medical Center<br /><b>Recruiting</b>
"A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma",http://classic.clinicaltrials.gov/ct2/show/NCT06102525?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Glioblastoma<br /><b>Interventions</b>:    Drug: RZ-001;   Combination Product: VGCV<br /><b>Sponsor</b>:    Rznomics, Inc.<br /><b>Not yet recruiting</b>"
A Study of [14C]-LOXO-783 in Healthy Adult Participants,http://classic.clinicaltrials.gov/ct2/show/NCT06102512?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Drug: [¹⁴C]-LOXO-783;   Drug: LOXO-783<br /><b>Sponsors</b>:    Eli Lilly and Company;   Loxo Oncology, Inc.<br /><b>Not yet recruiting</b>"
Comparison of Pulse Oximetry (SpO2) With Different Oximeters and Arterial Saturation (SaO2): Oxygap2 Study,http://classic.clinicaltrials.gov/ct2/show/NCT06102499?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Respiratory Failure;   Hypoxemia;   Hyperoxemia<br /><b>Intervention</b>:    Device: SpO2 and SaO2 comparison<br /><b>Sponsor</b>:    Laval University<br /><b>Not yet recruiting</b>
MCI Speech in Noise,http://classic.clinicaltrials.gov/ct2/show/NCT06102486?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Mild Cognitive Impairment<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Dartmouth-Hitchcock Medical Center;   Dartmouth College<br /><b>Not yet recruiting</b>
Effect of an Educational Intervention About Front of Package Labeling in Children and Caregivers.,http://classic.clinicaltrials.gov/ct2/show/NCT06102473?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Overweight and Obesity;   Malnutrition, Child<br /><b>Intervention</b>:    Other: Nutritional education<br /><b>Sponsor</b>:    Diana Avila Montiel<br /><b>Not yet recruiting</b>"
Pre-sleep Macros on Sleep Quality and Recovery,http://classic.clinicaltrials.gov/ct2/show/NCT06102460?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sleep<br /><b>Interventions</b>:    Dietary Supplement: Casein protein;   Dietary Supplement: a-lactalbumin protein;   Dietary Supplement: Carbohydrate;   Dietary Supplement: Placebo<br /><b>Sponsors</b>:    Florida State University;   Milk Specialties Global<br /><b>Enrolling by invitation</b>
Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell Carcinoma,http://classic.clinicaltrials.gov/ct2/show/NCT06102447?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Head and Neck Squamous Cell Carcinoma (HNSCC)<br /><b>Intervention</b>:    Drug: Netopitam Palonosetron capsules and dexamethasone<br /><b>Sponsor</b>:    Sichuan Cancer Hospital and Research Institute<br /><b>Not yet recruiting</b>
Safety Profile of Psilocybin for Cocaine Use Disorder,http://classic.clinicaltrials.gov/ct2/show/NCT06102434?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Cocaine Use Disorder<br /><b>Intervention</b>:    Drug: Psilocybin<br /><b>Sponsor</b>:    University of California, Los Angeles<br /><b>Not yet recruiting</b>"
Evaluation of the Effectiveness of Extracorporeal Shockwave Therapy in Patients With Patellar Tendinopathy on Its Micromorphology,http://classic.clinicaltrials.gov/ct2/show/NCT06102421?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Patellar Tendinopathy<br /><b>Intervention</b>:    Device: BTL-6000 FSWT<br /><b>Sponsor</b>:    University Hospital, Motol<br /><b>Enrolling by invitation</b>"
Relevance and Efficiency of SecOnd Line Workup for Uveitis,http://classic.clinicaltrials.gov/ct2/show/NCT06102408?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Uveitis<br /><b>Intervention</b>:    Other: second line investigations for uveitis etiological workup<br /><b>Sponsor</b>:    Central Hospital, Nancy, France<br /><b>Not yet recruiting</b>"
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC,http://classic.clinicaltrials.gov/ct2/show/NCT06102395?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy;   Pembrolizumab<br /><b>Interventions</b>:    Drug: Pembrolizumab;   Drug: Cisplatin;   Drug: Carboplatin;   Drug: Nedaplatin;   Drug: Nab paclitaxel;   Drug: Docetaxel;   Drug: Liposomal paclitaxel;   Drug: Fluorouracil<br /><b>Sponsor</b>:    Beijing Tongren Hospital<br /><b>Recruiting</b>
The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section,http://classic.clinicaltrials.gov/ct2/show/NCT06102382?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cesarean Section;   Hypotension;   Norepinephrine<br /><b>Interventions</b>:    Drug: Norepinephrine (0.1);   Drug: Norepinephrine (0.075)<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06102369?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pulmonary Cancer;   Lung Cancer<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Indonesia University<br /><b>Enrolling by invitation</b>
Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy,http://classic.clinicaltrials.gov/ct2/show/NCT06102356?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Psoriasis<br /><b>Intervention</b>:    Other: Questionnaire<br /><b>Sponsor</b>:    Fondazione Policlinico Universitario Agostino Gemelli IRCCS<br /><b>Recruiting</b>
Safety and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER:Glass 1540nm Laser Module in the Treatment of Acne Scars.,http://classic.clinicaltrials.gov/ct2/show/NCT06102343?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Acne Scars - Mixed Atrophic and Hypertrophic<br /><b>Intervention</b>:    Device: Alma Harmony<br /><b>Sponsor</b>:    Alma Lasers<br /><b>Not yet recruiting</b>
Multicenter HomeVENT: Home Values and Experiences Navigation Track,http://classic.clinicaltrials.gov/ct2/show/NCT06102330?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pediatric ALL;   Respiratory Insufficiency;   Communication<br /><b>Intervention</b>:    Other: HomeVENT decision support tool<br /><b>Sponsors</b>:    Johns Hopkins University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)<br /><b>Not yet recruiting</b>
the Use of Smart Mobile Application in Mothers With Cerebral Palsy Children,http://classic.clinicaltrials.gov/ct2/show/NCT06102317?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cerebral Palsy<br /><b>Intervention</b>:    Other: nursing consultancy with smartphone support<br /><b>Sponsor</b>:    Dr. Behcet Uz Children's Hospital<br /><b>Not yet recruiting</b>
Myo-Electrical and Nerve Root Function Response to Focused Extracorpeal Shock Wave in Cervical Radiculopathy,http://classic.clinicaltrials.gov/ct2/show/NCT06102304?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cervical Radiculopathy<br /><b>Interventions</b>:    Device: Focused Extracorpeal Shock wave;   Device: Sham Extracorpeal shock wave<br /><b>Sponsor</b>:    Cairo University<br /><b>Recruiting</b>
Acupoint Application With Yanqing Zhitong Ointment for Chronic Non-specific Low Back Pain,http://classic.clinicaltrials.gov/ct2/show/NCT06102291?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Non-specific Low Back Pain<br /><b>Interventions</b>:    Other: Yanqing Zhitong Ointment Acupoint application;   Other: Acupuncture<br /><b>Sponsor</b>:    Shanghai University of Traditional Chinese Medicine<br /><b>Recruiting</b>
ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture,http://classic.clinicaltrials.gov/ct2/show/NCT06102278?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Peritoneal Metastasis<br /><b>Intervention</b>:    Other: Peritoneal Metastasis<br /><b>Sponsor</b>:    Chen Xiaoping<br /><b>Completed</b>
Effect Of Reusing the Operative Supplies On Cataract Surgery and Climate Change,http://classic.clinicaltrials.gov/ct2/show/NCT06102265?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ophthalmopathy<br /><b>Intervention</b>:    Procedure: sterilization<br /><b>Sponsor</b>:    Sohag University<br /><b>Recruiting</b>
Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as an Adjuvant Treatment in Endometrial Carcinoma,http://classic.clinicaltrials.gov/ct2/show/NCT06102252?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Endometrial Carcinoma<br /><b>Interventions</b>:    Drug: Paclitaxel/epirubcin/carboplatin;   Drug: Paclitaxel/carboplatin<br /><b>Sponsor</b>:    Sohag University<br /><b>Not yet recruiting</b>
New Diagnostic Markers In Dignosis Of Complicated Appendix,http://classic.clinicaltrials.gov/ct2/show/NCT06102239?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Complicated Appendicitis<br /><b>Intervention</b>:    Diagnostic Test: Bilirubin level sodium level c reactive protein level<br /><b>Sponsor</b>:    Sohag University<br /><b>Recruiting</b>
Deep Learning Algorithm for Detecting Obstructive Coronary Artery Disease Using Fundus Photographs,http://classic.clinicaltrials.gov/ct2/show/NCT06102226?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Coronary Artery Disease;   Artificial Heart Device User<br /><b>Intervention</b>:    Diagnostic Test: coronary artery imaging (coronary CTA or coronary angiography)<br /><b>Sponsor</b>:    Yong Zeng<br /><b>Recruiting</b>
Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation,http://classic.clinicaltrials.gov/ct2/show/NCT06102213?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hematologic Malignancy<br /><b>Intervention</b>:    Drug: B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)<br /><b>Sponsor</b>:    Prolacta Bioscience<br /><b>Recruiting</b>
An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder,http://classic.clinicaltrials.gov/ct2/show/NCT06102200?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Standard of Care;   Standard of Care + CBT4CBT;   Standard of Care + CBT4CBT + RC<br /><b>Interventions</b>:    Behavioral: CBT4CBT;   Behavioral: RC;   Behavioral: Sandard of care<br /><b>Sponsors</b>:    Prisma Health-Upstate;   Clemson University;   National Institute on Drug Abuse (NIDA)<br /><b>Recruiting</b>
Cohort Study in Fujian Province,http://classic.clinicaltrials.gov/ct2/show/NCT06102187?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Chronic Disease<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Fujian Provincial Hospital;   Center for Disease Control and Prevention, Fujian;   China National Center for Cardiovascular Diseases<br /><b>Recruiting</b>"
A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV,http://classic.clinicaltrials.gov/ct2/show/NCT06102174?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Respiratory Syncytial Virus Infections<br /><b>Interventions</b>:    Drug: Placebo;   Drug: Active<br /><b>Sponsor</b>:    Pfizer<br /><b>Not yet recruiting</b>
Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020),http://classic.clinicaltrials.gov/ct2/show/NCT06102161?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Lung Cancer;   Wedge Resection;   Ground-glass Opacity<br /><b>Intervention</b>:    Procedure: Wedge resection<br /><b>Sponsor</b>:    Fudan University<br /><b>Not yet recruiting</b>
The Effect Of Proprioceptive Neuromuscular Facilitation Techniqueson in Patients With Multiple Sclerosis,http://classic.clinicaltrials.gov/ct2/show/NCT06102148?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Other: PNF Group;   Other: Control Group<br /><b>Sponsor</b>:    Nilay Comuk Balci<br /><b>Completed</b>
Acceptability and Tolerance Study of Peptide Feed With Fibre,http://classic.clinicaltrials.gov/ct2/show/NCT06102135?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Dietary Exposure<br /><b>Intervention</b>:    Dietary Supplement: Peptamen 1.3 PHGG<br /><b>Sponsor</b>:    Société des Produits Nestlé (SPN)<br /><b>Recruiting</b>
Acceptability and Tolerance Study of Adult Tube Feed With Food With Food Derived Ingredients.,http://classic.clinicaltrials.gov/ct2/show/NCT06102122?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Dietary Exposure<br /><b>Intervention</b>:    Dietary Supplement: Compleat<br /><b>Sponsor</b>:    Société des Produits Nestlé (SPN)<br /><b>Enrolling by invitation</b>
Long-term Results of Two Surgical Methods for Scleral IOL Implantation and Fixation in Eyes Without Capsular Support: Yamane- Versus 4-flanged Technique,http://classic.clinicaltrials.gov/ct2/show/NCT06102109?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Lens Luxation;   IOL Subluxation;   IOL Opacification;   Aphakia - No Lens Capsule<br /><b>Interventions</b>:    Procedure: Pars plana vitrectomy;   Procedure: IOL explantation;   Procedure: Scleral IOL fixation Yamane Technique;   Procedure: Scleral IOL fixation ""4-flanged"" Technique<br /><b>Sponsor</b>:    Medical University of Vienna<br /><b>Recruiting</b>"
Culturally Adapted iCBT for Arabic-speaking Refugee and Migrant Youth With Common Mental Health Problems,http://classic.clinicaltrials.gov/ct2/show/NCT06102096?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Depressive Symptoms;   Anxiety;   Insomnia;   Grief;   Psychological Trauma;   Resilience;   Stress;   Marital Relationship;   Psychological Well-Being<br /><b>Intervention</b>:    Behavioral: Culturally Adapted iCBT<br /><b>Sponsors</b>:    Karolinska Institutet;   Linkoping University<br /><b>Not yet recruiting</b>
A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis,http://classic.clinicaltrials.gov/ct2/show/NCT06102083?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Idiopathic Pulmonary Fibrosis<br /><b>Intervention</b>:    Drug: TDI01 suspension<br /><b>Sponsor</b>:    Beijing Tide Pharmaceutical Co., Ltd<br /><b>Not yet recruiting</b>"
Genetic Susceptibility to Severe Infections,http://classic.clinicaltrials.gov/ct2/show/NCT06102070?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Infectious Disease<br /><b>Interventions</b>:    Other: Blood samples drawing;   Other: Skin biopsy<br /><b>Sponsor</b>:    Institut National de la Santé Et de la Recherche Médicale, France<br /><b>Not yet recruiting</b>"
PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC,http://classic.clinicaltrials.gov/ct2/show/NCT06102057?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Stage III Non-small Cell Lung Cancer;   Locally Advanced;   Unresectable<br /><b>Interventions</b>:    Radiation: standard Radiotherapy;   Drug: Chemotherapy;   Drug: Immunotherapy;   Radiation: Experimental Radiotherapy<br /><b>Sponsors</b>:    TheraOp;   AstraZeneca<br /><b>Not yet recruiting</b>
Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania,http://classic.clinicaltrials.gov/ct2/show/NCT06102044?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Neonatal Infection<br /><b>Interventions</b>:    Dietary Supplement: Zinc Supplements;   Dietary Supplement: Placebo Supplements<br /><b>Sponsors</b>:    Harvard School of Public Health (HSPH);   Muhimbili University of Health and Allied Sciences<br /><b>Not yet recruiting</b>
Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure,http://classic.clinicaltrials.gov/ct2/show/NCT06102031?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Heart Failure<br /><b>Interventions</b>:    Device: ReDS-Guided;   Other: Usual care<br /><b>Sponsor</b>:    Shanghai Zhongshan Hospital<br /><b>Not yet recruiting</b>
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine,http://classic.clinicaltrials.gov/ct2/show/NCT06102018?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Breast Neoplasm Female<br /><b>Intervention</b>:    Diagnostic Test: Collect blood and urine，pathological specimens if necessary<br /><b>Sponsor</b>:    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University<br /><b>Recruiting</b>
Dose Ranging Study of SAR443765 Compared With Placebo-control in Adult Participants With Moderate to Severe Asthma,http://classic.clinicaltrials.gov/ct2/show/NCT06102005?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Asthma<br /><b>Interventions</b>:    Drug: SAR443765;   Drug: Placebo<br /><b>Sponsor</b>:    Sanofi<br /><b>Recruiting</b>
Mesoglycan for Acute Hemorrhoidal Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06101992?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hemorrhoids<br /><b>Interventions</b>:    Drug: Mesoglycan;   Other: Placebo<br /><b>Sponsor</b>:    Societa Italiana di Chirurgia ColoRettale<br /><b>Not yet recruiting</b>
A Prospective Study of Fortiva in Hernia Repair,http://classic.clinicaltrials.gov/ct2/show/NCT06101979?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Ventral Hernia;   Incisional Hernia;   Abdominal Wall Reconstruction<br /><b>Intervention</b>:    Device: Fortiva Tissue Matrix<br /><b>Sponsor</b>:    RTI Surgical<br /><b>Enrolling by invitation</b>
A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy,http://classic.clinicaltrials.gov/ct2/show/NCT06101966?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cervical Cancer;   Radiotherapy;   Distant Metastasis;   Prognostic Model;   Risk Factor<br /><b>Intervention</b>:    Radiation: external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)<br /><b>Sponsor</b>:    Fujian Cancer Hospital<br /><b>Not yet recruiting</b>
The Impact of Coping Strategies on Interoception and Psychological Resilience in Response to Stress,http://classic.clinicaltrials.gov/ct2/show/NCT06101953?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Stress<br /><b>Intervention</b>:    Behavioral: Stress management<br /><b>Sponsor</b>:    Hacettepe University<br /><b>Completed</b>
A Multicenter Phenotype-Genotype Analysis of DM1 Patients in China,http://classic.clinicaltrials.gov/ct2/show/NCT06101940?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Myotonic Dystrophy 1<br /><b>Intervention</b>:    Diagnostic Test: Brain MRI scan<br /><b>Sponsor</b>:    Huashan Hospital<br /><b>Enrolling by invitation</b>
Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413,http://classic.clinicaltrials.gov/ct2/show/NCT06101927?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Prostate Cancer<br /><b>Intervention</b>:    Drug: Whole body study and SPECT with [99mTc]Tc-BQ0413<br /><b>Sponsors</b>:    Tomsk National Research Medical Center of the Russian Academy of Sciences;   Uppsala University<br /><b>Enrolling by invitation</b>
Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06101914?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Treatment Resistant Depression<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Power Life Sciences Inc.<br /><b>Not yet recruiting</b>
Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06101901?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Diabetic Kidney Disease<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Power Life Sciences Inc.<br /><b>Not yet recruiting</b>
Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR),http://classic.clinicaltrials.gov/ct2/show/NCT06101888?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Aortic Regurgitation<br /><b>Intervention</b>:    Device: TaurusTrio™ Heart Valve System<br /><b>Sponsor</b>:    Peijia Medical Technology (Suzhou) Co., Ltd.<br /><b>Recruiting</b>"
Health Coaching for Patients Waiting for Hip or Knee Replacements,http://classic.clinicaltrials.gov/ct2/show/NCT06101875?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Osteoarthritis, Hip;   Osteo Arthritis Knee<br /><b>Interventions</b>:    Other: Health Coach (Health coaching);   Other: Digital Toolkit (Control)<br /><b>Sponsors</b>:    Sheffield Hallam University;   Sheffield Teaching Hospitals NHS Foundation Trust<br /><b>Active, not recruiting</b>"
Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary Syndrome,http://classic.clinicaltrials.gov/ct2/show/NCT06101862?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Ischemic Heart Disease;   Non STEMI;   Angina Pectoris, Unstable<br /><b>Interventions</b>:    Procedure: CCTA;   Procedure: Conventional ICA;   Other: Team-based interventional triage<br /><b>Sponsors</b>:    Herlev and Gentofte Hospital;   Rigshospitalet, Denmark;   Zealand University Hospital;   North Zealand Hospital, Denmark;   Amager Hospital;   Bispebjerg Hospital;   Hvidovre University Hospital<br /><b>Not yet recruiting</b>"
Chronic Cancer Pain Management Program,http://classic.clinicaltrials.gov/ct2/show/NCT06101849?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Breast Cancer;   Cancer, Treatment-Related;   Pain Cancer<br /><b>Intervention</b>:    Behavioral: I-Can-Manage-Pain after cancer (Pain Management Program)<br /><b>Sponsors</b>:    Hamilton Health Sciences Corporation;   McMaster University<br /><b>Not yet recruiting</b>"
The Impact of Remote Training on Colonoscopy KPIs,http://classic.clinicaltrials.gov/ct2/show/NCT06101836?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Training;   Colonoscopy;   Colorectal Cancer<br /><b>Intervention</b>:    Other: Training intervention<br /><b>Sponsor</b>:    University Hospital, Ghent<br /><b>Completed</b>"
Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis,http://classic.clinicaltrials.gov/ct2/show/NCT06101823?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Atopic Dermatitis<br /><b>Interventions</b>:    Biological: OpSCF;   Biological: Placebo;   Biological: OpSCF (Open Label Extension)<br /><b>Sponsors</b>:    Opsidio, LLC;   Innovaderm Research Inc.<br /><b>Not yet recruiting</b>"
The Efficacy of Treatments to Improve Self-esteem,http://classic.clinicaltrials.gov/ct2/show/NCT06101810?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Self Esteem<br /><b>Interventions</b>:    Behavioral: COMET;   Behavioral: CBT<br /><b>Sponsor</b>:    GGZ Noord-Holland-Noord<br /><b>Not yet recruiting</b>
Remote and In-person Supervised Exercise in Patients With Knee Osteoarthritis,http://classic.clinicaltrials.gov/ct2/show/NCT06101797?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Knee Osteoarthritis<br /><b>Interventions</b>:    Other: Remote supervised exercise group;   Other: In-person supervised exercise group<br /><b>Sponsor</b>:    Federal University of Pelotas<br /><b>Not yet recruiting</b>
Single and Multiple Ascending Oral Doses of Avenanthramide,http://classic.clinicaltrials.gov/ct2/show/NCT06101784?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Inflammation<br /><b>Interventions</b>:    Drug: Avenanthramide;   Drug: Placebo<br /><b>Sponsors</b>:    Montreal Heart Institute;   Ceapro Inc.;   The Montreal Health Innovations Coordinating Center (MHICC)<br /><b>Not yet recruiting</b>
Assessment of Epicardial Fat Thickness in Children With Familial Dyslipidemia,http://classic.clinicaltrials.gov/ct2/show/NCT06101771?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Dyslipidemia<br /><b>Intervention</b>:    Diagnostic Test: echoCARDIOGRAPHY<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study,http://classic.clinicaltrials.gov/ct2/show/NCT06101758?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Liver Cirrhosis;   Non-Alcoholic Fatty Liver Disease;   Hepatocellular Carcinoma<br /><b>Interventions</b>:    Diagnostic Test: Handgrip strength test;   Diagnostic Test: total body Dual Energy X-Ray Absorptiometry (DXA);   Diagnostic Test: Muscle ultrasound<br /><b>Sponsor</b>:    Fondazione Policlinico Universitario Agostino Gemelli IRCCS<br /><b>Recruiting</b>
Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06101745?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Injury of Ureter During Surgery (Disorder)<br /><b>Interventions</b>:    Drug: Nizaracianine Triflutate;   Drug: Placebo Comparator<br /><b>Sponsors</b>:    Curadel Surgical Innovations, Inc.;   Leiden University Medical Center<br /><b>Not yet recruiting</b>"
LIMBO : Breast Reconstruction by Lipomodeling Alone or With Flap: Evaluation in Franche-Comté,http://classic.clinicaltrials.gov/ct2/show/NCT06101732?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Breast Cancer;   Surgery<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Centre Hospitalier Universitaire de Besancon<br /><b>Completed</b>
Use of a Water Soluble Contrast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction,http://classic.clinicaltrials.gov/ct2/show/NCT06101719?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Small Bowel Obstruction;   Contrast Media Adverse Reaction<br /><b>Intervention</b>:    Diagnostic Test: Enteral contrast challenge<br /><b>Sponsors</b>:    Children's Hospital Colorado;   Children's Hospital Los Angeles;   University of California, San Francisco;   Oregon Health and Science University;   Rady Children's Hospital, San Diego;   Phoenix Children's Hospital;   Primary Children's Hospital;   Children's Medical Center Dallas;   Seattle Children's Hospital<br /><b>Active, not recruiting</b>"
Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06101706?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Psoriatic Arthritis;   Psoriasis<br /><b>Interventions</b>:    Behavioral: Fatigue assessment;   Behavioral: Quality of life assessment;   Other: Assess severity of psoriatic arthritis;   Other: Assess severity of cutaneous psoriasis<br /><b>Sponsor</b>:    Centre Hospitalier Henri Duffaut - Avignon<br /><b>Not yet recruiting</b>
Biomarkers in Patients With Suspected HFpEF,http://classic.clinicaltrials.gov/ct2/show/NCT06101693?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Heart Failure;   Obesity;   Heart Failure With Preserved Ejection Fraction<br /><b>Intervention</b>:    Diagnostic Test: Plasma biomarker levels<br /><b>Sponsors</b>:    NHS Greater Glasgow and Clyde;   University of Glasgow;   Roche Diagnostics<br /><b>Not yet recruiting</b>
RhabdomYolyse in Intensive caRe,http://classic.clinicaltrials.gov/ct2/show/NCT06101680?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Rhabdomyolysis<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Central Hospital, Nancy, France<br /><b>Active, not recruiting</b>"
Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO),http://classic.clinicaltrials.gov/ct2/show/NCT06101667?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Acute Ischemic Stroke;   Basilar Artery Occlusion<br /><b>Interventions</b>:    Drug: Best medical management;   Procedure: Endovascular treatment<br /><b>Sponsor</b>:    Beijing Tiantan Hospital<br /><b>Recruiting</b>
Accuracy of Evie Ring Pulse Oximeter in Profound Hypoxia,http://classic.clinicaltrials.gov/ct2/show/NCT06101654?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Hypoxia<br /><b>Intervention</b>:    Device: Pulse oximeter<br /><b>Sponsors</b>:    Movano Health;   University of California, San Francisco<br /><b>Not yet recruiting</b>"
Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals,http://classic.clinicaltrials.gov/ct2/show/NCT06101641?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Healthy Individuals;   Shellac Nail Polish;   Oxygen Saturation;   Nursing;   Perioperative Care<br /><b>Intervention</b>:    Other: Shellac nail polish application<br /><b>Sponsors</b>:    Tarsus University;   Mersin University;   Necmettin Erbakan University;   Mustafa Kemal University<br /><b>Recruiting</b>
Effect of Gel Prosthetic Nail Application on Pulse Oximetry Measurements in Healthy Individuals,http://classic.clinicaltrials.gov/ct2/show/NCT06101628?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Healthy Individuals;   Gel Prosthetic Nail;   Oxygen Saturation;   Nursing;   Perioperative Care<br /><b>Intervention</b>:    Other: Gel prosthetic nail application<br /><b>Sponsors</b>:    Tarsus University;   Mersin University;   Necmettin Erbakan University;   Mustafa Kemal University<br /><b>Completed</b>
Effects of IASTM vs. Foam Rolling on Knee and Hip Range of Motion in Soccer Players,http://classic.clinicaltrials.gov/ct2/show/NCT06101615?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Muscle Tightness<br /><b>Interventions</b>:    Other: IASTM (FAT);   Other: Foam Rolling<br /><b>Sponsor</b>:    Riphah International University<br /><b>Recruiting</b>
Immediate Effect of Dynamic Stretching With and Without Floss Band on Flexibility of Hamstrings in Futsal Players,http://classic.clinicaltrials.gov/ct2/show/NCT06101602?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sports Physical Therapy<br /><b>Interventions</b>:    Other: Dynamic Stretching with Floss Band;   Other: Dynamic Stretching without Floss Band<br /><b>Sponsor</b>:    Riphah International University<br /><b>Completed</b>
Effect of Vitamin D Supplementation on Allostatic Load and Chronic Stress Along Line of Control in Azad Jammu Kashmir,http://classic.clinicaltrials.gov/ct2/show/NCT06101589?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Mental Health Issue<br /><b>Interventions</b>:    Dietary Supplement: 25 hydroxy cholecalciferol (Vitamin D) /25(OH)D3.;   Dietary Supplement: Placebo<br /><b>Sponsor</b>:    University of the Punjab<br /><b>Not yet recruiting</b>
Readmission Following Prostatic Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06101576?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    BPH With Urinary Obstruction<br /><b>Interventions</b>:    Procedure: TUIP;   Procedure: TURP;   Procedure: Prostate Vaporization;   Procedure: AEEP<br /><b>Sponsor</b>:    Mansoura University<br /><b>Recruiting</b>
Duration Between Drainage and Ureteroscopic Lithotripsy,http://classic.clinicaltrials.gov/ct2/show/NCT06101563?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Ureter Stone;   Renal Stone;   Ureteric Obstruction<br /><b>Interventions</b>:    Procedure: Early ureteroscopy;   Procedure: Delayed Ureteroscopy<br /><b>Sponsor</b>:    Mansoura University<br /><b>Recruiting</b>
Evaluation of Partial Versus Complete Pulpotomy in Carious Immature Young Permanent Teeth Using Bioceramic Material,http://classic.clinicaltrials.gov/ct2/show/NCT06101550?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Carious Teeth<br /><b>Interventions</b>:    Procedure: partial pulpotomy;   Procedure: Complete pulpotomy<br /><b>Sponsor</b>:    Cairo University<br /><b>Not yet recruiting</b>
Correlation Patterns of Brain Temperature-Pressure in Acute Brain Injury,http://classic.clinicaltrials.gov/ct2/show/NCT06101537?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Intracranial Pressure;   Brain Injuries, Traumatic;   Subarachnoid Hemorrhage;   Cerebral Hemorrhage<br /><b>Intervention</b>:    Device: Brain temperature-pressure monitoring<br /><b>Sponsor</b>:    Beijing Tiantan Hospital<br /><b>Not yet recruiting</b>"
Volumetric Changes in Free Gingival Graft Procedures Taken With Different Techniques,http://classic.clinicaltrials.gov/ct2/show/NCT06101524?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Ndirectly Measuring the Difference Between the Free Gingival Graft and the Free Gingival Unit Via a Scanner<br /><b>Intervention</b>:    Procedure: Free gingival unit, free gingival greft<br /><b>Sponsor</b>:    Eda Cetin Ozdemir<br /><b>Completed</b>"
Driving Pressure During General Anesthesia for Minimally Invasive Abdominal Surgery (GENERATOR),http://classic.clinicaltrials.gov/ct2/show/NCT06101511?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Postoperative Complications;   Surgery<br /><b>Intervention</b>:    Procedure: Intraoperative ventilation with individualized high PEEP titrated to the lowest ΔP with RMs<br /><b>Sponsors</b>:    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Onze Lieve Vrouwe Gasthuis;   HagaZiekenhuis;   Dijklander Ziekenhuis;   The Netherlands Cancer Institute;   Isala;   Maasstad Hospital;   Medisch Spectrum Twente;   University Medical Center Groningen;   Leiden University Medical Center;   Hospital Universitario La Fe;   Ospedale Policlinico San Martino;   University Hospital Carl Gustav Carus;   Medical University Innsbruck;   Spaarne Gasthuis;   Zaans Medical Center;   Alrijne Hospital;   Albert Schweitzer Hospital;   Maastricht University Medical Center;   Noordwest Ziekenhuisgroep<br /><b>Not yet recruiting</b>
Peroperative Fluid Management in Major Gynecological Cancer Surgeries,http://classic.clinicaltrials.gov/ct2/show/NCT06101498?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Fluid Overload;   Fluid Loss;   Perioperative/Postoperative Complications;   Acute Kidney Injury<br /><b>Intervention</b>:    Diagnostic Test: Akut kidnet injury(AKI)<br /><b>Sponsor</b>:    Bakirkoy Dr. Sadi Konuk Research and Training Hospital<br /><b>Completed</b>
Future Patient - Telerehabilitation of Patients With Atrial Fibrillation,http://classic.clinicaltrials.gov/ct2/show/NCT06101485?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Atrial Fibrillation<br /><b>Intervention</b>:    Device: Telerehabilitation<br /><b>Sponsors</b>:    Aalborg University;   Department of Cardiology, Viborg Regional Hospital;   Department of Cardiology, Silkeborg Regional Hospital;   Center for Innovative Medical Technologies (CIMT), Odense University Hospital;   Laboratory for Welfare Technology, Department of Health Science and Technology, Aalborg University<br /><b>Recruiting</b>"
Rotational Stability and Clinical Response of the ASQELIO Toric Biaspheric Monofocal Lens.,http://classic.clinicaltrials.gov/ct2/show/NCT06101472?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Cataract<br /><b>Intervention</b>:    Device: ASQELIO Toric Biaspheric Monofocal Lens<br /><b>Sponsor</b>:    AST Products, Inc.<br /><b>Not yet recruiting</b>"
"A Study About Association Between Microbiome, Metabolome and Clinical Characteristics in COPD Patients",http://classic.clinicaltrials.gov/ct2/show/NCT06101459?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Chronic Obstructive Pulmonary Disease<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Asan Medical Center;   Seoul National University College of Medicine;   HEM Pharma Inc.<br /><b>Not yet recruiting</b>
"Evaluation of the Effectiveness of Aromatherapy on Anxiety, Vital Signs, and Postoperative Complications in Lower Impacted Wisdom Tooth Surgery",http://classic.clinicaltrials.gov/ct2/show/NCT06101446?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Tooth, Impacted;   Dental Anxiety<br /><b>Intervention</b>:    Other: Lavander Aromatherapy<br /><b>Sponsor</b>:    Yuzuncu Yıl University<br /><b>Completed</b>"
The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A,http://classic.clinicaltrials.gov/ct2/show/NCT06101433?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    NAFLD<br /><b>Interventions</b>:    Dietary Supplement: Soy isoflavone;   Other: Placebo<br /><b>Sponsor</b>:    Ahvaz Jundishapur University of Medical Sciences<br /><b>Completed</b>
Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication,http://classic.clinicaltrials.gov/ct2/show/NCT06101420?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Helicobacter Pylori Eradication<br /><b>Intervention</b>:    Drug: Vonoprazan<br /><b>Sponsor</b>:    Ain Shams University<br /><b>Completed</b>
Univent Tube for Thoracoscopic Thymectomy in Myasthenic Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06101407?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Myasthenia Gravis<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Nguyen Dang Thu;   Hanoi Medical University<br /><b>Completed</b>
Development of a Fluorescent Visualization System for Non-visible Lung Cancer Nodules,http://classic.clinicaltrials.gov/ct2/show/NCT06101394?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Lung Cancer;   Video-assisted Thoracic Surgery;   EGFR;   Cetuximab<br /><b>Intervention</b>:    Drug: Cetuximab-IRDye800<br /><b>Sponsors</b>:    University of Turin, Italy;   Azienda Ospedaliera Città della Salute e della Scienza di Torino<br /><b>Not yet recruiting</b>"
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma,http://classic.clinicaltrials.gov/ct2/show/NCT06101381?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Leukemia, Acute Lymphoblastic;   Lymphoma, Non-Hodgkin<br /><b>Intervention</b>:    Biological: CART-19<br /><b>Sponsors</b>:    University of Sao Paulo;   Blood Center of Ribeirao Preto;   Hospital das Clínicas de Ribeirão Preto<br /><b>Not yet recruiting</b>"
Effect of Physical Activity on Neurogenesis in Peripheral Diabetic Neuropathy Type-II Diabetes,http://classic.clinicaltrials.gov/ct2/show/NCT06101368?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Type II Diabetes Mellitus With Neurological Manifestations<br /><b>Interventions</b>:    Behavioral: Phsical Activity;   Drug: Medication<br /><b>Sponsor</b>:    Health Education Research Foundation (HERF)<br /><b>Not yet recruiting</b>
Effectiveness of Telerehabilitation in Total Knee Arthroplasty,http://classic.clinicaltrials.gov/ct2/show/NCT06101355?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Knee Osteoarthritis;   Total Knee Arthroplasty<br /><b>Interventions</b>:    Other: Telerehabilitation;   Other: Standard Home Based Exercise Group<br /><b>Sponsors</b>:    Hacettepe University;   Ankara Medipol University<br /><b>Recruiting</b>
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN-103),http://classic.clinicaltrials.gov/ct2/show/NCT06101342?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pre-Exposure Prophylaxis of HIV Infection<br /><b>Interventions</b>:    Drug: Lenacapavir Injection;   Drug: Lenacapavir Tablet;   Drug: Emtricitabine/tenofovir disoproxil fumarate (F/TDF)<br /><b>Sponsors</b>:    Gilead Sciences;   HIV Prevention Trials Network;   National Institute on Drug Abuse (NIDA);   National Institute of Allergy and Infectious Diseases (NIAID)<br /><b>Not yet recruiting</b>
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN-102),http://classic.clinicaltrials.gov/ct2/show/NCT06101329?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pre-Exposure Prophylaxis of HIV Infection<br /><b>Interventions</b>:    Drug: Lenacapavir Tablet;   Drug: Lenacapavir Injection;   Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF)<br /><b>Sponsors</b>:    Gilead Sciences;   HIV Prevention Trials Network<br /><b>Not yet recruiting</b>
"A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China",http://classic.clinicaltrials.gov/ct2/show/NCT06101316?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Healthy Volunteers<br /><b>Intervention</b>:    Drug: CB06-036<br /><b>Sponsor</b>:    Shanghai Zhimeng Biopharma, Inc.<br /><b>Recruiting</b>"
Endometriosis Pain,http://classic.clinicaltrials.gov/ct2/show/NCT06101303?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Pelvic Pain;   Endometriosis<br /><b>Interventions</b>:    Other: Psychophysical assessment;   Behavioral: Psychophysical assessments of experimental pain;   Diagnostic Test: Blood, urine and saliva samples;   Procedure: Biopsy and surgery-related data.<br /><b>Sponsor</b>:    Washington University School of Medicine<br /><b>Recruiting</b>"
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER),http://classic.clinicaltrials.gov/ct2/show/NCT06101290?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Prostate Cancer;   Oligoprogressive;   Urothelial Carcinoma;   Renal Cell Carcinoma<br /><b>Intervention</b>:    Device: Ablative local therapy<br /><b>Sponsors</b>:    University of California, Davis;   National Cancer Institute (NCI)<br /><b>Recruiting</b>"
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG),http://classic.clinicaltrials.gov/ct2/show/NCT06101277?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Esophageal Cancer;   Small Bowel Cancer;   Gastroesophageal-junction Cancer;   Gastric Cancer;   Colorectal Cancer;   Appendiceal Cancer;   Biliary Cancer;   Gall Bladder Cancer;   Intrahepatic Cholangiocarcinoma;   Extrahepatic Cholangiocarcinoma;   Oligoprogressive<br /><b>Intervention</b>:    Device: Ablative local therapy<br /><b>Sponsors</b>:    University of California, Davis;   National Cancer Institute (NCI)<br /><b>Recruiting</b>"
Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population,http://classic.clinicaltrials.gov/ct2/show/NCT06101264?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Adolescent Idiopathic Scoliosis<br /><b>Intervention</b>:    Device: Virtual Reality Intervention<br /><b>Sponsors</b>:    Connecticut Children's Medical Center;   University of Connecticut<br /><b>Not yet recruiting</b>
A Randomized Field Trial of Smartphone-based Feedback to Encourage Safe Driving,http://classic.clinicaltrials.gov/ct2/show/NCT06101251?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Distracted Driving;   Injury Prevention;   Behavioral Economics<br /><b>Interventions</b>:    Behavioral: Driving Tips;   Behavioral: Standard Feedback;   Behavioral: Assigned Focus Area Feedback;   Behavioral: Study Dashboard (Standard);   Behavioral: Study Dashboard (focused);   Behavioral: UBI-like Behavioral Incentive;   Behavioral: Sef-Chosen Focus Area Feedback<br /><b>Sponsors</b>:    University of Pennsylvania;   AAA Foundation for Traffic Safety<br /><b>Not yet recruiting</b>
BLOODSAFE Ghana- Iron and Nutritional Counselling Strategy,http://classic.clinicaltrials.gov/ct2/show/NCT06101238?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Blood Donation<br /><b>Intervention</b>:    Dietary Supplement: supplementation with low dose elemental iron<br /><b>Sponsors</b>:    University of Minnesota;   University of Ghana;   National Blood Service Ghana;   Syracuse University;   Liverpool School of Tropical Medicine;   National Heart, Lung, and Blood Institute (NHLBI)<br /><b>Not yet recruiting</b>"
Effects of a Relaxation and Guided Imagery Intervention in School Context,http://classic.clinicaltrials.gov/ct2/show/NCT06101225?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Mental Health Wellness 1;   Positive and Negative Affect;   Social Skills;   Happiness;   Self Esteem;   Self-Regulation, Emotion;   Anxiety;   Cognitive Change;   Heart Rate Variability;   Stress, Psychological;   Physical Activity<br /><b>Interventions</b>:    Other: MindRegulation Intervention;   Other: Relaxation;   Other: Waiting List Control Group<br /><b>Sponsors</b>:    Universidade Autónoma de Lisboa;   Faculdade de Psicologia, Universidade de Lisboa;   ISCTE-IUL;   ISAMB - Faculdade de Medicina da Universidade de Lisboa;   Technical University of Lisbon;   Universidade Católica Portuguesa;   Universidade Lusófona de Humanidades e Tecnologias;   Universidade Nova de Lisboa<br /><b>Recruiting</b>"
Predictors of Quality of Life in Bipolar Disorder,http://classic.clinicaltrials.gov/ct2/show/NCT06101212?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Bipolar Disorder<br /><b>Intervention</b>:    Other: survey<br /><b>Sponsor</b>:    Kubra TOHUMCU<br /><b>Not yet recruiting</b>
Combined Therapeutic Air Mixture and Electrical Stimulation to Improve Breathing and Hand Function in Spinal Cord Injury,http://classic.clinicaltrials.gov/ct2/show/NCT06101199?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cervical Spinal Cord Injury<br /><b>Interventions</b>:    Other: Acute Intermittent Hypercapnic Hypoxia;   Other: Transcutaneous spinal cord stimulation;   Other: SHAM Acute Intermittent Hypercapnic Hypoxia;   Other: SHAM Transcutaneous spinal cord stimulation<br /><b>Sponsor</b>:    Thomas Jefferson University<br /><b>Recruiting</b>
"The Effect of Nursing Counseling Perceived Stress, Coping and Birth Outcomes Among Pregnant Women",http://classic.clinicaltrials.gov/ct2/show/NCT06101186?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Preterm Birth<br /><b>Intervention</b>:    Other: NPECP based on NSM<br /><b>Sponsors</b>:    Erzurum Technical University;   Ondokuz Mayıs University<br /><b>Completed</b>
A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults,http://classic.clinicaltrials.gov/ct2/show/NCT06101173?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Poliomyelitis<br /><b>Interventions</b>:    Biological: Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio);   Biological: Inactivated poliomyelitis vaccine (IPOL);   Biological: VLP-Polio;   Biological: IPOL<br /><b>Sponsors</b>:    CanSino Biologics Inc.;   Novotech (Australia) Pty Limited<br /><b>Not yet recruiting</b>
Botulinum Toxin Injection for Sialorrhea in Cerebral Palsy,http://classic.clinicaltrials.gov/ct2/show/NCT06101160?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sialorrhea<br /><b>Intervention</b>:    Drug: onaBoNT-A<br /><b>Sponsor</b>:    Cairo University<br /><b>Completed</b>
"Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial",http://classic.clinicaltrials.gov/ct2/show/NCT06101147?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    PCOS;   Vitamin D<br /><b>Intervention</b>:    Drug: Vitamin D3<br /><b>Sponsor</b>:    Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh<br /><b>Recruiting</b>"
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations,http://classic.clinicaltrials.gov/ct2/show/NCT06101134?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Melanoma<br /><b>Interventions</b>:    Drug: relatlimab+nivolumab;   Drug: relatlimab+nivolumab+rHuPH20;   Drug: nivolumab;   Drug: nivolumab+rHuPH20<br /><b>Sponsor</b>:    Bristol-Myers Squibb<br /><b>Not yet recruiting</b>
Performance and Safety of Lubri-cream for Pain Minimization During Urethral Catheterization and Cystoscopy,http://classic.clinicaltrials.gov/ct2/show/NCT06101121?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Urethral Catheter; Complications<br /><b>Intervention</b>:    Device: Lubri-Cream<br /><b>Sponsor</b>:    B. Braun Medical SA<br /><b>Not yet recruiting</b>
Early Diagnosis of Age-Linked CArdiac TransThyRetin Amyloidosis by Selective Screening in Spinal Stenosis Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06101108?sfpd_d=14&sel_rss=new14,"Thu, 26 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Transthyretin Amyloid Cardiomyopathy<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Philippe Debonnaire<br /><b>Not yet recruiting</b>
A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial),http://classic.clinicaltrials.gov/ct2/show/NCT06101095?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Eosinophilic Oesophagitis<br /><b>Interventions</b>:    Drug: Dupilumab;   Drug: Placebo<br /><b>Sponsors</b>:    Sanofi;   Regeneron Pharmaceuticals<br /><b>Not yet recruiting</b>
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With HER2+ Locally Advanced and/ or Metastatic Solid Tumors,http://classic.clinicaltrials.gov/ct2/show/NCT06101082?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Solid Tumor<br /><b>Intervention</b>:    Biological: Intravenous infusion anti-HER2-CAR-T cell<br /><b>Sponsors</b>:    China Medical University, China;   Shanghai First Song Therapeutics Co., Ltd<br /><b>Not yet recruiting</b>"
Development of MRF for Characterization of Brain Tumors After Radiotherapy,http://classic.clinicaltrials.gov/ct2/show/NCT06101069?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Brain Tumor;   Brain Necrosis;   Brain Metastases<br /><b>Intervention</b>:    Procedure: MRF in conjunction with IVIM MRI without contrast<br /><b>Sponsors</b>:    Case Comprehensive Cancer Center;   The Cleveland Clinic<br /><b>Not yet recruiting</b>
Code of Respect (X-CoRe): Trial of a Multi-level Sexual Assault and Sexual Harassment Prevention Intervention for Active Duty Airmen,http://classic.clinicaltrials.gov/ct2/show/NCT06101056?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Sexual Assault;   Sexual Harassment<br /><b>Interventions</b>:    Behavioral: Junior Enlisted Component;   Behavioral: Leadership Component;   Behavioral: Social Marketing Campaign<br /><b>Sponsors</b>:    The University of Texas Health Science Center, Houston;   United States Department of Defense<br /><b>Not yet recruiting</b>"
PECS II Block and Single Port Robot-assisted Transaxillary Thyroidectomy,http://classic.clinicaltrials.gov/ct2/show/NCT06101043?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Thyroid Cancer<br /><b>Intervention</b>:    Procedure: Pectoral nerve block<br /><b>Sponsor</b>:    Min Suk Chae<br /><b>Not yet recruiting</b>
Comparing Use of Incentive Spirometry With and Without Reminder,http://classic.clinicaltrials.gov/ct2/show/NCT06101030?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Post Operative<br /><b>Intervention</b>:    Device: Signal On<br /><b>Sponsor</b>:    Tidal Medical Technologies<br /><b>Not yet recruiting</b>
Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06101017?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Corneal Disease;   Endothelial Corneal Dystrophy;   Corneal Transplant Failure;   Corneal Transplant Rejection<br /><b>Intervention</b>:    Diagnostic Test: Optical Coherence Tomography<br /><b>Sponsor</b>:    Keratoplasty Alliance International<br /><b>Recruiting</b>
"A Multi-center, Non-interventional Prospective Clinical Trial to Evaluate the Safety and Effectiveness of CVA-FLOW",http://classic.clinicaltrials.gov/ct2/show/NCT06101004?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Stroke<br /><b>Intervention</b>:    Device: CVA-Flow<br /><b>Sponsors</b>:    Cvaid Medical;   Donawa Lifescience Consulting<br /><b>Not yet recruiting</b>
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry,http://classic.clinicaltrials.gov/ct2/show/NCT06100991?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Generalized Pustular Psoriasis<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    CorEvitas<br /><b>Enrolling by invitation</b>
Patient-reported Outcome and Patient-reported Experience After Status Epilepticus,http://classic.clinicaltrials.gov/ct2/show/NCT06100978?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Patient Reported Outcomes;   Patient Satisfaction;   Long Term Outcomes;   Status Epilepticus;   Intensive Care Unit;   Burden;   Relatives<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Versailles Hospital<br /><b>Not yet recruiting</b>
Reduced-dose Alemtuzumab for Kidney Transplant Rejection,http://classic.clinicaltrials.gov/ct2/show/NCT06100965?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Kidney Transplant Rejection<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Erasmus Medical Center<br /><b>Not yet recruiting</b>
[Trial of device that is not approved or cleared by the U.S. FDA],http://classic.clinicaltrials.gov/ct2/show/NCT06100952?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    <br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    [Redacted]<br /><b>Withheld</b>
[Trial of device that is not approved or cleared by the U.S. FDA],http://classic.clinicaltrials.gov/ct2/show/NCT06100939?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    <br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    [Redacted]<br /><b>Withheld</b>
Effectiveness of Virtual Reality (VR) in Non-oncologic Chronic Musculoskeletal Pain,http://classic.clinicaltrials.gov/ct2/show/NCT06100926?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Musculoskeletal Pain;   Fibromyalgia, Primary<br /><b>Intervention</b>:    Device: software<br /><b>Sponsors</b>:    Azienda Sanitaria-Universitaria Integrata di Udine;   University of Udine<br /><b>Enrolling by invitation</b>"
Immunology of Ebola Vaccine,http://classic.clinicaltrials.gov/ct2/show/NCT06100913?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ebola Virus Disease<br /><b>Intervention</b>:    Biological: Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)<br /><b>Sponsors</b>:    Emory University;   Washington University School of Medicine;   Merck Sharp & Dohme LLC<br /><b>Not yet recruiting</b>
Dose Escalation of BCX10013 in Subjects With Paroxysmal Nocturnal Hemoglobinuria,http://classic.clinicaltrials.gov/ct2/show/NCT06100900?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Paroxysmal Nocturnal Hemoglobinuria<br /><b>Intervention</b>:    Drug: BCX10013<br /><b>Sponsor</b>:    BioCryst Pharmaceuticals<br /><b>Recruiting</b>
Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy (FOX),http://classic.clinicaltrials.gov/ct2/show/NCT06100887?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Duchenne Muscular Dystrophy<br /><b>Interventions</b>:    Drug: EDG-5506 Dose 1;   Drug: EDG-5506 Dose 2;   Drug: Placebo<br /><b>Sponsor</b>:    Edgewise Therapeutics, Inc.<br /><b>Not yet recruiting</b>"
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After progrEssion on ENhertu (SATEEN),http://classic.clinicaltrials.gov/ct2/show/NCT06100874?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Her 2 Positive Breast Cancer;   Breast Cancer Female;   Breast Cancer Metastatic<br /><b>Interventions</b>:    Drug: Sacituzumab Govitecan;   Drug: Trastuzumab;   Drug: Trastuzumab and Hyaluronidase-oysk<br /><b>Sponsors</b>:    Adrienne G. Waks;   Gilead Sciences<br /><b>Not yet recruiting</b>
[Trial of device that is not approved or cleared by the U.S. FDA],http://classic.clinicaltrials.gov/ct2/show/NCT06100861?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    <br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    [Redacted]<br /><b>Withheld</b>
Hydrogen Peroxide Fumigation in Dental Office Environment,http://classic.clinicaltrials.gov/ct2/show/NCT06100848?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Bacterial Infections;   Dental Caries;   Aerosol Disease<br /><b>Interventions</b>:    Diagnostic Test: Microbiological analysis after Caries treatment;   Diagnostic Test: Microbiological analysis after Caries treatment and fumigation<br /><b>Sponsor</b>:    Wroclaw Medical University<br /><b>Completed</b>
Feasibility of the JOIN4JOY Programme to Reduce Sedentary Behaviour and Increase Physical Activity in Older Adults.,http://classic.clinicaltrials.gov/ct2/show/NCT06100835?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Physical Inactivity;   Sedentary Behavior<br /><b>Intervention</b>:    Other: Complex intervention involving physical activity and behaviour change techniques<br /><b>Sponsors</b>:    University of Vic - Central University of Catalonia;   European Commission;   Fundació Blanquerna;   Fundació Salut i Envelliment;   Syddansk Universitet;   Istituto Europeo per lo Sviluppo socio economico Associazione;   Sport Initiative et Loisir Bleu Association;   Agaplesion Bethesda Klinik Ulm<br /><b>Not yet recruiting</b>
Managing Chronic Tendon Pain by Metformin,http://classic.clinicaltrials.gov/ct2/show/NCT06100822?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Tendinopathy;   Chronic Pain;   Achilles Tendinopathy<br /><b>Interventions</b>:    Drug: Metformin;   Drug: Placebo<br /><b>Sponsors</b>:    James Wang;   United States Department of Defense<br /><b>Not yet recruiting</b>
Does Fatigue Coaching Improve Functioning and Fatigue in Resident Night Shifts,http://classic.clinicaltrials.gov/ct2/show/NCT06100809?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Fatigue;   Shift Work Type Circadian Rhythm Sleep Disorder<br /><b>Interventions</b>:    Behavioral: Personalized coaching;   Behavioral: Nutrition handout<br /><b>Sponsor</b>:    University of Massachusetts, Worcester<br /><b>Not yet recruiting</b>"
Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI,http://classic.clinicaltrials.gov/ct2/show/NCT06100796?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Non Small Cell Lung Cancer Metastatic;   Diabetes Mellitus<br /><b>Intervention</b>:    Combination Product: Pembrolizumab<br /><b>Sponsor</b>:    Assiut University<br /><b>Recruiting</b>
Depot-medroxy Progesterone Acetate Injectable Contraceptives in Lactating Women 1st Week Versus 6 Week Postpartum Initiation,http://classic.clinicaltrials.gov/ct2/show/NCT06100783?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Complications of DMPA Injectable Contraceptives<br /><b>Intervention</b>:    Device: Depot-medroxy Progesterone Acetate Injectable Contraceptives<br /><b>Sponsor</b>:    Assiut University<br /><b>Completed</b>
Aveir AR Coverage With Evidence Development (CED) Study,http://classic.clinicaltrials.gov/ct2/show/NCT06100770?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cardiac Pacemaker;   Arrhythmia;   Bradycardia<br /><b>Interventions</b>:    Device: Aveir AR Leadless Pacemaker;   Device: Single-chamber atrial transvenous pacemaker<br /><b>Sponsor</b>:    Abbott Medical Devices<br /><b>Not yet recruiting</b>
Effect of Leadless Pacing on Heart Function,http://classic.clinicaltrials.gov/ct2/show/NCT06100757?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pacing-Induced Cardiomyopathy<br /><b>Interventions</b>:    Device: Micra Transcatheter Pacing System (TPS°;   Device: Conventional pacemaket type Medtronic Advisa ADSR03 or Azure XT VR<br /><b>Sponsors</b>:    Universitaire Ziekenhuizen KU Leuven;   Medtronic<br /><b>Completed</b>
"A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab",http://classic.clinicaltrials.gov/ct2/show/NCT06100744?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Juvenile Psoriatic Arthritis<br /><b>Interventions</b>:    Drug: Adalimumab;   Drug: Risankizumab<br /><b>Sponsor</b>:    AbbVie<br /><b>Not yet recruiting</b>
tDCS and Inhibitory Control in PTSD,http://classic.clinicaltrials.gov/ct2/show/NCT06100731?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Post Traumatic Stress Disorder<br /><b>Intervention</b>:    Device: tDCS<br /><b>Sponsor</b>:    University of Kentucky<br /><b>Not yet recruiting</b>
Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study,http://classic.clinicaltrials.gov/ct2/show/NCT06100718?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Cancer-related Stroke;   Paraneoplastic Coagulopathy;   Occult Cancer;   Ischemic Stroke;   Embolic Stroke of Undetermined Source;   D-dimer<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Insel Gruppe AG, University Hospital Bern<br /><b>Recruiting</b>"
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC,http://classic.clinicaltrials.gov/ct2/show/NCT06100705?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Metastatic Castration-resistant Prostate Cancer<br /><b>Interventions</b>:    Drug: Testosterone Cypionate;   Drug: Sipuleucel-T<br /><b>Sponsors</b>:    Yale University;   Dendreon<br /><b>Not yet recruiting</b>
Prophylactic Oral Vitamin D and Zinc for Radiation-Induced Oral Mucositis in Head and Neck Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06100692?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Oncology<br /><b>Intervention</b>:    Drug: Vitamin D<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Responsible Engaged and Loving (REAL) Fathers Intervention Evaluation,http://classic.clinicaltrials.gov/ct2/show/NCT06100679?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Violence, Gender-Based;   Violence, Domestic;   Violence, Sexual;   Violence, Physical;   Contraception Behavior;   Child Development;   Child Abuse;   Communication, Partner;   Conflict Resolution;   Parent-Child Relations<br /><b>Intervention</b>:    Behavioral: Responsible Engaged and Loving (REAL) Fathers Initiative<br /><b>Sponsors</b>:    University of California, San Diego;   Impact and Innovations Development Centre (IIDC), Uganda;   NaNa Development Consultants Ltd, Uganda;   LEGO Foundation<br /><b>Recruiting</b>"
Sustainable Eating Behaviors and Diet Quality,http://classic.clinicaltrials.gov/ct2/show/NCT06100666?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Nutrition, Healthy<br /><b>Intervention</b>:    Behavioral: Observational Tests<br /><b>Sponsors</b>:    Ankara University;   Tarsus University<br /><b>Not yet recruiting</b>"
BCG for Therapeutic Use Phase I Clinical Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06100653?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Non-muscular Invasive Bladder Cancer<br /><b>Intervention</b>:    Drug: BCG for therapeutic use<br /><b>Sponsor</b>:    Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.<br /><b>Not yet recruiting</b>"
Paracervical Pouch in Placenta Accreta Spectrum,http://classic.clinicaltrials.gov/ct2/show/NCT06100640?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Placenta Accreta<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Alexandria University<br /><b>Not yet recruiting</b>
A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers,http://classic.clinicaltrials.gov/ct2/show/NCT06100627?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy Subjects<br /><b>Intervention</b>:    Drug: AP301<br /><b>Sponsor</b>:    Alebund Pty Ltd<br /><b>Not yet recruiting</b>
Presepsin to Safely Reduce Antibiotics in Preterm Infants,http://classic.clinicaltrials.gov/ct2/show/NCT06100614?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Early-Onset Neonatal Sepsis<br /><b>Interventions</b>:    Diagnostic Test: Presepsin;   Diagnostic Test: Standard Care<br /><b>Sponsor</b>:    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)<br /><b>Not yet recruiting</b>
Autonomic Dysfunction in Functional Dysphonia,http://classic.clinicaltrials.gov/ct2/show/NCT06100601?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Functional Voice Disorder;   Psychogenic Voice Disorder;   Muscle Tension Dysphonia<br /><b>Interventions</b>:    Behavioral: ANS regulation therapy;   Behavioral: conventional voice therapy (CVT);   Behavioral: ANS regulation therapy + CVT<br /><b>Sponsors</b>:    University Ghent;   Universiteit Antwerpen;   University of Utah<br /><b>Recruiting</b>
The Classification and Treatment of Myofascial Headache: a Cross-sectional Study and Randomized Controlled Trial.,http://classic.clinicaltrials.gov/ct2/show/NCT06100588?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Tension-Type Headache;   Cervicogenic Headache;   Myofascial Headache<br /><b>Interventions</b>:    Other: Dry Needling;   Other: Manual therapy<br /><b>Sponsor</b>:    University Ghent<br /><b>Not yet recruiting</b>
Tool for Sibling and Children of Someone With Suicidal Thoughts,http://classic.clinicaltrials.gov/ct2/show/NCT06100575?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Suicide<br /><b>Intervention</b>:    Behavioral: Website (www.mee-leven.be)<br /><b>Sponsor</b>:    University Ghent<br /><b>Recruiting</b>
Dance Program for Youth With Cerebral Palsy,http://classic.clinicaltrials.gov/ct2/show/NCT06100562?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cerebral Palsy<br /><b>Intervention</b>:    Behavioral: Adapted Dance Program<br /><b>Sponsor</b>:    Texas Scottish Rite Hospital for Children<br /><b>Not yet recruiting</b>
Feasibility of Using Surplus qFIT Samples to Investigate the Gut Microbiota.,http://classic.clinicaltrials.gov/ct2/show/NCT06100549?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Gut Microbiota<br /><b>Intervention</b>:    Other: No intervention<br /><b>Sponsors</b>:    University of Aberdeen;   NHS Grampian<br /><b>Not yet recruiting</b>
A Stand-alone Therapeutic Music-with-Movement Programme for People With Cognitive Impairment,http://classic.clinicaltrials.gov/ct2/show/NCT06100536?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cognitive Impairment<br /><b>Intervention</b>:    Behavioral: Music-with-movement<br /><b>Sponsor</b>:    The Hong Kong Polytechnic University<br /><b>Recruiting</b>
PREVenting-ENvIronment-Reprotoxic Exposures Before In Vitro Fertilization (PREVENIR-FIV),http://classic.clinicaltrials.gov/ct2/show/NCT06100523?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Infertility<br /><b>Interventions</b>:    Behavioral: Visioconsulation;   Behavioral: self-assessment questionnaire;   Biological: hair sampling;   Behavioral: self-assessment questionnaire on dedicated application;   Behavioral: Specialized follow-up;   Behavioral: self-assessment questionnaire for follow-up<br /><b>Sponsor</b>:    Assistance Publique Hopitaux De Marseille<br /><b>Not yet recruiting</b>
PFA 100 Evaluation and Reference Interval HOACNY,http://classic.clinicaltrials.gov/ct2/show/NCT06100510?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Effect of Drug<br /><b>Intervention</b>:    Drug: Aspirin 325mg<br /><b>Sponsor</b>:    Hematology Oncology Associates of Central New York<br /><b>Not yet recruiting</b>
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC,http://classic.clinicaltrials.gov/ct2/show/NCT06100497?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Head and Neck Squamous Cell Carcinoma<br /><b>Interventions</b>:    Drug: Pembrolizumab;   Drug: Cisplatin;   Drug: Paclitaxel-albumin<br /><b>Sponsor</b>:    Beijing Tongren Hospital<br /><b>Not yet recruiting</b>
Blood Pressure Variability Effect on Right Ventricular Strain in Women With Hypertensive Disorders With Pregnancy,http://classic.clinicaltrials.gov/ct2/show/NCT06100484?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Hypertension, Pregnancy Induced;   Preeclampsia<br /><b>Intervention</b>:    Diagnostic Test: Echocardiography<br /><b>Sponsor</b>:    Aswan University<br /><b>Recruiting</b>"
Evaluation of Genetic Signature in Endometriosis Disease by Non Invasive Sampling,http://classic.clinicaltrials.gov/ct2/show/NCT06100471?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Endometriosis;   Hypofertility<br /><b>Intervention</b>:    Other: Observational study<br /><b>Sponsor</b>:    Eurofins Genoma<br /><b>Enrolling by invitation</b>
Use of Continence Care Protocol in UK Nursing Homes.,http://classic.clinicaltrials.gov/ct2/show/NCT06100458?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Urinary Incontinence Due to Cognitive Impairment;   Urinary Incontinence<br /><b>Intervention</b>:    Other: Skin and leakage protocol<br /><b>Sponsors</b>:    Essity Hygiene and Health AB;   Lincolnshire Community Health Services NHS Trust<br /><b>Completed</b>
Exercise Engagement in People Over 60 at Risk of Falls,http://classic.clinicaltrials.gov/ct2/show/NCT06100445?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Musculoskeletal Injury;   Frailty;   Physical Inactivity;   Health Behavior<br /><b>Intervention</b>:    Behavioral: Semi structured interviews<br /><b>Sponsors</b>:    East Lancashire Hospitals NHS Trust;   National Institute for Health Research, United Kingdom<br /><b>Not yet recruiting</b>"
Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ β-carotene) for Infertile Males,http://classic.clinicaltrials.gov/ct2/show/NCT06100432?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Male Infertility<br /><b>Interventions</b>:    Drug: DLBS5055 200mg;   Drug: Placebo DLBS5055;   Drug: Multivitamin (Vitamin C 500mg + Vitamin E 100IU + Beta Carotene 10000IU);   Drug: Placebo Multivitamin<br /><b>Sponsors</b>:    Duta Wacana Christian University;   Dexa Medica Group<br /><b>Not yet recruiting</b>
SPSIP Block in Breast Surgeries for Postoperative Analgesia,http://classic.clinicaltrials.gov/ct2/show/NCT06100419?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Postmastectomy Pain<br /><b>Intervention</b>:    Procedure: serratus posterior superior intercostal plane block<br /><b>Sponsor</b>:    Cumhuriyet University<br /><b>Completed</b>
Sound Healing for Anxiety: A Randomized Controlled Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06100406?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Anxiety;   Mental Health Issue;   Anxiety Generalized;   Anxiety State<br /><b>Intervention</b>:    Other: Biofield tuning<br /><b>Sponsor</b>:    Consciousness and Healing Initiative<br /><b>Not yet recruiting</b>
New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients.,http://classic.clinicaltrials.gov/ct2/show/NCT06100393?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hearing Loss<br /><b>Interventions</b>:    Device: Investigational Pre-Processing Algorithm;   Device: Cochlear Limited standard-of-care pre-processing algorithms<br /><b>Sponsor</b>:    Cochlear<br /><b>Not yet recruiting</b>
Elaboration of a Prioritization Score for Pharmaceutical Interviews in Patients Treated With Oral Anticoagulants,http://classic.clinicaltrials.gov/ct2/show/NCT06100380?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Thromboembolic Event<br /><b>Intervention</b>:    Other: Survey<br /><b>Sponsor</b>:    CHU de Reims<br /><b>Completed</b>
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours,http://classic.clinicaltrials.gov/ct2/show/NCT06100367?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Primary Aldosteronism Due to Aldosterone Producing Adenoma;   Primary Aldosteronism;   Adrenal Tumors<br /><b>Intervention</b>:    Combination Product: 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre<br /><b>Sponsors</b>:    Changi General Hospital;   National University Health System, Singapore;   Clinical Imaging Research Centre;   Singapore General Hospital;   Tan Tock Seng Hospital;   Khoo Teck Puat Hospital;   Ng Teng Fong General Hospital;   Sengkang General Hospital<br /><b>Recruiting</b>"
Study of Patient Preferences in Relation to the Fitting of a Personalized and Connected Joint Prosthesis.,http://classic.clinicaltrials.gov/ct2/show/NCT06100354?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Prosthesis User;   Orthopedic Disorder<br /><b>Intervention</b>:    Other: Answering preference<br /><b>Sponsor</b>:    University Hospital, Brest<br /><b>Active, not recruiting</b>"
ImGTS for Patients With Cerebral Palsy and With Mobility Limitations (Phase 2),http://classic.clinicaltrials.gov/ct2/show/NCT06100341?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cerebral Palsy<br /><b>Intervention</b>:    Other: Virtual reality<br /><b>Sponsor</b>:    Augmented eXperience E-health Laboratory<br /><b>Recruiting</b>
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE),http://classic.clinicaltrials.gov/ct2/show/NCT06100328?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cardiac Tumor<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    First Affiliated Hospital Xi'an Jiaotong University<br /><b>Not yet recruiting</b>
Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair,http://classic.clinicaltrials.gov/ct2/show/NCT06100315?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Complication Following Peripheral Nerve Block<br /><b>Intervention</b>:    Drug: Nalbuphine<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Study on the Mechanism of Immune Inflammation in Cognitive Impairment of Depression,http://classic.clinicaltrials.gov/ct2/show/NCT06100302?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Depression<br /><b>Intervention</b>:    Other: no-intervention<br /><b>Sponsor</b>:    First Affiliated Hospital Xi'an Jiaotong University<br /><b>Recruiting</b>
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06100289?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Ulcerative Colitis;   Crohn's Disease<br /><b>Interventions</b>:    Drug: Vedolizumab IV;   Drug: Vedolizumab SC<br /><b>Sponsor</b>:    Takeda<br /><b>Not yet recruiting</b>
"Safety, Tolerability, and Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in ALS Patients With SOD1 Mutations",http://classic.clinicaltrials.gov/ct2/show/NCT06100276?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Amyotrophic Lateral Sclerosis<br /><b>Intervention</b>:    Drug: AMT-162<br /><b>Sponsor</b>:    UniQure Biopharma B.V.<br /><b>Not yet recruiting</b>
Breast Cancer Resiliency Through Exercise Program (B-REP),http://classic.clinicaltrials.gov/ct2/show/NCT06100263?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Breast Cancer Female<br /><b>Interventions</b>:    Other: Individualized exercise program;   Other: Control Arm<br /><b>Sponsor</b>:    University of Michigan Rogel Cancer Center<br /><b>Not yet recruiting</b>
Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening,http://classic.clinicaltrials.gov/ct2/show/NCT06100250?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Sexually Transmitted Diseases;   Gonorrhea;   Chlamydia;   Syphilis;   HIV<br /><b>Intervention</b>:    Behavioral: Motivational interviewing and specimen self-collection<br /><b>Sponsors</b>:    University of Michigan;   National Institute of Allergy and Infectious Diseases (NIAID)<br /><b>Not yet recruiting</b>
Teclistamab or Talquetamab in Combination With Daratumumab for High-Risk Smoldering Myeloma (REVIVE Study),http://classic.clinicaltrials.gov/ct2/show/NCT06100237?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Multiple Myeloma<br /><b>Interventions</b>:    Drug: Teclistamab;   Drug: Talquetamab;   Drug: Daratumumab SC<br /><b>Sponsors</b>:    University of Miami;   Janssen Scientific Affairs, LLC<br /><b>Not yet recruiting</b>"
Piloting a Healthy Aging Cohort in Manitoba,http://classic.clinicaltrials.gov/ct2/show/NCT06100224?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy Aging<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    University of Manitoba;   Seven Oaks Hospital Chronic Disease Innovation Centre;   The Wellness Institute Powered by Seven Oaks General Hospital;   Medical Fitness Association<br /><b>Not yet recruiting</b>
HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART),http://classic.clinicaltrials.gov/ct2/show/NCT06100211?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    HIV Infections<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    University of Manchester<br /><b>Not yet recruiting</b>
The Effect of Nutrition and Exercise Program on the Health of Community-dwelling Older Adults,http://classic.clinicaltrials.gov/ct2/show/NCT06100198?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Healthy Aging;   Nutrition, Healthy;   Knowledge, Attitudes, Practice<br /><b>Intervention</b>:    Other: nutrition and exercise program<br /><b>Sponsor</b>:    Taipei City Hospital<br /><b>Not yet recruiting</b>"
Wearable tES for Insomnia,http://classic.clinicaltrials.gov/ct2/show/NCT06100185?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Insomnia<br /><b>Interventions</b>:    Device: PeakSleep;   Device: Sham<br /><b>Sponsor</b>:    Uniformed Services University of the Health Sciences<br /><b>Not yet recruiting</b>
Transcutaneous Auricular Neurostimulation After Lumbar Fusion Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06100172?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Pain, Postoperative;   Opioid Use;   Lumbar Spine Injury<br /><b>Interventions</b>:    Device: Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN);   Device: Sham Control Device<br /><b>Sponsor</b>:    University of Texas Southwestern Medical Center<br /><b>Not yet recruiting</b>"
Short-term Effects of Ventilation Tubes in Children With Chronic Otitis Media With Effusion,http://classic.clinicaltrials.gov/ct2/show/NCT06100159?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Otitis Media With Effusion in Children;   Quality of Life;   Sleep<br /><b>Intervention</b>:    Device: Tympanostomy tube insertion<br /><b>Sponsors</b>:    Zealand University Hospital;   Danish Medical Association<br /><b>Completed</b>
Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls,http://classic.clinicaltrials.gov/ct2/show/NCT06100146?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Folate Deficiency;   Vitamin B 12 Deficiency;   Anemia, Megaloblastic;   Cognitive Development;   Depressive Symptoms<br /><b>Interventions</b>:    Dietary Supplement: Folic acid and vitamin B12 fortified flour;   Other: Unfortified cereal flour<br /><b>Sponsors</b>:    University Ghent;   Arba Minch University;   Institut de Recherche en Sciences de la Sante, Burkina Faso;   Addis Ababa University<br /><b>Not yet recruiting</b>"
Treat Autosomal Dominant Polycystic Kidney Disease With Oral Ketone Ester?,http://classic.clinicaltrials.gov/ct2/show/NCT06100133?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    ADPKD<br /><b>Intervention</b>:    Dietary Supplement: Ketone ester<br /><b>Sponsor</b>:    Universitair Ziekenhuis Brussel<br /><b>Not yet recruiting</b>
A Triple-blinded Non-inferiority Multicentre Randomized Controlled Trial Comparing Hybrid and Fully Etched Implants P1,http://classic.clinicaltrials.gov/ct2/show/NCT06100120?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Dental Implants<br /><b>Intervention</b>:    Procedure: Implant placement<br /><b>Sponsor</b>:    University of Milan<br /><b>Not yet recruiting</b>
Mirror Therapy in Complex Regional Pain Syndrome Type I,http://classic.clinicaltrials.gov/ct2/show/NCT06100107?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Complex Regional Pain Syndrome Type I<br /><b>Intervention</b>:    Other: Mirror Therapy exercise<br /><b>Sponsor</b>:    University Hospital, Motol<br /><b>Completed</b>"
Qualitative Study on a Psychoeducation Group for Juvenile Sex Offenders,http://classic.clinicaltrials.gov/ct2/show/NCT06100094?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Sex Offense<br /><b>Intervention</b>:    Other: semi-structured qualitative interviews<br /><b>Sponsor</b>:    University Hospital, Montpellier<br /><b>Recruiting</b>"
Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck,http://classic.clinicaltrials.gov/ct2/show/NCT06100081?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Unknown Primary Tumors;   Oropharynx Cancer<br /><b>Intervention</b>:    Diagnostic Test: Detection of lesions using fluorescence molecular imaging<br /><b>Sponsor</b>:    University Medical Center Groningen<br /><b>Recruiting</b>
HOBBIT 3: Mental Exercises and Temporal Alteration,http://classic.clinicaltrials.gov/ct2/show/NCT06100068?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Breast Neoplasm;   Radiotherapy;   Breath Holding;   Mental Test<br /><b>Intervention</b>:    Behavioral: Mental Exercises and Temporal Alteration<br /><b>Sponsor</b>:    University Hospital, Ghent<br /><b>Not yet recruiting</b>"
The ReVo Study: Low-volume vs High-volume Rectal Irrigation,http://classic.clinicaltrials.gov/ct2/show/NCT06100055?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Constipation - Functional;   Constipation;   Constipation by Outlet Obstruction;   Defecation Disorder<br /><b>Intervention</b>:    Device: Rectal Irrigation<br /><b>Sponsor</b>:    Guy's and St Thomas' NHS Foundation Trust<br /><b>Not yet recruiting</b>
Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting,http://classic.clinicaltrials.gov/ct2/show/NCT06100042?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Asthma<br /><b>Intervention</b>:    Drug: BDP/FF/G<br /><b>Sponsors</b>:    Chiesi Italia;   Gesellschaft für Therapieforschung mbH<br /><b>Not yet recruiting</b>
Modified GuiGanLongMu Decoction for Preventing Delirium in Elderly Intensive Care Unit Patients: Study Protocol,http://classic.clinicaltrials.gov/ct2/show/NCT06100029?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Delirium in Old Age<br /><b>Interventions</b>:    Drug: The modified GGLM decoction;   Behavioral: A2F bundle<br /><b>Sponsor</b>:    Chongqing Traditional Chinese Medicine Hospital<br /><b>Not yet recruiting</b>
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method,http://classic.clinicaltrials.gov/ct2/show/NCT06100016?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Colorectal Cancer;   Organoids<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Funan Liu;   Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences;   Precedo Pharmaceuticals Co. Ltd.;   Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China<br /><b>Recruiting</b>"
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method,http://classic.clinicaltrials.gov/ct2/show/NCT06100003?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Gastric Cancer;   Organoids<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Funan Liu;   Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences;   Precedo Pharmaceuticals Co. Ltd.;   Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China<br /><b>Recruiting</b>"
"Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)",http://classic.clinicaltrials.gov/ct2/show/NCT06099990?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)<br /><b>Interventions</b>:    Drug: dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets;   Drug: placebo; abiraterone acetate tablets; prednisone tablets<br /><b>Sponsor</b>:    Jiangsu HengRui Medicine Co., Ltd.<br /><b>Not yet recruiting</b>"
Binaural Sound for Remimazolam Induction,http://classic.clinicaltrials.gov/ct2/show/NCT06099977?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    General Anesthesia;   Prostate Cancer;   Uterine Myoma<br /><b>Interventions</b>:    Procedure: Binaural sound;   Procedure: Placebo<br /><b>Sponsor</b>:    Gangnam Severance Hospital<br /><b>Not yet recruiting</b>
Brief Mindfulness Intervention for Orthopedic Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06099964?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pain<br /><b>Interventions</b>:    Behavioral: Pain Coping Information;   Behavioral: Mindful Pain Management<br /><b>Sponsor</b>:    Florida State University<br /><b>Not yet recruiting</b>
Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy,http://classic.clinicaltrials.gov/ct2/show/NCT06099951?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Colorectal Cancer<br /><b>Interventions</b>:    Drug: Serplulimab + FOLFOXIRI;   Radiation: Radiation therapy<br /><b>Sponsor</b>:    Sun Yat-sen University<br /><b>Not yet recruiting</b>
Effect of Different Labour Analgesics on Maternal and Fetal Blood Flow Observed by Doppler Ultrasonography,http://classic.clinicaltrials.gov/ct2/show/NCT06099938?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Labor Pain;   Analgesia;   Fetus Disorder<br /><b>Intervention</b>:    Drug: sufentanil, ropivacaine<br /><b>Sponsor</b>:    First Affiliated Hospital of Jinan University<br /><b>Completed</b>"
The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies,http://classic.clinicaltrials.gov/ct2/show/NCT06099925?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Chemotherapy-induced Thrombocytopenia<br /><b>Intervention</b>:    Drug: Hetrombopag<br /><b>Sponsor</b>:    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University<br /><b>Not yet recruiting</b>
Dynamic Frailty Assessment for Guiding the Treatment in Older Adults With Newly Diagnosed Multiple Myeloma,http://classic.clinicaltrials.gov/ct2/show/NCT06099912?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Multiple Myeloma;   Frailty<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    FengYan Jin<br /><b>Not yet recruiting</b>
Qualitative Study on Factors Impeding Physical Activity During the Post-discharge Period After Hematopoietic Stem Cell Transplantation in Children,http://classic.clinicaltrials.gov/ct2/show/NCT06099899?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Physical Activities<br /><b>Intervention</b>:    Other: interview<br /><b>Sponsor</b>:    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University<br /><b>Not yet recruiting</b>
Repurposing Lithium for Parkinson's Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06099886?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Parkinson's Disease<br /><b>Intervention</b>:    Dietary Supplement: Lithium aspartate<br /><b>Sponsor</b>:    State University of New York at Buffalo<br /><b>Not yet recruiting</b>
"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial of ZX-7101A Tablets to Evaluate the Efficacy and Safety in the Treatment of Uncomplicated Influenza in Adolescents",http://classic.clinicaltrials.gov/ct2/show/NCT06099873?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Respiratory Viral Infection<br /><b>Interventions</b>:    Drug: ZX-7101A;   Drug: Placebo<br /><b>Sponsor</b>:    Nanjing Zenshine Pharmaceuticals<br /><b>Not yet recruiting</b>
Therapeutic Impact of KT Along With BT in Patients With Chronic Low Back Pain of Sacroiliac Joint Dysfunction,http://classic.clinicaltrials.gov/ct2/show/NCT06099860?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sacroiliac Joint Dysfunction<br /><b>Interventions</b>:    Other: Kinesio Taping;   Other: Balance Training (BT);   Other: Hot Pack and Stretching Exercises<br /><b>Sponsor</b>:    Najran University<br /><b>Completed</b>
Sacral Transcutaneous Electrical Stimulation Efficacy in Chronic Pelvic Pain: A Randomized Clinical Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06099847?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Chronic Pelvic Pain Syndrome<br /><b>Interventions</b>:    Device: Sham TENS Stimulation;   Device: Sacral TENS Stimulation<br /><b>Sponsor</b>:    Istanbul University<br /><b>Completed</b>
EVALUATION OF OSSEOINTEGRATION PROCESS OF DENTAL IMPLANTS,http://classic.clinicaltrials.gov/ct2/show/NCT06099834?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Dental Implant Failed;   Osseointegration Failure of Dental Implant<br /><b>Interventions</b>:    Other: Patients selection;   Other: Implnat placement;   Other: Recall visits<br /><b>Sponsor</b>:    Istanbul Medipol University Hospital<br /><b>Completed</b>
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade,http://classic.clinicaltrials.gov/ct2/show/NCT06099821?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Digestive System Cancers<br /><b>Interventions</b>:    Drug: KN046;   Drug: Regorafenib;   Drug: Apatinib<br /><b>Sponsor</b>:    Peking University Cancer Hospital & Institute<br /><b>Recruiting</b>
Veterans Affairs Pharmacist Heart Failure Medication Titration Project 1,http://classic.clinicaltrials.gov/ct2/show/NCT06099808?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Heart Failure<br /><b>Interventions</b>:    Other: Audit and Feedback Emails;   Other: Patient Specific Targets;   Other: Educational Resources<br /><b>Sponsors</b>:    Stanford University;   VA Palo Alto Health Care System<br /><b>Not yet recruiting</b>
Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2,http://classic.clinicaltrials.gov/ct2/show/NCT06099795?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    SARS-CoV-2 Infection;   COVID-19;   Coronavirus<br /><b>Intervention</b>:    Device: eBAM Cov Testing<br /><b>Sponsors</b>:    Centre Hospitalier Universitaire de Nīmes;   University of Nimes;   brains' laboratory sas, FRANCE<br /><b>Not yet recruiting</b>"
A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11),http://classic.clinicaltrials.gov/ct2/show/NCT06099782?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Non-Small Cell Lung Cancer;   Renal Cell Carcinoma;   Melanoma<br /><b>Interventions</b>:    Biological: Pembrolizumab co-formulated with hyaluronidase;   Biological: Pembrolizumab<br /><b>Sponsor</b>:    Merck Sharp & Dohme LLC<br /><b>Not yet recruiting</b>
"A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer",http://classic.clinicaltrials.gov/ct2/show/NCT06099769?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Metastatic Breast Cancer<br /><b>Interventions</b>:    Drug: Enzalutamide;   Drug: Mifepristone;   Drug: TPC<br /><b>Sponsors</b>:    Memorial Sloan Kettering Cancer Center;   Astellas Pharma US, Inc.;   Breast Cancer Research Foundation;   Corcept Therapeutics<br /><b>Recruiting</b>"
Discharge Readmission Analysis and Management in Sepsis (DReAMS-2),http://classic.clinicaltrials.gov/ct2/show/NCT06099756?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Sepsis<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Measure Labs, Inc.;   Duke University<br /><b>Not yet recruiting</b>"
ASCENT Intervention for Brain Tumor Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06099743?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Malignant Brain Tumor;   Glioma;   Coping Skills;   Distress, Emotional<br /><b>Interventions</b>:    Behavioral: Psychosocial intervention;   Other: Usual supportive care<br /><b>Sponsor</b>:    Massachusetts General Hospital<br /><b>Not yet recruiting</b>"
[Trial of device that is not approved or cleared by the U.S. FDA],http://classic.clinicaltrials.gov/ct2/show/NCT06099730?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    <br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    [Redacted]<br /><b>Withheld</b>
Clinical Performance of Dual-cantilevered Single-implant Bridge,http://classic.clinicaltrials.gov/ct2/show/NCT06099717?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Dental Implant Failed<br /><b>Interventions</b>:    Device: Dual-cantilevered implant bridge;   Device: 3-unit iFDP<br /><b>Sponsors</b>:    University of Bern;   ITI International Team for Implantology, Switzerland<br /><b>Not yet recruiting</b>"
Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis,http://classic.clinicaltrials.gov/ct2/show/NCT06099704?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Moderate to Severe Atopic Dermatitis<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Sanofi;   Regeneron Pharmaceuticals<br /><b>Recruiting</b>
Outcomes That Matter and Questionnaires for Older People With Frailty,http://classic.clinicaltrials.gov/ct2/show/NCT06099691?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Frailty<br /><b>Intervention</b>:    Behavioral: Qualitative Interviews<br /><b>Sponsors</b>:    Royal Devon and Exeter NHS Foundation Trust;   University of Exeter<br /><b>Not yet recruiting</b>
Enhancing Strength Gains With the Power of the Mind,http://classic.clinicaltrials.gov/ct2/show/NCT06099678?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Behavioral: Elastic Band Training;   Behavioral: Elastic Band Training with Maximal Mental Effort<br /><b>Sponsor</b>:    Kennesaw State University<br /><b>Not yet recruiting</b>
Addressing Undertreatment and Health Equity in Aortic Stenosis Using an Integrated EHR Platform,http://classic.clinicaltrials.gov/ct2/show/NCT06099665?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Aortic Valve Stenosis<br /><b>Intervention</b>:    Behavioral: Automated alert<br /><b>Sponsors</b>:    Tempus Labs;   Medtronic<br /><b>Not yet recruiting</b>
Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06099652?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Pulmonary Disease, Chronic Obstructive<br /><b>Interventions</b>:    Drug: 611 300 mg Q2W;   Drug: 611 450 mg Q2W;   Drug: Matching placebo<br /><b>Sponsor</b>:    Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.<br /><b>Not yet recruiting</b>"
Medical Access Program for Patritumab Deruxtecan,http://classic.clinicaltrials.gov/ct2/show/NCT06099639?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer<br /><b>Intervention</b>:    Drug: HER3-DXd<br /><b>Sponsor</b>:    Daiichi Sankyo, Inc.<br /><b>Available</b>"
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis,http://classic.clinicaltrials.gov/ct2/show/NCT06099626?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Autoimmune Liver Disease, COVID-19<br /><b>Intervention</b>:    Other: Different types of disease<br /><b>Sponsor</b>:    The Second Affiliated Hospital of Chongqing Medical University<br /><b>Active, not recruiting</b>"
"Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult",http://classic.clinicaltrials.gov/ct2/show/NCT06099613?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    COVID-19<br /><b>Intervention</b>:    Biological: EG-COVII<br /><b>Sponsor</b>:    EyeGene Inc.<br /><b>Recruiting</b>
Randomized Study of Anterior Cruciate Ligament Reconstruction,http://classic.clinicaltrials.gov/ct2/show/NCT06099600?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ligament Rupture<br /><b>Intervention</b>:    Procedure: Reconstructive surgery of the anterior cruciate ligament<br /><b>Sponsor</b>:    GCS Ramsay Santé pour l'Enseignement et la Recherche<br /><b>Not yet recruiting</b>
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06099587?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Alzheimer Disease, Early Onset<br /><b>Intervention</b>:    Diagnostic Test: high-resolution diffusion MRI<br /><b>Sponsor</b>:    Rennes University Hospital<br /><b>Not yet recruiting</b>"
A Study on the Oral Health Status of Pregnant Women With Gestational Diabetes and Its Correlation With Oral Flora,http://classic.clinicaltrials.gov/ct2/show/NCT06099574?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Gestational Diabetes Mellitus;   Periodontitis;   Oral Health<br /><b>Intervention</b>:    Other: Periodontitis Group<br /><b>Sponsor</b>:    Fujian Medical University<br /><b>Recruiting</b>
Intractable Self-harm-What Support is Effective?,http://classic.clinicaltrials.gov/ct2/show/NCT06099561?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Self-harm<br /><b>Intervention</b>:    Behavioral: National specialized medical care unit for severe self-harm behaviour-Consultation model<br /><b>Sponsors</b>:    Region Skane;   Department of Psychology. Lund University.;   Department of Clinical Sciences, Malmö. Faculty of Medicine, Lund University.<br /><b>Recruiting</b>"
Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06099548?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    High-Risk Percutaneous Coronary Intervention<br /><b>Intervention</b>:    Device: The Elevate™ System<br /><b>Sponsor</b>:    Magenta Medical Ltd.<br /><b>Active, not recruiting</b>"
A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis,http://classic.clinicaltrials.gov/ct2/show/NCT06099535?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Rheumatoid Arthritis<br /><b>Interventions</b>:    Drug: LNK01001 Dose A;   Drug: LNK01001 Dose B;   Drug: placebo<br /><b>Sponsor</b>:    Lynk Pharmaceuticals Co., Ltd<br /><b>Completed</b>"
Internet-CBT for Gambling Disorder - a Randomized Controlled Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06099522?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Gambling Disorder<br /><b>Intervention</b>:    Behavioral: Internet-based cognitive behavioral therapy (iCBT)<br /><b>Sponsors</b>:    Karolinska Institutet;   Deakin University<br /><b>Not yet recruiting</b>
Self-Administered 2-Hour Oral Glucose Tolerance Test,http://classic.clinicaltrials.gov/ct2/show/NCT06099509?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Gestational Diabetes;   Postpartum Disorder;   Gestational Diabetes Mellitus in Pregnancy<br /><b>Intervention</b>:    Other: Self-administered oral glucose tolerance test<br /><b>Sponsor</b>:    Prisma Health-Upstate<br /><b>Not yet recruiting</b>
Association Analysis of Cardiovascular and Nervous System Diseases and Intestinal Microbiome Based on Multi-omics Big Data and Related Applications,http://classic.clinicaltrials.gov/ct2/show/NCT06099496?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Nervous System Diseases;   Cardiovascular and Cerebrovascular Diseases<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Tao Xin<br /><b>Recruiting</b>
The Effect of Exercise on Brain Functions,http://classic.clinicaltrials.gov/ct2/show/NCT06099483?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pulmonary;   EEG<br /><b>Interventions</b>:    Other: Action observation and motor imagery;   Other: Active breathing exercise;   Other: Control group<br /><b>Sponsors</b>:    Istanbul Medipol University Hospital;   Istanbul Gedik University<br /><b>Completed</b>
Investigation of the Effects of Telerehabilitation Groups for Chronic Non-specific Low Back Pain.,http://classic.clinicaltrials.gov/ct2/show/NCT06099470?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Chronic Non-specific Low Back Pain<br /><b>Interventions</b>:    Other: Real-time synchronized telerehabilitation program (STP).;   Other: Pre-recording non-synchronized telerehabilitation program (NSTP);   Other: Home non-supervised control group (HCG)<br /><b>Sponsor</b>:    Yeditepe University<br /><b>Completed</b>
SIBTime Phase II: Web Application for Typically Developing Siblings,http://classic.clinicaltrials.gov/ct2/show/NCT06099457?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Child-family Social-emotional Health<br /><b>Intervention</b>:    Behavioral: SIB-Time web-application tool<br /><b>Sponsors</b>:    Oregon Research Behavioral Intervention Strategies, Inc.;   National Institute on Minority Health and Health Disparities (NIMHD)<br /><b>Not yet recruiting</b>"
Muscle Coordination-Based Feedback for Stroke Rehabilitation,http://classic.clinicaltrials.gov/ct2/show/NCT06099444?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Stroke<br /><b>Interventions</b>:    Device: Conventional High Intensity Gait Training;   Device: Standard FES to the Tibialis Anterior (TA);   Device: Synergy-Based Multichannel FES (MFES);   Device: Muscle Synergy Visual Biofeedback<br /><b>Sponsor</b>:    Shirley Ryan AbilityLab<br /><b>Not yet recruiting</b>
Mandibular Reconstruction Bone Plate,http://classic.clinicaltrials.gov/ct2/show/NCT06099431?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Mandible Tumor<br /><b>Interventions</b>:    Procedure: Mandibular marginal resection and reconstruction;   Device: mandibular osteosynthesis a 2.3mm reconstruction bone plate<br /><b>Sponsor</b>:    Tanta University<br /><b>Enrolling by invitation</b>
Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.,http://classic.clinicaltrials.gov/ct2/show/NCT06099418?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    HPV-Related Cervical Carcinoma;   HPV-Related Malignancy;   Cervical Cancer<br /><b>Interventions</b>:    Biological: VB10.16;   Drug: Atezolizumab Injection [Tecentriq];   Drug: Placebo<br /><b>Sponsors</b>:    Nykode Therapeutics ASA;   Roche Pharma AG;   GOG Foundation<br /><b>Not yet recruiting</b>
Yoga Training and Retinal Vasculature,http://classic.clinicaltrials.gov/ct2/show/NCT06099405?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Cognitive Change<br /><b>Interventions</b>:    Behavioral: High-speed, Cognitive Challenge Yoga;   Behavioral: Traditional yoga<br /><b>Sponsors</b>:    University of Miami;   McKnight Brain Research Foundation<br /><b>Recruiting</b>"
The Effect of Transcutaneous Electrical Acustimulation on Small Bowel Preparation for Capsule Endoscopy,http://classic.clinicaltrials.gov/ct2/show/NCT06099392?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Quality of Small Bowel Preparation<br /><b>Intervention</b>:    Device: digital stimulators (SNM-FDC01, Ningbo MaidaMedical Device, Inc, Ningbo, China)<br /><b>Sponsors</b>:    Shanghai Changzheng Hospital;   RenJi Hospital<br /><b>Not yet recruiting</b>"
Modulation of THC Effects by CBD: a Dose-ranging Study,http://classic.clinicaltrials.gov/ct2/show/NCT06099379?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cannabis;   THC<br /><b>Intervention</b>:    Drug: ∆9-tetrahydrocannabinol<br /><b>Sponsor</b>:    Centre hospitalier de l'Université de Montréal (CHUM)<br /><b>Not yet recruiting</b>
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children,http://classic.clinicaltrials.gov/ct2/show/NCT06099366?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Lymphoblastic Leukemia in Children<br /><b>Interventions</b>:    Drug: induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate;   Drug: Consolidation: Vincristine, Mecaptopurine, Intrathecal Methotrexate;   Drug: Consolidation: Vincristine, Mecaptopurine, Cyclophosphamide, Cytarabine, L-asparaginase, Intrathecal Methotrexate;   Drug: Interim Maintenance(IM): Vincristine, Methotrexate, Intrathecal Methotrexate;   Drug: Interim Maintenance(IM): Vincristine, Methotrexate, Mercaptopurine, Intrathecal Methotrexate;   Drug: Delayed Intesification(DI): Vincristine, Mercaptopurine, L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Dexamethasone, Intrathecal Methotrexate;   Drug: Delayed Intesification(DI): Vincristine, L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Dexamethasone, Intrathecal Methotrexate;   Drug: Maintenance: Vincristine, Mercaptopurine, Methotrexate, Dexamethasone, Intrathecal Methotrexate<br /><b>Sponsor</b>:    Hee Young Ju<br /><b>Not yet recruiting</b>"
Healthy Living With Online suPport & Education for Cardiovascular Disease in the Primary Care Setting,http://classic.clinicaltrials.gov/ct2/show/NCT06099353?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Cardiovascular Diseases (CVD)<br /><b>Interventions</b>:    Behavioral: Heart Age;   Behavioral: HOPE-CVD App;   Behavioral: Communication of Genetic Risk Score<br /><b>Sponsors</b>:    Nanyang Technological University;   National University of Singapore;   National University Health System, Singapore;   Tan Tock Seng Hospital<br /><b>Not yet recruiting</b>"
"Effects of an Eccentric Muscle Strengthening Protocol on Force Moment, Muscle Activation and Plantar Flexor Structure of Patients With Central Nervous System Injuries.",http://classic.clinicaltrials.gov/ct2/show/NCT06099340?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Spinal Cord Injured;   Post-stroke<br /><b>Intervention</b>:    Other: muscle-strengthening program<br /><b>Sponsor</b>:    Nantes University Hospital<br /><b>Not yet recruiting</b>
Image-based Remote Monitoring in Cardiac Surgery Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06099327?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Vital Signs;   Clinical Deterioration<br /><b>Intervention</b>:    Device: Image-based vital sign monitoring<br /><b>Sponsors</b>:    Catharina Ziekenhuis Eindhoven;   Eindhoven University of Technology<br /><b>Not yet recruiting</b>
Fruquintinib in the Cross-line Treatment of Refractory mCRC,http://classic.clinicaltrials.gov/ct2/show/NCT06099314?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Fruquintinib;   Metastatic Colorectal Cancer<br /><b>Interventions</b>:    Drug: Fruquintinib+PD-1 inhibitors;   Drug: Fruquintinib+TAS-102<br /><b>Sponsor</b>:    Wuhan Union Hospital, China<br /><b>Recruiting</b>"
Mental Health Mobile Apps for Adults,http://classic.clinicaltrials.gov/ct2/show/NCT06099301?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Depressive Symptoms;   Anxiety;   Well-Being, Psychological<br /><b>Intervention</b>:    Behavioral: Brief advice of a list of mobile apps<br /><b>Sponsors</b>:    Hong Kong Metropolitan University;   Health and Medical Research Fund<br /><b>Active, not recruiting</b>"
Strong Families Start at Home/Familias Fuertes Comienzan en Casa,http://classic.clinicaltrials.gov/ct2/show/NCT06099288?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Metabolic Syndrome, Protection Against;   Diet, Healthy<br /><b>Interventions</b>:    Behavioral: Home-Based Video and Motivational Interviewing Intervention;   Behavioral: Read Educate and Develop Youth (READY) Comparison<br /><b>Sponsors</b>:    Brown University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)<br /><b>Not yet recruiting</b>"
Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography,http://classic.clinicaltrials.gov/ct2/show/NCT06099275?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Preeclampsia<br /><b>Intervention</b>:    Diagnostic Test: Transthoracic Echocardiography<br /><b>Sponsor</b>:    Brigham and Women's Hospital<br /><b>Not yet recruiting</b>
GenPMTO Evaluation,http://classic.clinicaltrials.gov/ct2/show/NCT06099262?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Violence;   Emotional Adjustment;   Parenting;   Parent-Child Relations<br /><b>Intervention</b>:    Behavioral: GenPMTO<br /><b>Sponsors</b>:    The Behavioural Insights Team;   Implementation Sciences International, Inc;   Barnardos<br /><b>Recruiting</b>"
Validation of ECG Measurement and Atrial Fibrillation Detection,http://classic.clinicaltrials.gov/ct2/show/NCT06099249?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Atrial Fibrillation<br /><b>Intervention</b>:    Device: ASUS ECG App<br /><b>Sponsors</b>:    ASUSTek Computer INC.;   Taipei Medical University Hospital<br /><b>Not yet recruiting</b>
"A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients",http://classic.clinicaltrials.gov/ct2/show/NCT06099236?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Atypical Hemolytic Uremic Syndrome(aHUS)<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    AstraZeneca<br /><b>Not yet recruiting</b>
Preoperative Acupuncture for Total Knee or Hip Arthroplasty,http://classic.clinicaltrials.gov/ct2/show/NCT06099223?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Knee Arthropathy;   Hip Arthropathy;   Anxiety<br /><b>Intervention</b>:    Device: Acupuncture needles<br /><b>Sponsor</b>:    Hartford Hospital<br /><b>Completed</b>
The Value of Multimodal MR Imaging in Cognitive Assessment of Patients With Moderate Traumatic Brain Injury,http://classic.clinicaltrials.gov/ct2/show/NCT06099210?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Brain Injuries<br /><b>Intervention</b>:    Diagnostic Test: Glasgow coma scale<br /><b>Sponsors</b>:    First Affiliated Hospital Xi'an Jiaotong University;   Ankang Central Hospital<br /><b>Recruiting</b>
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals,http://classic.clinicaltrials.gov/ct2/show/NCT06099197?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Caregiver Burden;   Alzheimer Disease<br /><b>Interventions</b>:    Behavioral: Brain CareNotes;   Behavioral: Dementia Guide Expert<br /><b>Sponsors</b>:    Indiana University;   National Institute on Aging (NIA)<br /><b>Recruiting</b>
Study of EYP-1901 in Patients With Diabetic Macular Edema (DME),http://classic.clinicaltrials.gov/ct2/show/NCT06099184?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Diabetic Macular Edema<br /><b>Interventions</b>:    Drug: EYP-1901;   Drug: Aflibercept 2Mg/0.05Ml Inj,Oph<br /><b>Sponsor</b>:    EyePoint Pharmaceuticals, Inc.<br /><b>Not yet recruiting</b>"
Therapy With Paravertebral Oxygen-ozone Injections and Topical Cannabidiol and β-Caryophyllene Patch in Neck Pain,http://classic.clinicaltrials.gov/ct2/show/NCT06099171?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Neck Pain<br /><b>Interventions</b>:    Drug: Cannabidiol and β-Caryophyllene Patch;   Device: Oxygen-Ozone Therapy<br /><b>Sponsor</b>:    Humanitas Clinical and Research Center<br /><b>Not yet recruiting</b>
Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes,http://classic.clinicaltrials.gov/ct2/show/NCT06099158?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Heart Failure<br /><b>Intervention</b>:    Other: HeartLogic<br /><b>Sponsors</b>:    Tor Biering-Sørensen;   Boston Scientific Corporation<br /><b>Not yet recruiting</b>
Clinical and Medico-economic Validation of the HEPHAI Solution.,http://classic.clinicaltrials.gov/ct2/show/NCT06099145?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Asthma COPD<br /><b>Intervention</b>:    Device: Hephaï<br /><b>Sponsor</b>:    Hephai<br /><b>Recruiting</b>
Antagonist Activation Measurement at the Ankle Using High-density and Bipolar Surface EMG in Chronic Hemiparesis,http://classic.clinicaltrials.gov/ct2/show/NCT06099132?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Stroke;   Muscle Hypertonia;   Spasticity, Muscle<br /><b>Intervention</b>:    Diagnostic Test: Electromyographic measurements<br /><b>Sponsor</b>:    Henri Mondor University Hospital<br /><b>Completed</b>"
Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.,http://classic.clinicaltrials.gov/ct2/show/NCT06099119?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Unresectable Pancreatic Cancer<br /><b>Interventions</b>:    Drug: creon 35.000 Ph.U (R);   Other: Best Standarard of Care<br /><b>Sponsors</b>:    Hospital Clinico Universitario de Santiago;   Complejo Hospitalario de Navarra;   Karolinska Institutet;   San Raffaele University Hospital, Italy;   Beaujon Hospital<br /><b>Not yet recruiting</b>"
Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device,http://classic.clinicaltrials.gov/ct2/show/NCT06099106?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Atrial Fibrillation<br /><b>Intervention</b>:    Device: SEPIOLA System<br /><b>Sponsor</b>:    Endomatic Ltd.<br /><b>Recruiting</b>
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan,http://classic.clinicaltrials.gov/ct2/show/NCT06099093?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Prostate Cancer;   Metastatic Castration-resistant Prostate Cancer;   Metastatic Castration-resistant Prostate Carcinoma<br /><b>Intervention</b>:    Drug: 18F-DCFPyl<br /><b>Sponsors</b>:    Dana-Farber Cancer Institute;   Progenics Pharmaceuticals, Inc.<br /><b>Not yet recruiting</b>"
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN),http://classic.clinicaltrials.gov/ct2/show/NCT06099080?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Dermatosis Papulosa Nigra<br /><b>Intervention</b>:    Drug: SM-020 gel 1.0%<br /><b>Sponsor</b>:    DermBiont, Inc.<br /><b>Recruiting</b>"
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP),http://classic.clinicaltrials.gov/ct2/show/NCT06099067?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Type 2 Diabetes Mellitus<br /><b>Interventions</b>:    Drug: Canagliflozin;   Drug: DPP4 inhibitor;   Drug: Liraglutide;   Drug: Saxagliptin;   Drug: 2nd generation Sulfonylurea<br /><b>Sponsor</b>:    AstraZeneca<br /><b>Completed</b>
Ultrasound-guided Pigtail Catheter Versus Intercostal Tube Drainage of Non-traumatic Exudative Pleural Effusion,http://classic.clinicaltrials.gov/ct2/show/NCT06099054?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pleural Effusion<br /><b>Interventions</b>:    Device: Pigtail catheter;   Device: Intercostal tube<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
ND-YAG Laser Iris Depigmentation for Cosmoses,http://classic.clinicaltrials.gov/ct2/show/NCT06099041?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Iris Depigmentation<br /><b>Intervention</b>:    Device: Nd-YAG Laser for iris depigmentation<br /><b>Sponsor</b>:    Sohag University<br /><b>Recruiting</b>
Heart Failure Treatment Pattern Analysis of HF Patients in HF Centers and Non-HF Centers in China,http://classic.clinicaltrials.gov/ct2/show/NCT06099028?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Heart Failure<br /><b>Intervention</b>:    Other: no intervention<br /><b>Sponsors</b>:    Peking University First Hospital;   China Cardiovascular Association;   AstraZeneca<br /><b>Completed</b>
Cera™ Vascular Plug System Post-Market Clinical Follow-Up,http://classic.clinicaltrials.gov/ct2/show/NCT06099015?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Aneurysm;   Endoleak;   Pulmonary Arteriovenous Malformation;   Portal Hypertension;   Arteriovenous Fistula;   Splenic Laceration<br /><b>Intervention</b>:    Device: Cera™ Vascular Plug System<br /><b>Sponsor</b>:    Lifetech Scientific (Shenzhen) Co., Ltd.<br /><b>Not yet recruiting</b>"
"Balance, Walking Speed, Quadriceps Femoris Muscle Strength and Quality of Life in Falling and Non-falling Individuals With COPD",http://classic.clinicaltrials.gov/ct2/show/NCT06099002?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Copd<br /><b>Intervention</b>:    Other: Changed Medical research Council,Mini Mental Test, Quadriceps Femoris muscle strength measurement,2 min walking test, fall effectiveness scale,Fall risk self-assessment scale<br /><b>Sponsor</b>:    Kırıkkale University<br /><b>Recruiting</b>"
A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation (REPAIR PERS-AF Study),http://classic.clinicaltrials.gov/ct2/show/NCT06098989?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Atrial Fibrillation, Persistent;   Atrial Fibrillation Recurrent<br /><b>Intervention</b>:    Procedure: Radio frequency ablation<br /><b>Sponsors</b>:    Haukeland University Hospital;   St. Olavs Hospital;   University Hospital of North Norway<br /><b>Not yet recruiting</b>"
The Effectiveness of the Water Jet Device in Removing Dental Plaque Around Orthodontic Braces in Adolescents,http://classic.clinicaltrials.gov/ct2/show/NCT06098976?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Plaque, Dental<br /><b>Interventions</b>:    Device: Water Jet;   Device: Manual toothbrush<br /><b>Sponsor</b>:    Damascus University<br /><b>Completed</b>"
Preliminary Outcomes of Sacral Neuromodulation Applications; Tertiary-Center Experience in Turkey,http://classic.clinicaltrials.gov/ct2/show/NCT06098963?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sacral Neuromodulation<br /><b>Intervention</b>:    Device: sacral neuromodulation<br /><b>Sponsor</b>:    Cigli Regional Training Hospital<br /><b>Completed</b>
Human Algorithm Interactions for Acute Respiratory Failure Diagnosis,http://classic.clinicaltrials.gov/ct2/show/NCT06098950?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Acute Respiratory Failure<br /><b>Interventions</b>:    Other: Artificial Intelligence model predictions without explanation;   Other: Artificial intelligence model predictions with explanation;   Other: AI model biased against heart failure;   Other: AI model biased against pneumonia;   Other: AI model biased against COPD<br /><b>Sponsors</b>:    University of Michigan;   National Heart, Lung, and Blood Institute (NHLBI)<br /><b>Completed</b>"
Kalifilcon A Toric Compared to Commercially Available Lenses,http://classic.clinicaltrials.gov/ct2/show/NCT06098937?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Refractive Ametropia<br /><b>Interventions</b>:    Device: Kalifilcon Toric Lens;   Device: Total1 for Astigmatism;   Device: Precision1 for Astigmatism;   Device: MyDay Toric<br /><b>Sponsor</b>:    Bausch & Lomb Incorporated<br /><b>Completed</b>
HD Patients' Depression and Happiness,http://classic.clinicaltrials.gov/ct2/show/NCT06098924?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hemodialysis<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Chang Gung University of Science and Technology<br /><b>Recruiting</b>
Modified Atraumatic Restorative Treatment Using CPP ACP,http://classic.clinicaltrials.gov/ct2/show/NCT06098911?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Caries<br /><b>Intervention</b>:    Device: MI varnish<br /><b>Sponsor</b>:    Cairo University<br /><b>Not yet recruiting</b>
Safety and Efficacy of NK510 to Treat Gastric Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06098898?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Gastric Cancer<br /><b>Interventions</b>:    Drug: NK510;   Drug: Tislelizumab，atezolizumab or Trastuzumab<br /><b>Sponsors</b>:    Base Therapeutics (Shanghai) Co., Ltd.;   Shanghai 10th People's Hospital<br /><b>Enrolling by invitation</b>"
The Effect of Different Treatment Modalities of Class II Malocclusion on Upper Third Molars.,http://classic.clinicaltrials.gov/ct2/show/NCT06098885?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Third Molar Impaction<br /><b>Intervention</b>:    Other: extraction orthodontic treatment<br /><b>Sponsor</b>:    Cairo University<br /><b>Completed</b>
Pilot Study on Trametinib for Surgical Unruptured AVMs,http://classic.clinicaltrials.gov/ct2/show/NCT06098872?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Arteriovenous Malformations<br /><b>Intervention</b>:    Drug: Trametinib tablet<br /><b>Sponsor</b>:    University Health Network, Toronto<br /><b>Not yet recruiting</b>"
Thoracic Epidural Analgesia and Bilateral Erector Spinae Plane Block on Postoperative Pain in Open Heart Surgeries,http://classic.clinicaltrials.gov/ct2/show/NCT06098859?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Pain, Postoperative;   Respiratory Complication<br /><b>Interventions</b>:    Procedure: Thoracic epidural analgesia;   Procedure: Erector spinae plane block<br /><b>Sponsor</b>:    Karadeniz Technical University<br /><b>Completed</b>"
Human Transdermal Vitamin D Supplement Study,http://classic.clinicaltrials.gov/ct2/show/NCT06098846?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Vitamin D Supplementation<br /><b>Interventions</b>:    Dietary Supplement: Vitamin D phosphate;   Dietary Supplement: Placebo transdermal patch<br /><b>Sponsors</b>:    King's College London;   Vitamax Wholesalers LLP<br /><b>Not yet recruiting</b>
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia,http://classic.clinicaltrials.gov/ct2/show/NCT06098833?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Neonatal Encephalopathy<br /><b>Interventions</b>:    Drug: Sildenafil;   Drug: Ora-Blend<br /><b>Sponsor</b>:    Pia Wintermark<br /><b>Not yet recruiting</b>
The Effect of UV-C Enriched Foods on Vitamin D Deficiency,http://classic.clinicaltrials.gov/ct2/show/NCT06098820?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Vitamin d Deficiency<br /><b>Intervention</b>:    Other: Vitamin D status<br /><b>Sponsors</b>:    Okan University;   Arçelik A.Ş.<br /><b>Completed</b>
Family Centered Treatment for Problematic Gaming and Excessive Screen Use,http://classic.clinicaltrials.gov/ct2/show/NCT06098807?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Internet Gaming Disorder;   Internet Addiction<br /><b>Intervention</b>:    Behavioral: Family Centered Treatment for Problematic Gaming and Excessive Screen Use<br /><b>Sponsor</b>:    Region Skane<br /><b>Not yet recruiting</b>
Effect of Sodium Bicarbonate on Exercise Performance,http://classic.clinicaltrials.gov/ct2/show/NCT06098794?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sodium Bicarbonate<br /><b>Interventions</b>:    Dietary Supplement: Sodium Bicarbonate;   Dietary Supplement: Placebo<br /><b>Sponsor</b>:    Faculdade de Motricidade Humana<br /><b>Completed</b>
Gynaecological Gender-affirming Surgeries - a Prospective Cohort Study,http://classic.clinicaltrials.gov/ct2/show/NCT06098781?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Gender Dysphoria<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Amsterdam UMC, location VUmc<br /><b>Recruiting</b>"
Parent Led Implementation of a VR Social Skills Training Program for Children With ASD,http://classic.clinicaltrials.gov/ct2/show/NCT06098768?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Autism Spectrum Disorder<br /><b>Intervention</b>:    Behavioral: VR Social Skills<br /><b>Sponsors</b>:    West Virginia University;   Floreo<br /><b>Not yet recruiting</b>
The Sequestration of Holistic Stress Management Techniques for Adults,http://classic.clinicaltrials.gov/ct2/show/NCT06098755?sfpd_d=14&sel_rss=new14,"Wed, 25 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Stress, Job<br /><b>Intervention</b>:    Behavioral: Transcendence Research: Holistic Education<br /><b>Sponsor</b>:    Goddess Zena I. Jones<br /><b>Recruiting</b>"
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers,http://classic.clinicaltrials.gov/ct2/show/NCT06098742?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Heartburn;   Acid-dependent Diseases of the Gastrointestinal Tract;   Symptomatic Treatment of Gastric and Duodenal Ulcers<br /><b>Intervention</b>:    Drug: Antareit<br /><b>Sponsor</b>:    Valenta Pharm JSC<br /><b>Not yet recruiting</b>
Digital Exercise for Middle-Aged Adults With Type 1 Diabetes and Other Absolute Insulin Deficiency Diabetes,http://classic.clinicaltrials.gov/ct2/show/NCT06098729?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Type 1 Diabetes;   Latent Autoimmune Diabetes in Adults;   Pancreatitis<br /><b>Intervention</b>:    Behavioral: Digital Exercise<br /><b>Sponsors</b>:    Yale University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Exerscrip LLC<br /><b>Recruiting</b>
All in the Family: Promoting Family Function Through Physical Activity,http://classic.clinicaltrials.gov/ct2/show/NCT06098716?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Physical Activity;   Family Functioning<br /><b>Interventions</b>:    Behavioral: Self Regulation;   Behavioral: Identity & Family functioning<br /><b>Sponsors</b>:    University of Victoria;   Social Sciences and Humanities Research Council of Canada<br /><b>Not yet recruiting</b>
CARD for Community Pharmacy Vaccinations,http://classic.clinicaltrials.gov/ct2/show/NCT06098703?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Vaccination Reaction;   Vaccination Pain;   Community Pharmacy<br /><b>Intervention</b>:    Behavioral: CARD (Comfort Ask Relax Distract)<br /><b>Sponsors</b>:    University of Toronto;   Public Health Agency of Canada (PHAC);   Wholehealth Pharmacy Partners<br /><b>Not yet recruiting</b>
Culturally Tailored HPV Psychoeducational Multimedia Intervention,http://classic.clinicaltrials.gov/ct2/show/NCT06098690?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Health Knowledge, Attitudes, Practice;   Vaccine-Preventable Diseases;   Intention;   Adherence, Patient<br /><b>Interventions</b>:    Behavioral: Culturally Tailored Multimedia Psychoeducational HPV Intervention;   Behavioral: General HPV Multimedia Psychoeducational Control Group<br /><b>Sponsors</b>:    University of Texas, El Paso;   National Institute on Minority Health and Health Disparities (NIMHD)<br /><b>Not yet recruiting</b>"
Effect of Carotenoids Supplementation on Visual Function in Chinese Subjects,http://classic.clinicaltrials.gov/ct2/show/NCT06098677?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Constrast Sensitivity<br /><b>Interventions</b>:    Dietary Supplement: Carotenoids supplementation;   Dietary Supplement: Placebo<br /><b>Sponsors</b>:    Zhongshan Ophthalmic Center, Sun Yat-sen University;   Blackmores (China) CO., Ltd<br /><b>Not yet recruiting</b>"
Observational Study of Sinus Rhythm Mapping in Pulmonary Vein Isolation Naive Patients With Atrial Fibrillation,http://classic.clinicaltrials.gov/ct2/show/NCT06098664?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Atrial Fibrillation<br /><b>Interventions</b>:    Diagnostic Test: AI-enabled ECG score for Atrial Fibrillation (DNN score);   Diagnostic Test: Atrial voltage map in sinus rhythm<br /><b>Sponsor</b>:    Ziekenhuis Oost-Limburg<br /><b>Recruiting</b>
A Study of DCR-STAT3 in Adults With Solid Tumors,http://classic.clinicaltrials.gov/ct2/show/NCT06098651?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Solid Tumor, Adult;   Refractory Tumor<br /><b>Intervention</b>:    Drug: DCR-STAT3<br /><b>Sponsor</b>:    Dicerna Pharmaceuticals, Inc., a Novo Nordisk company<br /><b>Recruiting</b>"
Effect of Aerobic and Resisted Exercise on Lipid Profile and Quality of Life in Overweight Breastfeeding Women,http://classic.clinicaltrials.gov/ct2/show/NCT06098638?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Postpartum Weight Retention<br /><b>Interventions</b>:    Other: Nutritional recommendation and Faradic stimulation program;   Other: aerobic and resisted exercise for 12 weeks<br /><b>Sponsor</b>:    Cairo University<br /><b>Completed</b>
Empagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus,http://classic.clinicaltrials.gov/ct2/show/NCT06098625?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Diabetes Mellitus;   Kidney Transplant; Complications<br /><b>Interventions</b>:    Drug: Empagliflozin 25 MG;   Drug: Linagliptin 5 mg Oral Tablet<br /><b>Sponsor</b>:    Medanta, The Medicity, India<br /><b>Not yet recruiting</b>"
PET Imaging Evaluation of [11C]SY08,http://classic.clinicaltrials.gov/ct2/show/NCT06098612?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Parkinson's Disease;   Multiple System Atrophy;   Dementia With Lewy Bodies;   Healthy Controls<br /><b>Intervention</b>:    Drug: C11-SY08<br /><b>Sponsor</b>:    Massachusetts General Hospital<br /><b>Not yet recruiting</b>
Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06098599?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Advanced Breast Cancer<br /><b>Intervention</b>:    Drug: Doxorubicin hydrochloride liposome injection<br /><b>Sponsor</b>:    Luye Pharma Group Ltd.<br /><b>Completed</b>
Wrist Denervation vs Exercise in Wrist Osteoarthritis,http://classic.clinicaltrials.gov/ct2/show/NCT06098586?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Osteoarthritis Wrist<br /><b>Interventions</b>:    Behavioral: Self-managed exercise therapy program;   Procedure: Partial wrist denervation<br /><b>Sponsor</b>:    Karolinska Institutet<br /><b>Not yet recruiting</b>
Development and Evaluation of HighAlert,http://classic.clinicaltrials.gov/ct2/show/NCT06098573?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Cannabis;   Youth Drinking<br /><b>Interventions</b>:    Behavioral: High Alert;   Behavioral: Information condition;   Behavioral: No contact<br /><b>Sponsor</b>:    Western University, Canada<br /><b>Not yet recruiting</b>"
A Biomarker Study for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06098560?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Colorectal Cancer<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Geneplus-Beijing Co. Ltd.<br /><b>Recruiting</b>
LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma,http://classic.clinicaltrials.gov/ct2/show/NCT06098547?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Intrahepatic Cholangiocarcinoma<br /><b>Intervention</b>:    Procedure: Liver transplantation<br /><b>Sponsors</b>:    Azienda Sanitaria Ospedaliera;   Istituto Oncologico Veneto IRCCS<br /><b>Not yet recruiting</b>
Evaluation of a Prototype for an Innovative Room for the Elderly,http://classic.clinicaltrials.gov/ct2/show/NCT06098534?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Elderly Inpatients<br /><b>Interventions</b>:    Behavioral: Hospi'Senior;   Behavioral: Conventional room<br /><b>Sponsor</b>:    University Hospital, Angers<br /><b>Not yet recruiting</b>"
Project CONSENT: Cognitive Behavioral Therapy to Prevent Sexual Recidivism,http://classic.clinicaltrials.gov/ct2/show/NCT06098521?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Sexual Offending Behavior<br /><b>Intervention</b>:    Behavioral: CONSENT<br /><b>Sponsors</b>:    Karolinska Institutet;   Swedish Prison and Probation Service (Kriminalvården, forskningshuvudman)<br /><b>Not yet recruiting</b>"
Osteopathic Manual Treatment for Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06098508?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Hemiplegic Shoulder Pain;   Osteopathic Manipulative Treatment<br /><b>Interventions</b>:    Other: Osteopathic Manual Treatment;   Other: Sham Treatment<br /><b>Sponsor</b>:    University of Wisconsin, Madison<br /><b>Not yet recruiting</b>"
Looking for a Blood Epigenetic Signature to Predict Female Infertility,http://classic.clinicaltrials.gov/ct2/show/NCT06098495?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Female Infertility<br /><b>Intervention</b>:    Genetic: search for epigenetic profile of infertility<br /><b>Sponsor</b>:    Università Vita-Salute San Raffaele<br /><b>Recruiting</b>
An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App,http://classic.clinicaltrials.gov/ct2/show/NCT06098482?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hearing Loss<br /><b>Interventions</b>:    Device: the Mobile Research App;   Device: SOC/validated delivery of the speech perception test material<br /><b>Sponsor</b>:    Cochlear<br /><b>Not yet recruiting</b>
Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression,http://classic.clinicaltrials.gov/ct2/show/NCT06098469?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Depression<br /><b>Intervention</b>:    Device: Neurofeedback sessions<br /><b>Sponsor</b>:    Centre Hospitalier Universitaire de Besancon<br /><b>Not yet recruiting</b>
Epigallocatechin Gallate and Other Antural Compounds in HPV Infections,http://classic.clinicaltrials.gov/ct2/show/NCT06098456?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Papilloma-induced Cervical Lesions<br /><b>Intervention</b>:    Drug: EGCG, FA, HA, B12<br /><b>Sponsor</b>:    Centro di Ricerca Clinica Salentino<br /><b>Enrolling by invitation</b>"
Acupressure Versus Transcutaneous Electrical Nerve Stimulation on Pain and Quality of Life Intradialysis,http://classic.clinicaltrials.gov/ct2/show/NCT06098443?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hemodialysis Complication<br /><b>Interventions</b>:    Other: Acupressure;   Device: Transcutaneous electrical nerve stimulation<br /><b>Sponsor</b>:    Cairo University<br /><b>Recruiting</b>
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL),http://classic.clinicaltrials.gov/ct2/show/NCT06098430?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Nodular Lymphocyte-Predominant Hodgkin Lymphoma<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    St. Jude Children's Research Hospital<br /><b>Not yet recruiting</b>
Biomarkers in the Diagnosis and Prognosis of NAFLD,http://classic.clinicaltrials.gov/ct2/show/NCT06098417?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    NAFLD;   Obesity;   Liver Fibrosis;   Diabetes Mellitus, Type 2<br /><b>Interventions</b>:    Diagnostic Test: Plasma Test;   Diagnostic Test: Plasma test;   Diagnostic Test: Liver biopsy;   Diagnostic Test: Visceral adipose tissue biopsy;   Diagnostic Test: Liver elastography;   Diagnostic Test: Blood test<br /><b>Sponsor</b>:    University of Trieste<br /><b>Recruiting</b>"
Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study,http://classic.clinicaltrials.gov/ct2/show/NCT06098404?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Cancer<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    The University of Texas Medical Branch, Galveston<br /><b>Not yet recruiting</b>"
Results at More Than 10 Years of Meniscal Sutures Without Avivement,http://classic.clinicaltrials.gov/ct2/show/NCT06098391?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Knee Arthroscopy<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    University Hospital, Strasbourg, France<br /><b>Recruiting</b>"
"Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab",http://classic.clinicaltrials.gov/ct2/show/NCT06098378?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Thrombotic Microangiopathies<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    University Hospital, Strasbourg, France<br /><b>Recruiting</b>"
"The Effects of CSE and ISE on Pain, Strength, Flexibility, Disability and QoL in Patients With CDH",http://classic.clinicaltrials.gov/ct2/show/NCT06098365?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cervical Disc Herniation<br /><b>Interventions</b>:    Other: segmental cervical stabilization exercises;   Other: cervical isometric exercises<br /><b>Sponsor</b>:    Uskudar University<br /><b>Not yet recruiting</b>
The Impact of a Continuous Performance Task on the Stress Response,http://classic.clinicaltrials.gov/ct2/show/NCT06098352?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Stress<br /><b>Intervention</b>:    Behavioral: PEBL Continuous Performance Task<br /><b>Sponsor</b>:    University of Redlands<br /><b>Completed</b>
Performance Evaluation of Reusable Contact Lenses When Worn For One Month By Habitual Soft Contact Lens Wearers,http://classic.clinicaltrials.gov/ct2/show/NCT06098339?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Myopia;   Hyperopia<br /><b>Interventions</b>:    Device: Lens A (fanfilcon A);   Device: Lens B (lotrafilcon B)<br /><b>Sponsors</b>:    Coopervision, Inc.;   CORE<br /><b>Not yet recruiting</b>"
CyFluATG in Lower Risk MDS,http://classic.clinicaltrials.gov/ct2/show/NCT06098326?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Myelodysplastic Syndromes<br /><b>Intervention</b>:    Drug: cyclophosphamide, fludarabine, and antithymocyte globulin<br /><b>Sponsor</b>:    Asan Medical Center<br /><b>Active, not recruiting</b>"
HCT With PTCy in Higher-risk MDS,http://classic.clinicaltrials.gov/ct2/show/NCT06098313?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)<br /><b>Intervention</b>:    Drug: Cyclophosphamide<br /><b>Sponsor</b>:    Asan Medical Center<br /><b>Active, not recruiting</b>"
Effects of Change in Blood Pressure on Retinal Capillary Rarefaction in Patients With Arterial Hypertension,http://classic.clinicaltrials.gov/ct2/show/NCT06098300?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Arterial Hypertension;   Blood Pressure, High<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Medical University of Vienna<br /><b>Recruiting</b>"
Residential Ventilation Systems and Filtration for Asthma Control in Adults,http://classic.clinicaltrials.gov/ct2/show/NCT06098287?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Asthma;   Pollution; Exposure<br /><b>Interventions</b>:    Device: Residential mechanical ventilation system (Exhaust);   Device: Residential mechanical ventilation system (CFIS) and air filtration upgrades;   Device: Residential mechanical ventilation system (ERV) and air filtration upgrades<br /><b>Sponsors</b>:    Illinois Institute of Technology;   Elevate<br /><b>Completed</b>
Motivational Interview Based Intervention Program on Smartphone Addiction and Sleep Quality,http://classic.clinicaltrials.gov/ct2/show/NCT06098274?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Smartphone Addiction;   Students, Nursing<br /><b>Intervention</b>:    Behavioral: Motivational interviewing program based on transtheoretical model<br /><b>Sponsors</b>:    Mustafa Yumusak;   Cumhuriyet University<br /><b>Not yet recruiting</b>"
Bioequivalence Study of Bilastine Tablets in Healthy Chinese Subjects,http://classic.clinicaltrials.gov/ct2/show/NCT06098261?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Drug: Test (T) Bilastine;   Drug: Reference (R) Bilastine<br /><b>Sponsor</b>:    The Affiliated Hospital of Qingdao University<br /><b>Not yet recruiting</b>
cCeLL - Ex Vivo (Confocal Fluorescence Endomicroscopy) for Intraoperative Brain Tumor Diagnosis,http://classic.clinicaltrials.gov/ct2/show/NCT06098248?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Benign Brain Tumor;   Malignant Brain Tumor<br /><b>Intervention</b>:    Diagnostic Test: cCeLL Ex Vivo<br /><b>Sponsors</b>:    VPIX Medical;   Unity Health Toronto;   Korea University Anam Hospital;   Samsung Medical Center;   Seoul National University Hospital<br /><b>Not yet recruiting</b>
Oriental Intervention for Enhanced Neurocognitive Health (Orient) Diet in Populations With High Risk of Stroke (ENDS),http://classic.clinicaltrials.gov/ct2/show/NCT06098235?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    High Risk of Stroke<br /><b>Interventions</b>:    Behavioral: Usual Diet advice;   Behavioral: ORIENT diet intervention<br /><b>Sponsor</b>:    Second Affiliated Hospital, School of Medicine, Zhejiang University<br /><b>Not yet recruiting</b>"
"The Effect of Slow Breathing Exercise Applied to Patients on Pulse, Blood Pressure and Quality of Life",http://classic.clinicaltrials.gov/ct2/show/NCT06098222?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Slow Breathing;   Acute Myocardial Infarction<br /><b>Intervention</b>:    Behavioral: Slow breathing exercise training<br /><b>Sponsors</b>:    Saglik Bilimleri Universitesi;   The Scientific and Technological Research Council of Turkey<br /><b>Not yet recruiting</b>
Dexmedetomidine and Propofol in Mechanically Ventilated Patients by Using Salivary Alpha-amylase as a Stress Marker,http://classic.clinicaltrials.gov/ct2/show/NCT06098209?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Dexmedetomidine;   Propofol;   Mechanical Ventilation;   Salivary Alpha Amylase;   Stress<br /><b>Interventions</b>:    Drug: Dexmedetomidine;   Drug: Propofol<br /><b>Sponsor</b>:    Tanta University<br /><b>Recruiting</b>
Effects of Aminophylline Bolus on TCI (Target Controlled Infusion) Concentrations at Return of Responsiveness,http://classic.clinicaltrials.gov/ct2/show/NCT06098196?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Propofol;   Anesthesia Brain Monitoring<br /><b>Intervention</b>:    Drug: Aminophyllin<br /><b>Sponsor</b>:    University of Padova<br /><b>Not yet recruiting</b>
Metabolic Effects of Perimenopause,http://classic.clinicaltrials.gov/ct2/show/NCT06098183?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Perimenopausal Disorder<br /><b>Interventions</b>:    Other: Whey Protein Isolate;   Other: Non-caloric Placebo water<br /><b>Sponsors</b>:    University of North Carolina, Chapel Hill;   American Diabetes Association<br /><b>Not yet recruiting</b>"
Acceptance and Commitment Therapy for Chronic Pain in SCI: Development and Testing of an eHealth Program,http://classic.clinicaltrials.gov/ct2/show/NCT06098170?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Spinal Cord Injuries<br /><b>Interventions</b>:    Behavioral: Unguided use of the My SCI Toolkit program;   Behavioral: Coached My SCI Toolkit<br /><b>Sponsors</b>:    University of Michigan;   The Craig H. Neilsen Foundation<br /><b>Not yet recruiting</b>
Tuebingen Register of Union Failure After Fractures of the Upper and Lower Extremities,http://classic.clinicaltrials.gov/ct2/show/NCT06098157?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Bone Non-union After Fracture;   Delayed Bone Non-union After Fracture<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu<br /><b>Recruiting</b>"
Smoking Cessation Program in the Construction Sector,http://classic.clinicaltrials.gov/ct2/show/NCT06098144?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Smoking Cessation;   Tobacco Use Cessation;   Tobacco Smoking<br /><b>Interventions</b>:    Drug: Nicoderm C-Q Gum;   Behavioral: Tobacco Quit-line;   Behavioral: Brief Behavioral Counseling;   Behavioral: Intensive Behavioral Counseling<br /><b>Sponsors</b>:    University of Miami;   Florida Department of Health<br /><b>Not yet recruiting</b>
Comparative Effects of the Neurodynamic Slider and Tensioner Mobilisation Techniques on Sympathetic Nervous System Function: A Randomised Controlled Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06098131?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Health Care Acceptor<br /><b>Intervention</b>:    Other: Neurodynamic<br /><b>Sponsor</b>:    European University Cyprus<br /><b>Completed</b>
Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS,http://classic.clinicaltrials.gov/ct2/show/NCT06098118?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Breast Cancer Screening<br /><b>Intervention</b>:    Behavioral: MyMammogram decision aid<br /><b>Sponsor</b>:    Dartmouth-Hitchcock Medical Center<br /><b>Not yet recruiting</b>
Laparoscopic vs Ultrasound-Guided Transversus Abdominis Plane Block vs Laparoscopic Intraperitoneal Instillation of Local Anesthetic in Pediatrics,http://classic.clinicaltrials.gov/ct2/show/NCT06098105?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Laparoscopic;   Ultrasound;   Transversus Abdominis Plane Block;   Laparoscopic Intraperitoneal Instillation;   Pediatrics;   Inguinal Hernia Repair<br /><b>Interventions</b>:    Procedure: Ultrasound-guided transversus abdominis plane block;   Procedure: Laparoscopic-assisted transversus abdominis plane block;   Procedure: Laparoscopic-assisted intraperitoneal instillation;   Drug: Bupivacaine<br /><b>Sponsor</b>:    Tanta University<br /><b>Recruiting</b>
Experimental Validation of the Long-term Accuracy of Blood Pressure Measurement Using a Smartwatch,http://classic.clinicaltrials.gov/ct2/show/NCT06098092?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Hypertension;   Blood Pressure<br /><b>Intervention</b>:    Other: Long-term non-invasive Blood pressure monitoring<br /><b>Sponsor</b>:    Czech Technical University in Prague<br /><b>Enrolling by invitation</b>
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE),http://classic.clinicaltrials.gov/ct2/show/NCT06098079?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Obesity<br /><b>Interventions</b>:    Drug: Naltrexone-Bupropion (NB) Combination;   Drug: Placebo<br /><b>Sponsor</b>:    Currax Pharmaceuticals<br /><b>Not yet recruiting</b>
Decoding Risks and Rewards in Ischemic Stroke Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06098066?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ischemic Stroke<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    China Medical University Hospital<br /><b>Completed</b>
Efficacy of Muscle Energy Technique Alone and in Combination With Interferential Therapy for the Treatment of Non-specific Low Back Pain.,http://classic.clinicaltrials.gov/ct2/show/NCT06098053?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Back Pain<br /><b>Interventions</b>:    Other: muscle energy technique;   Other: Muscel energy technique along with interferential therapy<br /><b>Sponsor</b>:    Neuro Counsel Hospital, Pakistan<br /><b>Completed</b>"
Long-Term Feedback Effect of FGM in Newly-Diagnosed T2D Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06098040?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Type 2 Diabetes<br /><b>Interventions</b>:    Device: flash glucose monitoring continuous;   Diagnostic Test: capillary blood test;   Device: flash glucose monitoring intermittent<br /><b>Sponsor</b>:    Campus Bio-Medico University<br /><b>Recruiting</b>
Study of [14C]CS0159 in China Healthy Subjects,http://classic.clinicaltrials.gov/ct2/show/NCT06098027?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Primary Biliary Cholangitis<br /><b>Intervention</b>:    Drug: [14C]CS0159<br /><b>Sponsor</b>:    Cascade Pharmaceuticals, Inc<br /><b>Not yet recruiting</b>"
Safety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia,http://classic.clinicaltrials.gov/ct2/show/NCT06098014?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Transfusion-dependent Thalassemia<br /><b>Interventions</b>:    Drug: Thalidomide Capsules;   Drug: Placebo<br /><b>Sponsor</b>:    Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh<br /><b>Recruiting</b>"
Bioavailability Study of Hemp Phenolics,http://classic.clinicaltrials.gov/ct2/show/NCT06098001?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Bioavailability;   Metabolites;   Excretion<br /><b>Interventions</b>:    Dietary Supplement: Low dose dietary fiber;   Dietary Supplement: High dose dietary fiber<br /><b>Sponsors</b>:    Brightseed;   Biofortis Mérieux NutriSciences;   University of Arkansas<br /><b>Active, not recruiting</b>"
Pilot Study of Knee Osteoarthritis Treatment,http://classic.clinicaltrials.gov/ct2/show/NCT06097988?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Knee Osteoarthritis<br /><b>Intervention</b>:    Device: ABIO3419<br /><b>Sponsor</b>:    Symatese<br /><b>Not yet recruiting</b>
A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma,http://classic.clinicaltrials.gov/ct2/show/NCT06097975?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Recurrent Glioblastoma<br /><b>Interventions</b>:    Drug: Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV;   Procedure: Neurosurgery and intracavitary injection nivolumab and ipililumab;   Drug: Adjuvant nivolumab IV + nivolumab and ipililumab intracavitary<br /><b>Sponsor</b>:    Universitair Ziekenhuis Brussel<br /><b>Not yet recruiting</b>
Safety and Efficacy of NK510 to Treat NSCLC,http://classic.clinicaltrials.gov/ct2/show/NCT06097962?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    NSCLC<br /><b>Interventions</b>:    Drug: NK510;   Drug: Tislelizumab，atezolizumab or sugemalimab<br /><b>Sponsors</b>:    Base Therapeutics (Shanghai) Co., Ltd.;   The General Hospital of Eastern Theater Command<br /><b>Recruiting</b>"
AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy,http://classic.clinicaltrials.gov/ct2/show/NCT06097949?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Sleep Apnea, Obstructive<br /><b>Intervention</b>:    Device: AcuPebble SA100<br /><b>Sponsors</b>:    Royal Free Hospital NHS Foundation Trust;   Acurable Ltd.<br /><b>Recruiting</b>"
New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06097936?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    PREDICTIVE BIOMARKERS;   Evaluation of HPV-specific E5 Transcript Expression in a Cohort of Patients With HPV-associated OPC;   HPV 16 Positive Oropharyngeal Tumors (OPC)<br /><b>Intervention</b>:    Diagnostic Test: HPV-ASSOCIATED OROPHARYNGEAL CANCER<br /><b>Sponsors</b>:    Regina Elena Cancer Institute;   University of California, San Diego;   Lega Italiana per la Lotta contro i Tumori<br /><b>Recruiting</b>"
Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU),http://classic.clinicaltrials.gov/ct2/show/NCT06097923?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Fluid Overload;   Fluid Loss<br /><b>Interventions</b>:    Drug: Active fluid management with BIA monitoring;   Drug: Conventional fluid management without BIA monitoring<br /><b>Sponsor</b>:    Seoul St. Mary's Hospital<br /><b>Completed</b>
Watchful Waiting for Patients With Multifocal Ground-glass Opacities (ECTOP-1021),http://classic.clinicaltrials.gov/ct2/show/NCT06097910?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Lung Ground-glass Opacities;   Watchful Waiting<br /><b>Intervention</b>:    Procedure: Watchful waiting<br /><b>Sponsor</b>:    Fudan University<br /><b>Not yet recruiting</b>
Imaging of Vitreous Opacities in Human Eyes,http://classic.clinicaltrials.gov/ct2/show/NCT06097897?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Floaters;   Vitreous Opacities<br /><b>Intervention</b>:    Device: SVO-ID<br /><b>Sponsor</b>:    PulseMedica<br /><b>Not yet recruiting</b>
Healthy School mEAls With Less Salt：an Action to Reduce Salt Intake in School Meals for Children in Rural China,http://classic.clinicaltrials.gov/ct2/show/NCT06097884?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Blood Pressure<br /><b>Interventions</b>:    Other: Main study intervention-Salt substitute;   Other: Main study control-Usual salt;   Other: Ancillary study intervention-Meal trays;   Other: Ancillary study control-Bowls<br /><b>Sponsors</b>:    Peking University;   China development research foundation<br /><b>Not yet recruiting</b>
RCT of an Oral Acne Supplement for Adult Women,http://classic.clinicaltrials.gov/ct2/show/NCT06097871?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Acne<br /><b>Interventions</b>:    Dietary Supplement: Skin Nutraceutical Supplement;   Other: Placebo pill<br /><b>Sponsor</b>:    Nutraceutical Wellness Inc.<br /><b>Recruiting</b>
"Spiritual Well-being, Self-compassion, Physical Symptoms Distress and Demoralization Among HD Patients",http://classic.clinicaltrials.gov/ct2/show/NCT06097858?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hemodialysis<br /><b>Intervention</b>:    Other: this is an observation study<br /><b>Sponsor</b>:    National Taiwan University Hospital<br /><b>Completed</b>
Transcranial Ultrasound Via Sonolucent Cranioplasty,http://classic.clinicaltrials.gov/ct2/show/NCT06097845?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cranioplasty;   Sonolucent Cranioplasty;   Reconstructive Cranioplasty<br /><b>Intervention</b>:    Diagnostic Test: Transcranial Ultrasound<br /><b>Sponsor</b>:    Northwell Health<br /><b>Recruiting</b>
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis,http://classic.clinicaltrials.gov/ct2/show/NCT06097832?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Light Chain (AL) Amyloidosis<br /><b>Intervention</b>:    Biological: NXC-201 CAR-T<br /><b>Sponsor</b>:    Nexcella Inc.<br /><b>Not yet recruiting</b>
Therapy-Based Games' Effects on Motor and Cognitive Skills in Intellectual Disabilities,http://classic.clinicaltrials.gov/ct2/show/NCT06097819?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Intellectual Disability<br /><b>Interventions</b>:    Other: Mobile app-based game group;   Other: Supervised combined sensor-based game group;   Other: Individualized occupational therapy group<br /><b>Sponsor</b>:    Istanbul Medipol University Hospital<br /><b>Recruiting</b>
Effects of Different Fresh Gas Flows on Carboxyhemoglobin Levels and Postoperative Patient Outcomes in Pediatric Cardiovascular Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06097806?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Low Flow Anesthesia;   High Flow Anesthesia<br /><b>Intervention</b>:    Other: low and high flow<br /><b>Sponsor</b>:    Basaksehir Cam & Sakura Şehir Hospital<br /><b>Not yet recruiting</b>
KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06097793?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Nasopharyngeal Carcinoma<br /><b>Intervention</b>:    Biological: KSD-101<br /><b>Sponsor</b>:    Kousai Bio Co., Ltd.<br /><b>Not yet recruiting</b>"
Efficacy and Safety of NestaCell® in Huntington's Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06097780?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Huntington Disease<br /><b>Intervention</b>:    Genetic: NestaCell®<br /><b>Sponsors</b>:    Azidus Brasil;   Cellavita Pesquisa Científica Ltda<br /><b>Not yet recruiting</b>
the Incidence of Necrotizing Enterocolitis in Preterm With Respiratory Distress Syndrome Undergoing Caffeine Therapy,http://classic.clinicaltrials.gov/ct2/show/NCT06097767?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Pharmacological Action of Drug<br /><b>Interventions</b>:    Drug: Caffeine citrate;   Drug: Amikacin<br /><b>Sponsor</b>:    Al-Azhar University<br /><b>Active, not recruiting</b>"
Intermittent Exogenous Ketosis (IEK) at High Altitude,http://classic.clinicaltrials.gov/ct2/show/NCT06097754?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Ketosis;   Hypoxia<br /><b>Interventions</b>:    Dietary Supplement: Ketone ester;   Dietary Supplement: Placebo<br /><b>Sponsors</b>:    Jozef Stefan Institute;   KU Leuven;   University of Lausanne<br /><b>Active, not recruiting</b>"
Pulmonary MRI Using Ultra Short /Zero TE Sequences,http://classic.clinicaltrials.gov/ct2/show/NCT06097741?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Image<br /><b>Intervention</b>:    Device: MRI sequences<br /><b>Sponsor</b>:    IWK Health Centre<br /><b>Not yet recruiting</b>
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma,http://classic.clinicaltrials.gov/ct2/show/NCT06097728?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Unresectable Pleural Mesothelioma<br /><b>Interventions</b>:    Drug: Volrustomig;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Nivolumab;   Drug: Ipilimumab<br /><b>Sponsor</b>:    AstraZeneca<br /><b>Not yet recruiting</b>
"Clinical,Endoscopic and Radiological Assessment of Portal Hypertension in Children With Chronic Liver Diseases",http://classic.clinicaltrials.gov/ct2/show/NCT06097715?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Portal Hypertension<br /><b>Interventions</b>:    Diagnostic Test: upper gastrointestinal endoscopy;   Diagnostic Test: 1- Complete blood count 2- Coagulation profile<br /><b>Sponsor</b>:    Sohag University<br /><b>Not yet recruiting</b>
"A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmakinetics of BX-001N After Intravenous Bolus in Healthy Participants",http://classic.clinicaltrials.gov/ct2/show/NCT06097702?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Ischemia-reperfusion Injury<br /><b>Interventions</b>:    Drug: BX-001N Part 1;   Drug: BX-001N Part 2;   Drug: Placebo<br /><b>Sponsor</b>:    Bilix Co.,Ltd.<br /><b>Not yet recruiting</b>"
A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus,http://classic.clinicaltrials.gov/ct2/show/NCT06097689?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Type 1 Diabetes Mellitus;   Type 1 Diabetes Mellitus With Hypoglycemia;   Type 1 Diabetes Mellitus With Hyperglycemia<br /><b>Intervention</b>:    Device: Lab Demo 1.0<br /><b>Sponsors</b>:    Spiden AG;   DCB Research AG<br /><b>Not yet recruiting</b>
"An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users",http://classic.clinicaltrials.gov/ct2/show/NCT06097676?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Abuse Potential<br /><b>Interventions</b>:    Drug: Placebo;   Drug: Alprazolam 2 mg;   Drug: Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg;   Drug: Gabapentin Enacarbil Immediate Release (GE-IR) 450 mg;   Drug: Gabapentin Enacarbil Immediate Release (GE-IR) 700 mg<br /><b>Sponsor</b>:    Azurity Pharmaceuticals<br /><b>Completed</b>
"A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)",http://classic.clinicaltrials.gov/ct2/show/NCT06097663?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Coronary Heart Disease;   Clonal Hematopoiesis of Indeterminate Potential (CHIP)<br /><b>Interventions</b>:    Drug: MAS825;   Drug: MAS825 Placebo;   Drug: DFV890;   Drug: DFV890 placebo<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>
Cold Snare Polypectomy Versus Hot Snare Polypectomy for Resection of Small Pedunculated Colorectal Polyps：a Randomized Controlled Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06097650?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pedunculated Colorectal Polyps;   Haemorrhage<br /><b>Interventions</b>:    Other: cold snare polypectomy;   Other: hot snare polypectomy<br /><b>Sponsor</b>:    Ningbo No. 1 Hospital<br /><b>Recruiting</b>
Underwater Endoscopic Mucosal Resection Versus Metal Clips With Hot Snare Polypectomy for Resection of Big Pedunculated Colorectal Polyps：a Randomized Controlled Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06097637?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pedunculated Colorectal Polyps;   Haemorrhage<br /><b>Interventions</b>:    Other: underwater endoscopic mucosal resection;   Other: hot snare polypectomy<br /><b>Sponsor</b>:    Ningbo No. 1 Hospital<br /><b>Recruiting</b>
Effectiveness of Synchronized Tele-exercise,http://classic.clinicaltrials.gov/ct2/show/NCT06097624?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Intervention</b>:    Other: synchronized tele-exercise<br /><b>Sponsors</b>:    Okan University;   Ankara Medipol University;   Istanbul University - Cerrahpasa (IUC);   Duha Saydam Physical Therapy and Clinical Pilates Center (name of the center);   Ozel Uç Ufuk Çizgisi Special Education and Rehabilitation Center (name of the center<br /><b>Completed</b>
Tranexamic Acid Effect in Pediatric,http://classic.clinicaltrials.gov/ct2/show/NCT06097611?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Tranexamic Acid Effect in Pediatric Polytraumatized Patients<br /><b>Intervention</b>:    Drug: Tranexamic Acid administration<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Prevalence of Irritable Bowel Syndrome in Medical Students Africa,http://classic.clinicaltrials.gov/ct2/show/NCT06097598?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Faculty of Medicine<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Assiut University;   AsyutUniversity<br /><b>Not yet recruiting</b>
Gliflozins on HF in Regurgitant Rheumatic Heart,http://classic.clinicaltrials.gov/ct2/show/NCT06097585?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Rheumatic Heart Disease;   Heart Failure<br /><b>Intervention</b>:    Drug: SGLT2 inhibitor<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Improved Diagnostics in Food Allergy Study,http://classic.clinicaltrials.gov/ct2/show/NCT06097572?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Food Allergy<br /><b>Interventions</b>:    Diagnostic Test: Intranasal food challenge;   Diagnostic Test: Mast cell activation test<br /><b>Sponsors</b>:    Imperial College London;   Royal College of Surgeons, Ireland;   University of Manchester<br /><b>Enrolling by invitation</b>"
International Non-selection Study for ERA® Test in Patients With Previous Implantation Failures,http://classic.clinicaltrials.gov/ct2/show/NCT06097559?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Infertility of Uterine Origin;   Implantation Failure<br /><b>Intervention</b>:    Diagnostic Test: Endometrial fluid and biopsy collection<br /><b>Sponsor</b>:    Igenomix<br /><b>Not yet recruiting</b>
Serum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06097546?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Breast Cancer<br /><b>Intervention</b>:    Diagnostic Test: laboratory test (RAI14 and MACC-1 )<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Improvement of Quality of Life by Cannabinoids in Oncologic Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06097533?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Medical Oncology;   Palliative Care;   Quality of Life;   Cannabinoids<br /><b>Intervention</b>:    Drug: Cannabisextrakt Avextra 10/10 Lösung<br /><b>Sponsors</b>:    University Hospital Schleswig-Holstein;   Avextra Pharma GmbH;   SocraMetrics GmbH<br /><b>Not yet recruiting</b>
Virtual Reality in Postoperative Acute Pain Management in Thoracic Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06097520?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Postoperative Pain<br /><b>Intervention</b>:    Other: VR Intervention<br /><b>Sponsor</b>:    University Hospital, Basel, Switzerland<br /><b>Recruiting</b>"
Patient Perspective on Climate Impact of Inhalers,http://classic.clinicaltrials.gov/ct2/show/NCT06097507?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Asthma<br /><b>Intervention</b>:    Behavioral: Educational intervention<br /><b>Sponsor</b>:    McGill University Health Centre/Research Institute of the McGill University Health Centre<br /><b>Not yet recruiting</b>
Investigating Healthcare Disparities in Vitiligo,http://classic.clinicaltrials.gov/ct2/show/NCT06097494?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Vitiligo<br /><b>Intervention</b>:    Other: No intervention<br /><b>Sponsors</b>:    Momentum Data;   Pfizer<br /><b>Active, not recruiting</b>"
Narrative Intervention for Chronic Illness,http://classic.clinicaltrials.gov/ct2/show/NCT06097481?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Heart Failure;   Heart Failure NYHA Class III;   Heart Failure NYHA Class IV<br /><b>Intervention</b>:    Behavioral: Narrative Intervention for Chronic Illness-Heart Failure<br /><b>Sponsor</b>:    University of Colorado, Denver<br /><b>Not yet recruiting</b>"
Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC),http://classic.clinicaltrials.gov/ct2/show/NCT06097468?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Oral Cavity Squamous Cell Carcinoma<br /><b>Interventions</b>:    Drug: NisinZ® P;   Procedure: Surgery (non-interventional, standard of care)<br /><b>Sponsors</b>:    University of California, San Francisco;   University of California, Los Angeles;   National Cancer Institute (NCI)<br /><b>Not yet recruiting</b>"
First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma,http://classic.clinicaltrials.gov/ct2/show/NCT06097455?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Refractory Non-Hodgkin Lymphoma;   Relapsed Non-Hodgkin Lymphoma<br /><b>Intervention</b>:    Genetic: ARI0003<br /><b>Sponsor</b>:    Fundacion Clinic per a la Recerca Biomédica<br /><b>Not yet recruiting</b>
Effect of Apollo Wearable on Long COVID-19 Symptoms.,http://classic.clinicaltrials.gov/ct2/show/NCT06097442?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Post-acute Sequelae of SARS-COV-2 Infection<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    The Board of Medicine;   Apollo Neuroscience, Inc.<br /><b>Recruiting</b>"
Platelet Aggregation in COVID-19 Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06097429?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    COVID-19<br /><b>Intervention</b>:    Diagnostic Test: blood sample for platelet aggregation<br /><b>Sponsor</b>:    Mansoura University<br /><b>Completed</b>
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06097416?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Rectal Cancer<br /><b>Interventions</b>:    Drug: Neoadjuvant Chemoradiotherapy;   Drug: Total Neoadjuvant Therapy<br /><b>Sponsor</b>:    St. James's Hospital, Ireland<br /><b>Not yet recruiting</b>"
Cardiovascular Complications in Children With COVID 19,http://classic.clinicaltrials.gov/ct2/show/NCT06097403?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    COVID 19 Associated Coagulopathy<br /><b>Intervention</b>:    Diagnostic Test: Covid 19 swap<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III,http://classic.clinicaltrials.gov/ct2/show/NCT06097390?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy Participants<br /><b>Intervention</b>:    Drug: Semaglutide<br /><b>Sponsor</b>:    Novo Nordisk A/S<br /><b>Recruiting</b>
Lymphatic Magnetic Resonance Imaging Abnormalities in Children With Tetralogy of Fallot: A Case-Control Study,http://classic.clinicaltrials.gov/ct2/show/NCT06097377?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Tetralogy of Fallot;   Lymphatic<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Rigshospitalet, Denmark<br /><b>Completed</b>"
A Study to Learn How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Compared to Rituximab and Chemotherapy in Adult Participants With Previously Untreated Follicular Lymphoma,http://classic.clinicaltrials.gov/ct2/show/NCT06097364?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Follicular Lymphoma (FL)<br /><b>Interventions</b>:    Drug: Odronextamab;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone/Prenisolone<br /><b>Sponsor</b>:    Regeneron Pharmaceuticals<br /><b>Recruiting</b>
Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value,http://classic.clinicaltrials.gov/ct2/show/NCT06097351?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Diabetic Nephropathy<br /><b>Intervention</b>:    Other: Grouping based on previous laboratory results, no intervention.<br /><b>Sponsor</b>:    Yipeng Liu<br /><b>Active, not recruiting</b>"
Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF,http://classic.clinicaltrials.gov/ct2/show/NCT06097338?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Fatty Liver Disease, Nonalcoholic<br /><b>Intervention</b>:    Procedure: bariatric surgery (BS)<br /><b>Sponsor</b>:    Qianfoshan Hospital<br /><b>Not yet recruiting</b>"
Impostor Syndrome and Burnout in Swiss Residents and Chief Residents Anaesthesiologists,http://classic.clinicaltrials.gov/ct2/show/NCT06097325?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Impostor Phenomenon;   Imposter Syndrome;   Burnout, Professional;   Burnout, Student<br /><b>Interventions</b>:    Diagnostic Test: Clance impostor phenomenon scale;   Diagnostic Test: Maslach Burnout Inventory for Medical Professional<br /><b>Sponsors</b>:    University Hospital, Geneva;   Prof. Savoldelli Georges Louis<br /><b>Enrolling by invitation</b>"
PREHEVBRIO Pregnancy Outcomes Registry,http://classic.clinicaltrials.gov/ct2/show/NCT06097312?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Vaccine Exposure During Pregnancy<br /><b>Intervention</b>:    Other: Data collection<br /><b>Sponsor</b>:    VBI Vaccines Inc.<br /><b>Not yet recruiting</b>
"A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus",http://classic.clinicaltrials.gov/ct2/show/NCT06097299?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Respiratory Syncytial Virus<br /><b>Interventions</b>:    Biological: mRNA-1345;   Biological: Placebo<br /><b>Sponsor</b>:    ModernaTX, Inc.<br /><b>Not yet recruiting</b>"
A Comparative Study Between Ultrasound Guided External Oblique Intercostal Plane (EOIP) Block and Erector Spinae Plane (ESP) Block for Postoperative Analgesia in Upper Abdominal Surgeries,http://classic.clinicaltrials.gov/ct2/show/NCT06097286?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Block<br /><b>Interventions</b>:    Procedure: external oblique intercostal plane block;   Procedure: erector spinae plane block<br /><b>Sponsor</b>:    Ain Shams University<br /><b>Not yet recruiting</b>
"A Study of mRNA-1083 (SARS-Cov-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age",http://classic.clinicaltrials.gov/ct2/show/NCT06097273?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    SARS-CoV-2;   Influenza<br /><b>Interventions</b>:    Biological: mRNA-1083;   Biological: Placebo;   Biological: Influenza Vaccine;   Biological: COVID-19 Vaccine<br /><b>Sponsor</b>:    ModernaTX, Inc.<br /><b>Not yet recruiting</b>"
"Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis",http://classic.clinicaltrials.gov/ct2/show/NCT06097260?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Idiopathic Pulmonary Fibrosis<br /><b>Interventions</b>:    Drug: PLN-74809;   Drug: Placebo<br /><b>Sponsor</b>:    Pliant Therapeutics, Inc.<br /><b>Recruiting</b>"
Family Functioning and Adverse Side Effects of Family-based Therapy for Anorexia Nervosa,http://classic.clinicaltrials.gov/ct2/show/NCT06097247?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Anorexia in Adolescence;   Anorexia in Children;   Family Relations<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Mental Health Services in the Capital Region, Denmark;   Foreningen Spiseforstyrrelser og Selvskade<br /><b>Recruiting</b>"
Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.,http://classic.clinicaltrials.gov/ct2/show/NCT06097234?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Stress Urinary Incontinence;   Pelvic Floor Disorders<br /><b>Interventions</b>:    Device: Pelex Upp;   Behavioral: Pelvic Floor Physical Therapy<br /><b>Sponsor</b>:    Pelex<br /><b>Not yet recruiting</b>
"The Advance Project - Advancing Sleep Timing to Improve Depression, a Randomised Clinical Trial.",http://classic.clinicaltrials.gov/ct2/show/NCT06097221?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Depression<br /><b>Interventions</b>:    Behavioral: CRT-Advance;   Behavioral: Treatment as usual<br /><b>Sponsor</b>:    Mental Health Centre Copenhagen<br /><b>Not yet recruiting</b>
BMI Development and Risk of Overweight and Obesity in Children,http://classic.clinicaltrials.gov/ct2/show/NCT06097208?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Health Behavior;   Child Obesity;   Body Weight<br /><b>Intervention</b>:    Behavioral: community-based health promotion and obesity prevention intervention<br /><b>Sponsor</b>:    University of Aarhus<br /><b>Completed</b>
The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy,http://classic.clinicaltrials.gov/ct2/show/NCT06097195?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Epilepsy<br /><b>Intervention</b>:    Device: BioEP<br /><b>Sponsor</b>:    Neuronostics Ltd<br /><b>Not yet recruiting</b>
Postbiotic Intervention for Acute Stress Management,http://classic.clinicaltrials.gov/ct2/show/NCT06097182?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Stress Response;   Mood State;   Sleep;   Cognition<br /><b>Interventions</b>:    Dietary Supplement: Postbiotic (Colonic-Delivery capsule);   Dietary Supplement: Postbiotic (Regular Administration capsule);   Other: Placebo<br /><b>Sponsor</b>:    Singapore Institute for Clinical Sciences<br /><b>Recruiting</b>
Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Dental Treatment,http://classic.clinicaltrials.gov/ct2/show/NCT06097169?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Anxiety;   Postoperative Pain;   Nausea<br /><b>Interventions</b>:    Drug: Fentanyl;   Drug: Dexmedetomidine<br /><b>Sponsor</b>:    Medipol University<br /><b>Enrolling by invitation</b>
Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications,http://classic.clinicaltrials.gov/ct2/show/NCT06097156?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Healthy Participants;   Breast Cancer<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Tethis S.p.A.<br /><b>Not yet recruiting</b>
Clinical Performance of Flowable Giomer Versus Nanofilled Composite in Conservative Occlusal Cavities,http://classic.clinicaltrials.gov/ct2/show/NCT06097143?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Occlusal Caries<br /><b>Interventions</b>:    Other: Flowable Giomer;   Other: Flowable Nano-filled composite with S-PRG barrier coat;   Other: Flowable Nano-filled composite<br /><b>Sponsor</b>:    Cairo University<br /><b>Not yet recruiting</b>
Batch Fermentation and Microbiome Analysis,http://classic.clinicaltrials.gov/ct2/show/NCT06097130?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Société des Produits Nestlé (SPN)<br /><b>Not yet recruiting</b>
Role of Multiplex PCR in CAP,http://classic.clinicaltrials.gov/ct2/show/NCT06097117?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Community-acquired Pneumonia<br /><b>Intervention</b>:    Diagnostic Test: MultiplexPCR<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Electrolytes Disturbances in Critically Ill Egyptian Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06097104?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Electrolyte Imbalance<br /><b>Intervention</b>:    Other: electrolytes - serum blood samples<br /><b>Sponsor</b>:    Ain Shams University<br /><b>Enrolling by invitation</b>
Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia,http://classic.clinicaltrials.gov/ct2/show/NCT06097091?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Fibromyalgia<br /><b>Interventions</b>:    Other: Self-management education;   Behavioral: pain neuroscience education<br /><b>Sponsors</b>:    Taipei Medical University;   Ministry of Science and Technology, Taiwan<br /><b>Recruiting</b>"
Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06097078?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Esophageal Cancer;   Esophagus Cancer;   Anastomotic Leak<br /><b>Intervention</b>:    Device: Eso-SPONGE®<br /><b>Sponsors</b>:    Aesculap AG;   B.Braun Surgical SA<br /><b>Not yet recruiting</b>
Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.,http://classic.clinicaltrials.gov/ct2/show/NCT06097065?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Prediabetes;   Diabetes Mellitus;   Gestational Diabetes Mellitus;   Proteomics<br /><b>Intervention</b>:    Diagnostic Test: Oral Glucose Tolerance Test<br /><b>Sponsor</b>:    Zhujiang Hospital<br /><b>Recruiting</b>
Hypotension Predictive Index Effect on Intraoperative Hypotension During Pancreatic Surgery.,http://classic.clinicaltrials.gov/ct2/show/NCT06097052?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Hypotension During Surgery;   Perioperative Complication<br /><b>Intervention</b>:    Device: Hypotension Predictive Index<br /><b>Sponsor</b>:    Istituto Clinico Humanitas<br /><b>Recruiting</b>
"Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease",http://classic.clinicaltrials.gov/ct2/show/NCT06097039?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Non-Alcoholic Fatty Liver Disease<br /><b>Interventions</b>:    Device: abdominal U/S;   Device: Fibroscan with Controlled Attenuated Parameter (CAP scan):<br /><b>Sponsors</b>:    Zagazig University;   Suez University;   Benha University<br /><b>Enrolling by invitation</b>
Role of Inhaled Nitric Oxide in Vascular Mechanics and Right Ventricular Function,http://classic.clinicaltrials.gov/ct2/show/NCT06097026?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Collapsed Lung;   Hemodynamic Stability<br /><b>Interventions</b>:    Procedure: Alveolar recruitment maneuver;   Drug: Nitric Oxide<br /><b>Sponsors</b>:    Fernando Suarez Sipmann;   Air Liquide SA<br /><b>Not yet recruiting</b>
Study of Brain Function Evaluation System for Acute and Prolonged Disorders of Consciousness,http://classic.clinicaltrials.gov/ct2/show/NCT06097013?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Disorder of Consciousness<br /><b>Intervention</b>:    Other: Routine clinical rehabilitation<br /><b>Sponsors</b>:    Xuanwu Hospital, Beijing;   Tianjin University;   Jilin University<br /><b>Enrolling by invitation</b>"
A Study of the Safety and Efficacy of Intelligent Powered Exoskeletons in Postoperative Spinal Rehabilitation,http://classic.clinicaltrials.gov/ct2/show/NCT06097000?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Exoskeleton Device<br /><b>Intervention</b>:    Device: powered exoskeletons<br /><b>Sponsors</b>:    Xuanwu Hospital, Beijing;   BEIJING DNSYS INNOVATION Co. Ltd;   Beijing Haidian Hospital<br /><b>Not yet recruiting</b>"
Teen-to-Teen Videos to Improve Electronic Medical Record Portal Knowledge and Personal Health Information Engagement,http://classic.clinicaltrials.gov/ct2/show/NCT06096987?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Inflammatory Bowel Diseases<br /><b>Interventions</b>:    Other: Electronic medical record portal videos;   Other: General adolescent health videos<br /><b>Sponsors</b>:    Huang, Jeannie, M.D.;   North American Society for Pediatric Gastroenterology Hepatology and Nutrition<br /><b>Active, not recruiting</b>"
"Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS",http://classic.clinicaltrials.gov/ct2/show/NCT06096974?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Advanced Solid Tumors<br /><b>Intervention</b>:    Drug: YL-17231<br /><b>Sponsor</b>:    Shanghai YingLi Pharmaceutical Co. Ltd.<br /><b>Not yet recruiting</b>
"The Effect Of Baby Smell On The Amount Of Breast Milk, Salivary Cortisol Level And Mother Baby Attachment",http://classic.clinicaltrials.gov/ct2/show/NCT06096961?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Mother-Infant Interaction;   Premature Birth<br /><b>Intervention</b>:    Behavioral: Baby smell<br /><b>Sponsor</b>:    Eskisehir Osmangazi University<br /><b>Not yet recruiting</b>
Nexpowder to Prevent Delayed Bleeding After Endoscopic Resection,http://classic.clinicaltrials.gov/ct2/show/NCT06096948?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Gastro Intestinal Bleeding;   Polyps<br /><b>Intervention</b>:    Device: NEXPOWDER-ENDOHS<br /><b>Sponsor</b>:    Erasme University Hospital<br /><b>Recruiting</b>
Exome Evaluation in Patients Living With Diabetes Complicated by Charcot Neuroarthropathy.,http://classic.clinicaltrials.gov/ct2/show/NCT06096935?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Type 2 Diabetes<br /><b>Intervention</b>:    Other: bood sample<br /><b>Sponsor</b>:    Centre Hospitalier Sud Francilien<br /><b>Not yet recruiting</b>
AI-based Frailty Assessment Tool for Patients Undergoing Cardiac Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06096922?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Frailty<br /><b>Intervention</b>:    Other: No intervention<br /><b>Sponsor</b>:    China National Center for Cardiovascular Diseases<br /><b>Not yet recruiting</b>
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population,http://classic.clinicaltrials.gov/ct2/show/NCT06096909?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Acute Coronary Syndrome;   Non ST Segment Elevation Acute Coronary Syndrome<br /><b>Interventions</b>:    Drug: Tafolecimab;   Drug: Cholesterol Absorption Inhibitor;   Drug: Statin<br /><b>Sponsors</b>:    China National Center for Cardiovascular Diseases;   Innovent Biologics, Inc.<br /><b>Not yet recruiting</b>"
"The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study",http://classic.clinicaltrials.gov/ct2/show/NCT06096896?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Early Hepatocellular Carcinoma<br /><b>Intervention</b>:    Procedure: MWA<br /><b>Sponsor</b>:    Shandong Provincial Hospital<br /><b>Active, not recruiting</b>"
Hip Socket Erosion Study,http://classic.clinicaltrials.gov/ct2/show/NCT06096883?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Femoral Neck Fractures;   Hemiarthroplasty;   Acetabulum; Protrusion<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Rijnstate Hospital;   Isala;   Jeroen Bosch Ziekenhuis;   Maxima Medical Center;   Noordwest Ziekenhuisgroep<br /><b>Not yet recruiting</b>
Enzalutamide and M9241 in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy,http://classic.clinicaltrials.gov/ct2/show/NCT06096870?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Prostate Cancer;   Recurrent Prostate Cancer;   PET Positive<br /><b>Interventions</b>:    Drug: Enzalutamide;   Drug: M9241<br /><b>Sponsor</b>:    National Cancer Institute (NCI)<br /><b>Not yet recruiting</b>
Cardamom and Topical Roseomonas in Atopic Dermatitis,http://classic.clinicaltrials.gov/ct2/show/NCT06096857?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Atopic Dermatitis;   Eczema<br /><b>Interventions</b>:    Drug: Roseomonas mucosa (RSM2015) and Cardamom seeds;   Drug: Placebo (sucrose)<br /><b>Sponsor</b>:    National Institute of Allergy and Infectious Diseases (NIAID)<br /><b>Not yet recruiting</b>
"Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial",http://classic.clinicaltrials.gov/ct2/show/NCT06096844?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Advanced Lung Non-Small Cell Carcinoma;   Stage IIIB Lung Cancer AJCC v8;   Stage IIIC Lung Cancer AJCC v8;   Stage IV Lung Cancer AJCC v8<br /><b>Interventions</b>:    Drug: Carboplatin;   Procedure: Computed Tomography;   Procedure: Magnetic Resonance Imaging;   Drug: Nab-paclitaxel;   Drug: Paclitaxel;   Biological: Pembrolizumab;   Drug: Pemetrexed;   Procedure: Positron Emission Tomography;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration<br /><b>Sponsor</b>:    National Cancer Institute (NCI)<br /><b>Not yet recruiting</b>
Living With Stroke - Sustainable Utilization of Healthcare Services,http://classic.clinicaltrials.gov/ct2/show/NCT06096831?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Stroke;   Cerebrovascular Disorders;   Cerebrovascular Accident;   Healthcare Utilization<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    University of Haifa;   Ben-Gurion University of the Negev;   Clalit Health Services;   Carmel Medical Center<br /><b>Not yet recruiting</b>
"Kegel and Abdominal Exercises on Urinary Incontinence Severity, Quality of Life, and Sleep Quality in Menopausal Women",http://classic.clinicaltrials.gov/ct2/show/NCT06096818?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Urinary Incontinence;   Postmenopausal Symptoms;   Sleep Quality<br /><b>Interventions</b>:    Behavioral: Experimental Group: Kegel exercises and abdominal exercises;   Behavioral: Control Group: Kegel exercises<br /><b>Sponsors</b>:    Istanbul University - Cerrahpasa (IUC);   Ondokuz Mayıs University<br /><b>Recruiting</b>
Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR),http://classic.clinicaltrials.gov/ct2/show/NCT06096805?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Fetal Growth Retardation<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Shanghai First Maternity and Infant Hospital<br /><b>Recruiting</b>
Muscle Recovery After Total Knee Arthroplasty,http://classic.clinicaltrials.gov/ct2/show/NCT06096792?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Knee Arthritis, Osteoarthritis<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Hacettepe University<br /><b>Active, not recruiting</b>"
"A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis",http://classic.clinicaltrials.gov/ct2/show/NCT06096779?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Hepatocellular Carcinoma<br /><b>Interventions</b>:    Drug: Atezolizumab;   Drug: Bevacizumab<br /><b>Sponsor</b>:    Genentech, Inc.<br /><b>Not yet recruiting</b>"
the Correlation Between Ovarian Function and Serum Biomarkers,http://classic.clinicaltrials.gov/ct2/show/NCT06096766?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Premature Ovarian Insufficiency;   Diminished Ovarian Reserve;   Biomarker;   Copper;   Ceruloplasmin;   Aging<br /><b>Intervention</b>:    Diagnostic Test: blood test<br /><b>Sponsor</b>:    Shi Yun<br /><b>Recruiting</b>
Comparative Evaluation of Gnathological Function With Bruxoff®,http://classic.clinicaltrials.gov/ct2/show/NCT06096753?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Gnathological Function<br /><b>Intervention</b>:    Device: Bruxoff gnathological function analysis<br /><b>Sponsors</b>:    University of Turin, Italy;   Prof. Andrea Deregibus;   Dr. Armando Crupi;   Dra. Giulia Ambrogio;   Dr. Andrea Roccuzzo;   Miss Lisa Sannicolo<br /><b>Not yet recruiting</b>"
Psychotherapy Effects on Reward Processing in PTSD,http://classic.clinicaltrials.gov/ct2/show/NCT06096740?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Post Traumatic Stress Disorder;   Diminished Pleasure;   Anhedonia;   PTSD;   Chronic PTSD;   Chronic Post-Traumatic Stress Disorder<br /><b>Intervention</b>:    Behavioral: Cognitive Processing Therapy<br /><b>Sponsor</b>:    University of Texas at Austin<br /><b>Not yet recruiting</b>
The Energize! Study for Adults With Knee Replacement,http://classic.clinicaltrials.gov/ct2/show/NCT06096727?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Knee Arthroplasty<br /><b>Intervention</b>:    Behavioral: Energize!<br /><b>Sponsor</b>:    University of South Carolina<br /><b>Recruiting</b>
Addictive Threshold of Nicotine,http://classic.clinicaltrials.gov/ct2/show/NCT06096714?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Smoking Addiction<br /><b>Intervention</b>:    Drug: Nicotine<br /><b>Sponsors</b>:    Yale University;   National Institute on Drug Abuse (NIDA)<br /><b>Not yet recruiting</b>
Use of a Cloud-connected Remote Blood Pressure Monitoring Program During the Postpartum Period for Hypertensive Women,http://classic.clinicaltrials.gov/ct2/show/NCT06096701?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hypertensive Disorder<br /><b>Intervention</b>:    Device: Blood pressure cuff<br /><b>Sponsors</b>:    University of South Carolina;   Prisma Health-Midlands<br /><b>Not yet recruiting</b>
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction,http://classic.clinicaltrials.gov/ct2/show/NCT06096688?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Colorectal Cancer;   Endometrial Cancer;   Hereditary Cancer Syndromes<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Weill Medical College of Cornell University;   National Cancer Institute (NCI)<br /><b>Recruiting</b>
CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study,http://classic.clinicaltrials.gov/ct2/show/NCT06096675?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cardiac Amyloidosis<br /><b>Intervention</b>:    Behavioral: • Cardiac Rehabilitation<br /><b>Sponsor</b>:    Wake Forest University Health Sciences<br /><b>Not yet recruiting</b>
Effects of Verb Network Strenghtening Treatment (VNeST) Via Telerehabilitation on Word Finding in Post-stroke Aphasia.,http://classic.clinicaltrials.gov/ct2/show/NCT06096662?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Aphasia;   Anomia;   Stroke<br /><b>Intervention</b>:    Behavioral: Verb Network Strenghtening Treatment (VNeST)<br /><b>Sponsors</b>:    Vastra Gotaland Region;   The Swedish Research Council<br /><b>Not yet recruiting</b>
The Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged Skin,http://classic.clinicaltrials.gov/ct2/show/NCT06096649?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Photoaging<br /><b>Interventions</b>:    Other: Topical Vehicle + Zinc Di-(dibutyryl lisinate);   Other: Topical Vehicle<br /><b>Sponsors</b>:    Integrative Skin Science and Research;   Sytheon Ltd.<br /><b>Not yet recruiting</b>
National Survey of Young Adult Nutrition,http://classic.clinicaltrials.gov/ct2/show/NCT06096636?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Overweight or Obesity<br /><b>Intervention</b>:    Other: Study participants<br /><b>Sponsors</b>:    USDA Grand Forks Human Nutrition Research Center;   Texas A&amp;M University<br /><b>Recruiting</b>
The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment,http://classic.clinicaltrials.gov/ct2/show/NCT06096623?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cancer;   Breast Cancer;   Colorectal Cancer<br /><b>Intervention</b>:    Behavioral: Weekly Survey<br /><b>Sponsor</b>:    UNC Lineberger Comprehensive Cancer Center<br /><b>Not yet recruiting</b>
Resistance Training in Children,http://classic.clinicaltrials.gov/ct2/show/NCT06096610?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Intervention</b>:    Other: Resistance exercise training<br /><b>Sponsors</b>:    University of Kansas Medical Center;   National Strength and Conditioning Association Foundation<br /><b>Recruiting</b>
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome,http://classic.clinicaltrials.gov/ct2/show/NCT06096597?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Interstitial Cystitis;   Painful Bladder Syndrome;   Painful Bladder Syndrome (PBS)<br /><b>Interventions</b>:    Drug: Clarix Flo;   Drug: Placebo<br /><b>Sponsor</b>:    David Sheyn<br /><b>Not yet recruiting</b>
TIPS Block vs Dual Subsartorial Block,http://classic.clinicaltrials.gov/ct2/show/NCT06096584?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Anesthesia, Local;   Knee Arthropathy<br /><b>Interventions</b>:    Procedure: Triple Injection Perisartorius block;   Procedure: Dual sub sartorial block;   Procedure: Femoral triangle block;   Procedure: Distal adductor canal block;   Procedure: Suprasartorial plane block<br /><b>Sponsor</b>:    Alexandria University<br /><b>Not yet recruiting</b>"
Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers,http://classic.clinicaltrials.gov/ct2/show/NCT06096571?sfpd_d=14&sel_rss=new14,"Tue, 24 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Viral Infection COVID-19<br /><b>Intervention</b>:    Drug: Aterixen<br /><b>Sponsor</b>:    Valenta Pharm JSC<br /><b>Not yet recruiting</b>
The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06096558?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Peritoneal Dialysis<br /><b>Interventions</b>:    Dietary Supplement: Melatonin;   Other: placebo<br /><b>Sponsor</b>:    National Nutrition and Food Technology Institute<br /><b>Not yet recruiting</b>
Axillary Management After Neoadjuvant Chemotherapy,http://classic.clinicaltrials.gov/ct2/show/NCT06096545?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Breast Cancer;   Breast Neoplasms;   Breast Cancer Female<br /><b>Intervention</b>:    Procedure: Axillary sentinal lymph node biopsy<br /><b>Sponsor</b>:    Medipol University<br /><b>Not yet recruiting</b>
Adipose Tissue Blood Flow in Aging Humans,http://classic.clinicaltrials.gov/ct2/show/NCT06096532?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Healthy;   Aging<br /><b>Intervention</b>:    Other: 75 gm oral glucose load<br /><b>Sponsors</b>:    Mayo Clinic;   National Center for Advancing Translational Sciences (NCATS)<br /><b>Not yet recruiting</b>
Text Messaging for Human Immunodeficiency Virus (HIV) Testing in Sexual and Gender Minority (SGM) Teens,http://classic.clinicaltrials.gov/ct2/show/NCT06096519?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    HIV<br /><b>Interventions</b>:    Behavioral: Information, motivation, behavioral skills treatment arm;   Behavioral: Information only control arm<br /><b>Sponsors</b>:    Northwestern University;   National Institute of Mental Health (NIMH)<br /><b>Not yet recruiting</b>"
Nourishing the Community Through Culinary Medicine- Acres Homes,http://classic.clinicaltrials.gov/ct2/show/NCT06096506?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Diabetes;   Elevated Body Mass Index<br /><b>Intervention</b>:    Behavioral: Virtual Culinary Medicine<br /><b>Sponsors</b>:    The University of Texas Health Science Center, Houston;   National Cancer Institute (NCI)<br /><b>Not yet recruiting</b>"
Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum,http://classic.clinicaltrials.gov/ct2/show/NCT06096493?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Rectal Cancer<br /><b>Intervention</b>:    Procedure: curative surgery for cancer rectum<br /><b>Sponsor</b>:    South Valley University<br /><b>Recruiting</b>
Effect of Spinae Erector Block (ESP) and Gabapentin on Recovery and Length of Stay in Adolescent Spinal Fusion Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06096480?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Adolescent Idiopathic Scoliosis<br /><b>Intervention</b>:    Procedure: gabapentin + bilateral spine erector block<br /><b>Sponsor</b>:    Hospital Italiano de Buenos Aires<br /><b>Active, not recruiting</b>"
"The Impact of Exercise Intervention on Physical Function Falls, and Physical Restraint for Long-term Care Residents",http://classic.clinicaltrials.gov/ct2/show/NCT06096467?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Exercise Intervention;   Protein Supplementation<br /><b>Interventions</b>:    Behavioral: Comprehension Exercise Training;   Dietary Supplement: Placebo milk;   Dietary Supplement: Protein Supplement<br /><b>Sponsor</b>:    Cardinal Tien Hospital<br /><b>Recruiting</b>
Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance,http://classic.clinicaltrials.gov/ct2/show/NCT06096454?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Hypothyroidism;   Insulin Resistance<br /><b>Intervention</b>:    Drug: Metformin<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
FSHD Molecular Characterization,http://classic.clinicaltrials.gov/ct2/show/NCT06096441?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Facio-Scapulo-Humeral Dystrophy<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Nationwide Children's Hospital<br /><b>Recruiting</b>
Hemolysis During Pulsed-field and Radiofrequency Ablation,http://classic.clinicaltrials.gov/ct2/show/NCT06096428?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Atrial Fibrillation;   Hemolysis;   Pulsed-field Ablation<br /><b>Interventions</b>:    Device: Pulsed-field ablation;   Device: Radiofrequency ablation<br /><b>Sponsor</b>:    Charles University, Czech Republic<br /><b>Not yet recruiting</b>"
Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury,http://classic.clinicaltrials.gov/ct2/show/NCT06096415?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Traumatic Brain Injury;   Cerebral Edema<br /><b>Interventions</b>:    Drug: ABX-101 1mg;   Drug: ABX-101 2mg<br /><b>Sponsor</b>:    Abalonex, LLC<br /><b>Not yet recruiting</b>"
Gastropexy as a Treatment Option for Paraesophageal Hernia,http://classic.clinicaltrials.gov/ct2/show/NCT06096402?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Paraesophageal Hernia<br /><b>Intervention</b>:    Procedure: no intervention, but surgical practice as usual is continued. Its a pragmatic study<br /><b>Sponsors</b>:    University Hospital of North Norway;   Hvidovre University Hospital;   St. Olavs Hospital<br /><b>Not yet recruiting</b>"
Effect of Acheta Domesticus Supplementation on Post-Exercise Muscle Recovery in Recreationally Active Male,http://classic.clinicaltrials.gov/ct2/show/NCT06096389?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Muscle Soreness<br /><b>Interventions</b>:    Other: 100 Drop Jumps;   Dietary Supplement: Whey supplementation;   Dietary Supplement: Carbohydrate supplementation;   Dietary Supplement: House cricket supplementation<br /><b>Sponsor</b>:    University of Malaya<br /><b>Recruiting</b>
Predictors of HFNC Failure in Patients With AHRF Using Diaphragm Ultrasound,http://classic.clinicaltrials.gov/ct2/show/NCT06096376?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Acute Hypoxemic Respiratory Failure<br /><b>Intervention</b>:    Diagnostic Test: Diaphragm Ultrasound<br /><b>Sponsor</b>:    Queen Mary Hospital, Hong Kong<br /><b>Recruiting</b>"
Predictors of HFNC Failure in Patients With AHRF Using Echocardiography Parameters,http://classic.clinicaltrials.gov/ct2/show/NCT06096363?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Acute Hypoxemic Respiratory Failure<br /><b>Intervention</b>:    Diagnostic Test: Transthoracic Echocardiography<br /><b>Sponsor</b>:    Queen Mary Hospital, Hong Kong<br /><b>Recruiting</b>"
Nutritional Status in Subacute Stroke Patients Under Rehabilitation 2.0,http://classic.clinicaltrials.gov/ct2/show/NCT06096350?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Stroke<br /><b>Interventions</b>:    Device: robotic assisted intervention;   Diagnostic Test: hematochemical analysis;   Device: BIA, hand grip;   Diagnostic Test: nutritional assessment, MNA<br /><b>Sponsor</b>:    Fondazione Don Carlo Gnocchi Onlus<br /><b>Not yet recruiting</b>"
[Trial of device that is not approved or cleared by the U.S. FDA],http://classic.clinicaltrials.gov/ct2/show/NCT06096337?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    <br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    [Redacted]<br /><b>Withheld</b>
Intervention for Sexual and Biomedical HIV Prevention in Vulnerable U.S. Young Adults,http://classic.clinicaltrials.gov/ct2/show/NCT06096324?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Economic Hardship;   Condomless Sex;   Utilization, Health Care<br /><b>Interventions</b>:    Behavioral: Job announcements plus educational sessions, mentoring, a micro-grant, and behavioral economic text messages;   Behavioral: Job announcements<br /><b>Sponsors</b>:    University of North Carolina, Chapel Hill;   National Institute on Minority Health and Health Disparities (NIMHD)<br /><b>Recruiting</b>"
Improvement of Hyperglycemia/Diabetes in Patients to Improve Safety,http://classic.clinicaltrials.gov/ct2/show/NCT06096311?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Diabetes Mellitus, Type 2<br /><b>Intervention</b>:    Other: Interviews<br /><b>Sponsor</b>:    Northwestern University<br /><b>Recruiting</b>"
Bioavailability of Vitamin B12 in Bread Using Fermented Faba Bean as B12 Source in Healthy Volunteers (BeanBread),http://classic.clinicaltrials.gov/ct2/show/NCT06096298?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Vitamin B12 Absorption<br /><b>Interventions</b>:    Other: Vitamin B12 bread;   Other: Control bread<br /><b>Sponsor</b>:    University of Helsinki<br /><b>Not yet recruiting</b>
Heterogeneity and Development of Early COPD,http://classic.clinicaltrials.gov/ct2/show/NCT06096285?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Chronic Obstructive Pulmonary Disease<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    China-Japan Friendship Hospital<br /><b>Recruiting</b>
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy,http://classic.clinicaltrials.gov/ct2/show/NCT06096272?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cerebral Palsy;   Mobile Phone Use;   Pediatric ALL;   Physical Disability;   Physical Inactivity<br /><b>Intervention</b>:    Device: Augment Reality Exergames<br /><b>Sponsor</b>:    Children's Hospital Los Angeles<br /><b>Recruiting</b>
Preventing Injured Knees From osteoArthritis: Severity Outcomes,http://classic.clinicaltrials.gov/ct2/show/NCT06096259?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Osteoarthritis, Knee;   Post-traumatic Osteoarthritis;   ACL Tear<br /><b>Interventions</b>:    Drug: Metformin;   Drug: Placebo<br /><b>Sponsors</b>:    Brigham and Women's Hospital;   Arthritis Foundation<br /><b>Not yet recruiting</b>"
Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF),http://classic.clinicaltrials.gov/ct2/show/NCT06096246?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Persistent Atrial Fibrillation;   Cardiac Arrhythmia;   Catheter Ablation<br /><b>Interventions</b>:    Procedure: Pulmonary vein isolation;   Procedure: DC Cardioversion;   Device: Implantable loop recorder;   Procedure: Femoral sheath insertion<br /><b>Sponsor</b>:    Barts & The London NHS Trust<br /><b>Not yet recruiting</b>
Effect of Exercise on Appetite in Response to Meals,http://classic.clinicaltrials.gov/ct2/show/NCT06096233?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Intervention</b>:    Other: Bouts of Exercise<br /><b>Sponsor</b>:    University of Glasgow<br /><b>Not yet recruiting</b>
Usage of 5-fluorouracil and Carnoy's Solution in Surgical Treatment of Odontogenic Keratocysts,http://classic.clinicaltrials.gov/ct2/show/NCT06096220?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Odontogenic Keratocyst<br /><b>Interventions</b>:    Procedure: Enucleation;   Diagnostic Test: incisional biopsy;   Drug: Application of 5-fluorouracil;   Drug: Application of Carnoy solution<br /><b>Sponsor</b>:    University of Belgrade<br /><b>Enrolling by invitation</b>
DBS for Depression,http://classic.clinicaltrials.gov/ct2/show/NCT06096207?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Treatment Resistant Depression<br /><b>Intervention</b>:    Device: Medtronic SenSight Directional DBS lead<br /><b>Sponsors</b>:    Northwell Health;   Medtronic<br /><b>Recruiting</b>
Vitamin D3-enhanced Eggs in Preschool Children,http://classic.clinicaltrials.gov/ct2/show/NCT06096194?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Vitamin D Deficiency;   25-Hydroxyvitamin D3 Deficiency, Selective<br /><b>Interventions</b>:    Dietary Supplement: vitamin D-enhanced egg;   Other: Control<br /><b>Sponsors</b>:    Instituto Nacional de Salud Publica, Mexico;   DSM Nutritional Products, Inc.<br /><b>Completed</b>"
Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06096181?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Adolescent Idiopathic Scoliosis;   Multimodal Analgesia;   Opioid Induced Hyperalgesia;   Remifentanil;   Dexmedetomidine;   Posterior Spinal Fusion<br /><b>Interventions</b>:    Drug: Remifentanil TIVA;   Drug: Dexmedetomidine TIVA;   Drug: Propofol TIVA<br /><b>Sponsor</b>:    Cedars-Sinai Medical Center<br /><b>Not yet recruiting</b>
Ambispective Study Evaluating the Clinical Results of SAGITTA EVL R Revision Stems,http://classic.clinicaltrials.gov/ct2/show/NCT06096168?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Hip Arthropathy<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Societe dEtude, de Recherche et de Fabrication<br /><b>Recruiting</b>"
Ambispective Study to Assess the Safety and the Performance of SAGITTA EVL R Stem,http://classic.clinicaltrials.gov/ct2/show/NCT06096155?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Hip Arthropathy<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Societe dEtude, de Recherche et de Fabrication<br /><b>Recruiting</b>"
The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion,http://classic.clinicaltrials.gov/ct2/show/NCT06096142?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Venous Stenosis;   Venous Occlusion;   Chronic Renal Failure<br /><b>Interventions</b>:    Device: Solaris DE;   Device: PTA<br /><b>Sponsor</b>:    Scitech Produtos Medicos Ltda<br /><b>Not yet recruiting</b>
Cholangioscopy With Spyglass DS Using Percutaneous Transhepatic Cholangiography Access,http://classic.clinicaltrials.gov/ct2/show/NCT06096129?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Biliary Stricture<br /><b>Intervention</b>:    Procedure: Spy PTC<br /><b>Sponsor</b>:    Rigshospitalet, Denmark<br /><b>Completed</b>"
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass,http://classic.clinicaltrials.gov/ct2/show/NCT06096116?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Acquired Antithrombin Deficiency<br /><b>Interventions</b>:    Drug: Human plasma derived antithrombin;   Drug: Placebo<br /><b>Sponsor</b>:    Octapharma<br /><b>Not yet recruiting</b>
A Clinical Study to Check the Safety and Effectiveness of Botanical Extract Standardized for Iron + Vitamin c and Botanical Extract Standardized for Iron in Adult Human Subjects With Anemia or Iron-deficiency Anemia,http://classic.clinicaltrials.gov/ct2/show/NCT06096103?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Anemia, Iron Deficiency<br /><b>Interventions</b>:    Dietary Supplement: placebo;   Dietary Supplement: Botanical Extract Standardized for Iron + Vitamin C;   Dietary Supplement: Botanical Extract Standardised for Iron<br /><b>Sponsors</b>:    NovoBliss Research Pvt Ltd;   Orgenetics, Inc.<br /><b>Not yet recruiting</b>"
Phase II Clinical Trial of Interleukin-2 in AD,http://classic.clinicaltrials.gov/ct2/show/NCT06096090?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Alzheimer Disease<br /><b>Interventions</b>:    Drug: Interleukin-2;   Drug: Placebo<br /><b>Sponsor</b>:    The Methodist Hospital Research Institute<br /><b>Recruiting</b>
Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department,http://classic.clinicaltrials.gov/ct2/show/NCT06096077?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Angioedema<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Methodist Health System<br /><b>Completed</b>
Medication Use Evaluation (MUE) for Continuous Heparin Infusions in Hospitalized Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06096064?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Unfractionated Heparin<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Methodist Health System<br /><b>Completed</b>
Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage,http://classic.clinicaltrials.gov/ct2/show/NCT06096051?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Intracranial Hemorrhage<br /><b>Intervention</b>:    Procedure: Use of fixed-dosed 4F-PCC<br /><b>Sponsor</b>:    Methodist Health System<br /><b>Recruiting</b>
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC,http://classic.clinicaltrials.gov/ct2/show/NCT06096038?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Head and Neck Cancer;   Relapse;   Recurrent;   Refractory Cancer<br /><b>Interventions</b>:    Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Cell Therapy<br /><b>Sponsors</b>:    UNC Lineberger Comprehensive Cancer Center;   Bellicum Pharmaceuticals;   University Cancer Research Fund at Lineberger Comprehensive Cancer Center<br /><b>Not yet recruiting</b>
Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections,http://classic.clinicaltrials.gov/ct2/show/NCT06096025?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Streptococcus Pneumoniae<br /><b>Intervention</b>:    Drug: pneumoniae bacteremia therapy<br /><b>Sponsor</b>:    Methodist Health System<br /><b>Recruiting</b>
Don't Treat Ghosts Anti-MRSA Antibiotics in Osteomyelitis Without Identified MRSA,http://classic.clinicaltrials.gov/ct2/show/NCT06096012?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Osteomyelitis<br /><b>Intervention</b>:    Drug: Anti-MRSA therapy<br /><b>Sponsor</b>:    Methodist Health System<br /><b>Recruiting</b>
Perfect Fit: Evaluation of a Virtual Coach for Smoking Cessation and Physical Activity,http://classic.clinicaltrials.gov/ct2/show/NCT06095999?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Smoking;   Physical Inactivity<br /><b>Intervention</b>:    Behavioral: Perfect Fit intervention: virtual coaching intervention to quit smoking and increase physical activity<br /><b>Sponsor</b>:    Leiden University Medical Center<br /><b>Recruiting</b>
"A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis",http://classic.clinicaltrials.gov/ct2/show/NCT06095986?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Primary Sclerosing Cholangitis<br /><b>Intervention</b>:    Drug: Aramchol meglumine<br /><b>Sponsors</b>:    Galmed Research and Development, Ltd.;   Virginia Commonwealth University<br /><b>Not yet recruiting</b>"
"Dose-Escalation, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GB-6002 Local Infiltration in Healthy Male Adults",http://classic.clinicaltrials.gov/ct2/show/NCT06095973?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Pain, Postoperative<br /><b>Interventions</b>:    Drug: GB-6002;   Drug: Placebo;   Drug: Naropin injection<br /><b>Sponsor</b>:    G2GBio, Inc.<br /><b>Recruiting</b>"
Telehealth Multi-Component Optional Model (MOM) Study,http://classic.clinicaltrials.gov/ct2/show/NCT06095960?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Maternal Health<br /><b>Interventions</b>:    Behavioral: Telehealth MOM;   Other: Enhanced Standard of Care<br /><b>Sponsors</b>:    University of Arkansas;   Patient-Centered Outcomes Research Institute<br /><b>Not yet recruiting</b>
Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years,http://classic.clinicaltrials.gov/ct2/show/NCT06095947?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    GCP<br /><b>Intervention</b>:    Biological: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent<br /><b>Sponsor</b>:    Hualan Biological Bacterin Co. Ltd.<br /><b>Completed</b>"
Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment,http://classic.clinicaltrials.gov/ct2/show/NCT06095934?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    NSCLC;   EGFR Gene Mutation<br /><b>Intervention</b>:    Other: neo-antigen vaccine<br /><b>Sponsor</b>:    The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School<br /><b>Recruiting</b>
The Effect of a Self-Management Program on Individuals With Scleroderma,http://classic.clinicaltrials.gov/ct2/show/NCT06095921?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Scleroderma;   Systemic Sclerosis<br /><b>Intervention</b>:    Behavioral: Self Management Intervention Program<br /><b>Sponsor</b>:    Emirhan Karakuş<br /><b>Completed</b>
The Effect of Bilateral Rectus Sheath Block Versus Wound Infiltration in Gynecooncological Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06095908?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Postoperative Pain<br /><b>Intervention</b>:    Drug: Bupivacain<br /><b>Sponsor</b>:    Dr. Lutfi Kirdar Kartal Training and Research Hospital<br /><b>Recruiting</b>
Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment,http://classic.clinicaltrials.gov/ct2/show/NCT06095895?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pharmacokinetics;   Area Under Curve;   Tacrolimus;   Immunosuppressive Agents;   Mycophenolic Acid<br /><b>Intervention</b>:    Other: venipuncture<br /><b>Sponsor</b>:    Radboud University Medical Center<br /><b>Not yet recruiting</b>
"Randomized Controlled, Open Clinical Study on Efficacy and Safety of Acupuncture for Bladder Function Recovery After Radical Cervical Cancer Surgery",http://classic.clinicaltrials.gov/ct2/show/NCT06095882?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cervical Cancer<br /><b>Intervention</b>:    Other: acupuncture<br /><b>Sponsor</b>:    Qilu Hospital of Shandong University<br /><b>Not yet recruiting</b>
"Progressive Relaxation Exercises,Breastfeeding",http://classic.clinicaltrials.gov/ct2/show/NCT06095869?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Progressive Relaxation Exercises<br /><b>Interventions</b>:    Other: progressive relaxation exercise;   Other: relaxation background music;   Other: control group<br /><b>Sponsor</b>:    Ege University<br /><b>Recruiting</b>
Evaluation of Masseter and Anterior Temporalis Muscles Activity After Locating Centric Relation,http://classic.clinicaltrials.gov/ct2/show/NCT06095856?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Centric Occlusion - Centric Relation Discrepancy (Disorder)<br /><b>Interventions</b>:    Device: Leaf Gauge;   Device: Lucia Jig;   Device: Kois Deprogrammer<br /><b>Sponsor</b>:    Cairo University<br /><b>Not yet recruiting</b>
"""Bony Changes Around Dental Implant in Free Fibular Graft Versus Non-Vascularized Iliac Crest Graft""",http://classic.clinicaltrials.gov/ct2/show/NCT06095843?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Crestal Bone Loss;   Survival Rate<br /><b>Intervention</b>:    Procedure: placement of dental implants<br /><b>Sponsor</b>:    Ain Shams University<br /><b>Completed</b>
Blood Indices of Systemic Inflammation in Critically Ill Patients With Abdominal Sepsis,http://classic.clinicaltrials.gov/ct2/show/NCT06095830?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Abdominal Sepsis;   Critically Ill<br /><b>Intervention</b>:    Diagnostic Test: Complete blood count<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>
Project VALOR: Veteran Stress and Wellbeing,http://classic.clinicaltrials.gov/ct2/show/NCT06095817?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Alcohol Use Disorder;   Depression<br /><b>Intervention</b>:    Behavioral: Internet Delivered Brief Intervention (IDBI)<br /><b>Sponsors</b>:    Cornell University;   University of Washington<br /><b>Terminated</b>
Clinical Pilot Study of the Percutaneous Ultrasound Jejunostomy Procedure,http://classic.clinicaltrials.gov/ct2/show/NCT06095804?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Jejunostomy; Complications;   Enteral and Supplement Feeds Adverse Reaction;   Safety Issues<br /><b>Intervention</b>:    Device: Percutaneous Ultrasound Jejunostomy<br /><b>Sponsors</b>:    CoapTech;   University of Maryland, Baltimore;   University of Maryland Medical Center<br /><b>Not yet recruiting</b>"
Identification of Immunomodulators Associated With Atrial Fibrillation Reporting: Analysis of the WHO Pharmacovigilance Database,http://classic.clinicaltrials.gov/ct2/show/NCT06095791?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Atrial Fibrillation<br /><b>Intervention</b>:    Drug: Immunomodulators with FDA approval on the 1st January 2023.<br /><b>Sponsor</b>:    University Hospital, Caen<br /><b>Completed</b>"
rTMS Therapy for Treatment-Resistant Depression With Different Targets Guided by pBFS,http://classic.clinicaltrials.gov/ct2/show/NCT06095778?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    MDD;   Major Depressive Disorder;   Treatment Resistant Depression<br /><b>Intervention</b>:    Device: active rTMS<br /><b>Sponsor</b>:    Changping Laboratory<br /><b>Not yet recruiting</b>
Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention,http://classic.clinicaltrials.gov/ct2/show/NCT06095765?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Coronary Artery Disease<br /><b>Interventions</b>:    Drug: Colchicine 0.5 MG Oral Tablet;   Drug: Placebo<br /><b>Sponsors</b>:    AZ Sint-Jan AV;   University Hospital, Ghent;   Belgium Health Care Knowledge Centre<br /><b>Not yet recruiting</b>"
Multiple Myeloma Prognostic Indices,http://classic.clinicaltrials.gov/ct2/show/NCT06095752?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Multiple Myeloma;   Hematologic Diseases<br /><b>Intervention</b>:    Other: blood viscosity , albumin / fibrinogen ratio and red cell distribution<br /><b>Sponsor</b>:    Assiut University<br /><b>Recruiting</b>"
Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002,http://classic.clinicaltrials.gov/ct2/show/NCT06095739?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Hair Diseases;   Alopecia;   Hair Loss<br /><b>Intervention</b>:    Combination Product: DA-OTC-002<br /><b>Sponsor</b>:    Applied Biology, Inc.<br /><b>Completed</b>"
Peppermint Inhalation Versus Swedish Massage on Chemotherapy Induced-Nausea and Vomiting in Children With Leukemia,http://classic.clinicaltrials.gov/ct2/show/NCT06095726?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Leukemia<br /><b>Interventions</b>:    Behavioral: Peppermint Inhalation;   Behavioral: Swedish Massage<br /><b>Sponsor</b>:    Alexandria University<br /><b>Completed</b>
German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa,http://classic.clinicaltrials.gov/ct2/show/NCT06095713?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Fabry Disease<br /><b>Intervention</b>:    Drug: Pegunigalsidase-alfa<br /><b>Sponsors</b>:    Westfälische Wilhelms-Universität Münster;   Chiesi GmbH<br /><b>Recruiting</b>
First Rib Resection Versus Avulsion for Thoracic Outlet Syndrome,http://classic.clinicaltrials.gov/ct2/show/NCT06095700?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Thoracic Outlet Syndrome<br /><b>Interventions</b>:    Procedure: first rib resection;   Procedure: First rib avulsion<br /><b>Sponsor</b>:    University of Sulaimani<br /><b>Recruiting</b>
Mind-body Therapies for Injury-related Pain Management in Elite Athletes,http://classic.clinicaltrials.gov/ct2/show/NCT06095687?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Pain, Acute<br /><b>Interventions</b>:    Behavioral: Mindfulness Meditation;   Behavioral: Clinical Hypnosis<br /><b>Sponsors</b>:    The University of Queensland;   University of Alabama, Tuscaloosa<br /><b>Not yet recruiting</b>"
ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study,http://classic.clinicaltrials.gov/ct2/show/NCT06095674?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cervical Cancer<br /><b>Intervention</b>:    Drug: Anti-PD-1 antibody balstilimab<br /><b>Sponsors</b>:    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Dutch Cancer Society;   Agenus Inc.<br /><b>Not yet recruiting</b>
Virtual Reality as a Postoperative Pain Management Adjunct in Older Adults: An Acceptability and Feasibility Study,http://classic.clinicaltrials.gov/ct2/show/NCT06095661?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Aged;   Surgery;   Pain, Postoperative;   Virtual Reality<br /><b>Intervention</b>:    Other: REAL System i-Series VR head-mounted display (HMD) from Penumbra, Inc.<br /><b>Sponsor</b>:    University of California, San Francisco<br /><b>Recruiting</b>"
Study Comparing Platelet Transfusion Volumes in Premature Babies,http://classic.clinicaltrials.gov/ct2/show/NCT06095648?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Thrombocytopenia;   Transfusion<br /><b>Intervention</b>:    Other: Dose of platelet transfusion<br /><b>Sponsors</b>:    University College Dublin;   Health Research Board, Ireland;   National Maternity Hospital, Ireland;   Irish Blood Transfusion Service<br /><b>Not yet recruiting</b>"
Acute Influence of Resveratrol Supplementation and Beet Extract in Recovery After Exercise in Coronary Paths,http://classic.clinicaltrials.gov/ct2/show/NCT06095635?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Coronary Artery Disease;   Autonomic Nervous System Disease;   Blood Pressure;   Heart Rate<br /><b>Interventions</b>:    Other: Placebo Protocol;   Other: Protocol Beet;   Other: Protocol Resveratrol;   Other: Protocol Beet and Resveratrol<br /><b>Sponsor</b>:    Universidade Estadual Paulista Júlio de Mesquita Filho<br /><b>Completed</b>
Chickpea Pulao Using Fenugreek Seeds and Indian Rennet for Improving Blood Glycaemic Levels,http://classic.clinicaltrials.gov/ct2/show/NCT06095622?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Glucose Metabolism Disorders (Including Diabetes Mellitus)<br /><b>Intervention</b>:    Dietary Supplement: Fenugreek Seeds and Indian Rennet<br /><b>Sponsor</b>:    University of Management and Technology Lahore<br /><b>Completed</b>
The Implementation of Early Mobilization and Chest Physiotherapy on Weaning Rate of Prolong Weaning Patients.,http://classic.clinicaltrials.gov/ct2/show/NCT06095609?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Prolonged Weaning, Early Mobilization, Chest Physiotherapy<br /><b>Intervention</b>:    Other: Early mobilization plus chest physiotherapy<br /><b>Sponsor</b>:    Taoyuan General Hospital<br /><b>Completed</b>"
Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis,http://classic.clinicaltrials.gov/ct2/show/NCT06095596?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Crohn Disease<br /><b>Interventions</b>:    Drug: Upadacitinib;   Drug: Vedolizumab<br /><b>Sponsor</b>:    Sixth Affiliated Hospital, Sun Yat-sen University<br /><b>Not yet recruiting</b>"
A Study to Assess Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC),http://classic.clinicaltrials.gov/ct2/show/NCT06095583?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Limited-stage Small Cell Lung Cancer (LS-SCLC)<br /><b>Interventions</b>:    Drug: Tifcemalimab injection;   Drug: toripalimab injection;   Drug: Placebo for Tifcemalimab;   Drug: Placebo for toripalimab<br /><b>Sponsor</b>:    Shanghai Junshi Bioscience Co., Ltd.<br /><b>Not yet recruiting</b>"
The Study of Ciprofol for the Suppression of Cardiovascular Responses to Tracheal Intubation,http://classic.clinicaltrials.gov/ct2/show/NCT06095570?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Intubation, Intratracheal;   Adverse Effects<br /><b>Interventions</b>:    Drug: Ciprofol;   Drug: Remimazolam<br /><b>Sponsor</b>:    The Second Affiliated Hospital of Hainan Medical University<br /><b>Recruiting</b>"
MCG Discovery Study in Emergency Departments,http://classic.clinicaltrials.gov/ct2/show/NCT06095557?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    ACS - Acute Coronary Syndrome;   NSTEMI - Non-ST Segment Elevation MI<br /><b>Intervention</b>:    Device: Sponsor MCG device<br /><b>Sponsor</b>:    SB Technology, Inc.<br /><b>Recruiting</b>"
Enhanced Recovery After Surgery for SPK Transplantation Recipients,http://classic.clinicaltrials.gov/ct2/show/NCT06095544?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Transplant Complication;   Diabetic Nephropathy;   Perioperative/Postoperative Complications<br /><b>Intervention</b>:    Procedure: Enhanced recovery for SPK recipients<br /><b>Sponsor</b>:    Second Affiliated Hospital of Guangzhou Medical University<br /><b>Completed</b>
[Trial of device that is not approved or cleared by the U.S. FDA],http://classic.clinicaltrials.gov/ct2/show/NCT06095531?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    <br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    [Redacted]<br /><b>Withheld</b>
DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study,http://classic.clinicaltrials.gov/ct2/show/NCT06095518?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Extracorporeal Circulation; Complications;   Extracorporeal Membrane Oxygenation Complication<br /><b>Intervention</b>:    Diagnostic Test: DIC markers and Thrombin Generation Parameters<br /><b>Sponsor</b>:    Queen Mary Hospital, Hong Kong<br /><b>Recruiting</b>"
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06095505?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Small Cell Lung Cancer<br /><b>Intervention</b>:    Drug: Alisertib<br /><b>Sponsor</b>:    Puma Biotechnology, Inc.<br /><b>Not yet recruiting</b>"
"Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus",http://classic.clinicaltrials.gov/ct2/show/NCT06095492?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Kidney Transplant; Complications;   Diabetes Mellitus<br /><b>Interventions</b>:    Drug: Empagliflozin 25 MG;   Drug: Linagliptin<br /><b>Sponsor</b>:    Medanta, The Medicity, India<br /><b>Not yet recruiting</b>"
Ultrasound Liver Fat Quantification on Pediatric Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06095479?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Non-Alcoholic Fatty Liver Disease<br /><b>Intervention</b>:    Device: 2D ultrasound scan and MRI examination<br /><b>Sponsors</b>:    Philips (China) Investment CO., LTD;   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine<br /><b>Recruiting</b>"
"Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology",http://classic.clinicaltrials.gov/ct2/show/NCT06095466?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Cirrhotic Cardiomyopathy;   Cirrhosis, Liver;   Cardiac Disease<br /><b>Interventions</b>:    Device: Echocardiographic assessment;   Diagnostic Test: Histopathology and Immunohistochemistry<br /><b>Sponsor</b>:    Postgraduate Institute of Medical Education and Research<br /><b>Recruiting</b>"
Evaluation of the Analgesic Efficacy of Multimodal Pain Control Regimens That Aim to Limit the Use of Narcotics in Cholecystectomy and Hernia Repairs,http://classic.clinicaltrials.gov/ct2/show/NCT06095453?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Acute Pain<br /><b>Intervention</b>:    Other: Pain control regimens<br /><b>Sponsor</b>:    Methodist Health System<br /><b>Active, not recruiting</b>"
A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center,http://classic.clinicaltrials.gov/ct2/show/NCT06095440?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hepatorenal Syndrome<br /><b>Intervention</b>:    Other: Hepatorenal Syndrome outcome in Patients at Methodist Health systems<br /><b>Sponsor</b>:    Methodist Health System<br /><b>Recruiting</b>
"A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection",http://classic.clinicaltrials.gov/ct2/show/NCT06095427?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Biological: LY06006 (Denosumab Biosimilar);   Biological: US-Prolia (Denosumab);   Biological: EU-Prolia<br /><b>Sponsors</b>:    Luye Pharma Group Ltd.;   Parexel<br /><b>Completed</b>
Prospective Radiomics Study for Breast Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06095414?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Breast Cancer<br /><b>Intervention</b>:    Diagnostic Test: MRI<br /><b>Sponsor</b>:    Korea University Ansan Hospital<br /><b>Completed</b>
Swelling Management After Knee Replacement,http://classic.clinicaltrials.gov/ct2/show/NCT06095401?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Arthroplasties, Knee Replacement<br /><b>Interventions</b>:    Other: Inelastic adjustable compression garment (INCOM);   Other: Elastic compression garment (CONTROL)<br /><b>Sponsors</b>:    University of Colorado, Denver;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)<br /><b>Not yet recruiting</b>"
Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA,http://classic.clinicaltrials.gov/ct2/show/NCT06095388?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Mucopolysaccharidosis III-A<br /><b>Intervention</b>:    Drug: JR-441<br /><b>Sponsor</b>:    JCR Pharmaceuticals Co., Ltd.<br /><b>Recruiting</b>"
"Regorafenib in Combination With Temozolomide With or Without Radiotherapy in Patients With Newly Diagnosed MGMT-Methylated, IDH Wild-type Glioblastoma.",http://classic.clinicaltrials.gov/ct2/show/NCT06095375?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Glioblastoma, IDH-wildtype;   MGMT-Methylated Glioblastoma<br /><b>Interventions</b>:    Drug: Regorafenib;   Drug: Temozolomide<br /><b>Sponsor</b>:    Istituto Oncologico Veneto IRCCS<br /><b>Recruiting</b>"
Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW,http://classic.clinicaltrials.gov/ct2/show/NCT06095362?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Thyroid Carcinoma;   Surgery<br /><b>Intervention</b>:    Drug: Bevacizumab-IRDye800CW<br /><b>Sponsors</b>:    University Medical Center Groningen;   Dutch Cancer Society<br /><b>Enrolling by invitation</b>
Effect of Sulfur Thermal Water on Circulating H2S Levels and Markers of Bone Metabolism in Osteopenic Subjects.,http://classic.clinicaltrials.gov/ct2/show/NCT06095349?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Hydrogen Sulfide;   Osteoporosis<br /><b>Intervention</b>:    Other: inhalatory treatment with sulfureous aerosol<br /><b>Sponsor</b>:    Istituto Ortopedico Rizzoli<br /><b>Recruiting</b>
Telerehabilitation and Conventional Physiotherapy Program for Caregivers of Individuals With Special Needs,http://classic.clinicaltrials.gov/ct2/show/NCT06095336?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Telerehabilitation;   Neck Pain<br /><b>Intervention</b>:    Other: telerehabilitation<br /><b>Sponsor</b>:    Inonu University<br /><b>Not yet recruiting</b>
Comparing Level 1 Compression Sleeves With Routine Care in Preventing Breast Cancer-related Arm Lymphedema,http://classic.clinicaltrials.gov/ct2/show/NCT06095323?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Breast Cancer-related Arm Lymphedema<br /><b>Intervention</b>:    Device: compression sleeves for upper limbs with a pressure level of 1 (15-20mmHg)<br /><b>Sponsor</b>:    Zhenzhen Liu<br /><b>Not yet recruiting</b>
Clinical and Objective Psychiatric Analyses in Severe Depression.,http://classic.clinicaltrials.gov/ct2/show/NCT06095310?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Depression<br /><b>Intervention</b>:    Behavioral: New computer vision methods<br /><b>Sponsor</b>:    University Hospital, Lille<br /><b>Not yet recruiting</b>"
Long COVID Brain Fog: Cognitive Rehabilitation Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06095297?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Long COVID;   Brain Fog;   Cognitive Impairment;   Cognitive Dysfunction;   Post-Acute COVID-19 Syndrome<br /><b>Interventions</b>:    Behavioral: Speed of Processing Training;   Behavioral: In-lab Instrumental Activities of Daily Living Training;   Behavioral: In-lab Brain Health Training;   Behavioral: Transfer Package;   Behavioral: Follow Up Phone Calls;   Behavioral: Vocational Rehabilitation;   Behavioral: Peer Mentoring<br /><b>Sponsors</b>:    University of Alabama at Birmingham;   National Institute on Disability, Independent Living, and Rehabilitation Research<br /><b>Not yet recruiting</b>"
Prescribing Trends and Associated Outcomes of Antiepileptic Drugs in US Nursing Homes Surrounding the COVID-19 Pandemic,http://classic.clinicaltrials.gov/ct2/show/NCT06095284?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Dementia<br /><b>Interventions</b>:    Other: Pre-Extraction Phase;   Other: Extraction Phase;   Other: Post-Extraction Phase<br /><b>Sponsors</b>:    Virginia Commonwealth University;   National Institute on Aging (NIA)<br /><b>Enrolling by invitation</b>
MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC,http://classic.clinicaltrials.gov/ct2/show/NCT06095271?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Multiple Sclerosis, Relapsing-Remitting<br /><b>Intervention</b>:    Diagnostic Test: serum Neurofilament Filament Light chain (sNfL) monitoring<br /><b>Sponsor</b>:    University Hospital, Basel, Switzerland<br /><b>Not yet recruiting</b>"
A Practical RCT of TCM in the Treatment of LCOVID and Analysis of Syndrome Types and Medication Characteristics.,http://classic.clinicaltrials.gov/ct2/show/NCT06095258?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Long COVID<br /><b>Interventions</b>:    Drug: Traditional Chinese medicine treatment;   Drug: Western medicine treatment<br /><b>Sponsor</b>:    Chinese University of Hong Kong<br /><b>Not yet recruiting</b>
The Outcome of Subthalamic Deep Brain Stimulation in Advanced Parkinson's Disease and Morphometry,http://classic.clinicaltrials.gov/ct2/show/NCT06095245?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Parkinson Disease<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Hospital District of Helsinki and Uusimaa<br /><b>Active, not recruiting</b>"
Pilot Study to Investigate Dietary Changes During Pregnancy,http://classic.clinicaltrials.gov/ct2/show/NCT06095232?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pregnancy Related<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    German Institute of Human Nutrition<br /><b>Recruiting</b>
MRI-based 3D Hip Labrum and Cartilage Morphology in Patients With Hip Deformities Compared to Asymptomatic Volunteers,http://classic.clinicaltrials.gov/ct2/show/NCT06095219?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Hip Disease<br /><b>Interventions</b>:    Other: Non- contrast Magnetic Resonance Imaging (MRI) of the hip;   Other: Magnetic Resonance Imaging (MRI) of the hip with intra-articular contrast agent<br /><b>Sponsor</b>:    Insel Gruppe AG, University Hospital Bern<br /><b>Recruiting</b>"
The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site,http://classic.clinicaltrials.gov/ct2/show/NCT06095206?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Infertility<br /><b>Intervention</b>:    Drug: GenSci094<br /><b>Sponsors</b>:    Changchun GeneScience Pharmaceutical Co., Ltd.;   Afﬁliated Hospital of North Sichuan Medical College<br /><b>Recruiting</b>"
The Effect of Education on Vaginal Effects of Menopausal Women,http://classic.clinicaltrials.gov/ct2/show/NCT06095193?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Menopause;   Aging;   Failure of Genital Response<br /><b>Intervention</b>:    Behavioral: menopause education<br /><b>Sponsor</b>:    Gaziantep Islam Science and Technology University<br /><b>Not yet recruiting</b>
Comparison of Ultrasound-guided Steroid Injection and Dry Needling in Piriformis Muscle Syndrome,http://classic.clinicaltrials.gov/ct2/show/NCT06095180?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Piriformis Muscle Syndrome<br /><b>Interventions</b>:    Other: corticosteroid injection;   Other: dry needling;   Other: exercise<br /><b>Sponsor</b>:    Gaziler Physical Medicine and Rehabilitation Education and Research Hospital<br /><b>Not yet recruiting</b>
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC,http://classic.clinicaltrials.gov/ct2/show/NCT06095167?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Nasopharyngeal Carcinoma<br /><b>Interventions</b>:    Drug: without concurrent cisplatin chemotherapy;   Drug: with concurrent cisplatin chemotherapy<br /><b>Sponsor</b>:    Fujian Cancer Hospital<br /><b>Not yet recruiting</b>
New-mode Clinical Target Volume Delineation of Nasopharyngeal Carcinoma,http://classic.clinicaltrials.gov/ct2/show/NCT06095154?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Nasopharyngeal Carcinoma by AJCC V8 Stage<br /><b>Intervention</b>:    Radiation: New-mode reduce-volume target IMRT<br /><b>Sponsor</b>:    Fujian Cancer Hospital<br /><b>Not yet recruiting</b>
Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency,http://classic.clinicaltrials.gov/ct2/show/NCT06095141?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Pancreatic Adenocarcinoma;   Homologous Recombination Deficiency<br /><b>Intervention</b>:    Drug: Cisplatin<br /><b>Sponsor</b>:    Fudan University<br /><b>Not yet recruiting</b>
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC),http://classic.clinicaltrials.gov/ct2/show/NCT06095128?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ulcerative Colitis<br /><b>Interventions</b>:    Drug: Vedolizumab;   Drug: Tofacitinib<br /><b>Sponsor</b>:    Takeda<br /><b>Not yet recruiting</b>
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis,http://classic.clinicaltrials.gov/ct2/show/NCT06095115?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Plaque Psoriasis<br /><b>Interventions</b>:    Drug: JNJ-77242113;   Drug: Placebo<br /><b>Sponsor</b>:    Janssen Research & Development, LLC<br /><b>Recruiting</b>"
"A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)",http://classic.clinicaltrials.gov/ct2/show/NCT06095102?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Plaque Psoriasis<br /><b>Interventions</b>:    Drug: JNJ-77242113;   Drug: Placebo<br /><b>Sponsor</b>:    Janssen Research & Development, LLC<br /><b>Recruiting</b>"
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06095089?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Advanced Prostate Cancer<br /><b>Interventions</b>:    Drug: JNJ-78278343;   Drug: JNJ-87189401<br /><b>Sponsor</b>:    Janssen Research & Development, LLC<br /><b>Not yet recruiting</b>"
Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc),http://classic.clinicaltrials.gov/ct2/show/NCT06095076?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Dysbiosis;   Catheter-Related Infections<br /><b>Interventions</b>:    Diagnostic Test: Skin swabbing;   Other: Data collection<br /><b>Sponsors</b>:    Centre Hospitalier de Cayenne;   Tropical Biome and ImmunoPhysiopathology (TBIP) - French Guiana University (Université de Guyane)<br /><b>Recruiting</b>
dTMS for Subjective Cognitive Decline,http://classic.clinicaltrials.gov/ct2/show/NCT06095063?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Alzheimer Disease;   Subjective Cognitive Decline<br /><b>Interventions</b>:    Device: Active Brainsway H7-Coil Deep TMS System;   Device: Sham Brainsway H7-Coil Deep TMS System;   Other: Cognitive Training<br /><b>Sponsors</b>:    Rotman Research Institute at Baycrest;   Brainsway;   Centre for Addiction and Mental Health<br /><b>Recruiting</b>
Embolization Treatment of Chronic Refractory Shoulder Tendinopathy,http://classic.clinicaltrials.gov/ct2/show/NCT06095050?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Shoulder Pain;   Tendinopathy;   Rotator Cuff Tendinitis;   Rotator Cuff Tendinosis;   Embolization;   Arterial Occlusion<br /><b>Interventions</b>:    Device: Embolization with Physical Therapy;   Other: Physical Therapy<br /><b>Sponsor</b>:    Brigham and Women's Hospital<br /><b>Not yet recruiting</b>
Mindful Yoga for Older Adults and Caregivers,http://classic.clinicaltrials.gov/ct2/show/NCT06095037?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Psychological<br /><b>Interventions</b>:    Behavioral: Mindful yoga;   Behavioral: Psychoeducation<br /><b>Sponsor</b>:    The University of Hong Kong<br /><b>Not yet recruiting</b>
INvestigating DIGital Outcomes in the Community,http://classic.clinicaltrials.gov/ct2/show/NCT06095024?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cancer<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Imperial College London;   Imperial College Healthcare NHS Trust<br /><b>Not yet recruiting</b>
Posture Correction in Cubital Tunnel Syndrome,http://classic.clinicaltrials.gov/ct2/show/NCT06095011?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cubital Tunnel Syndrome<br /><b>Intervention</b>:    Device: UpRight Go<br /><b>Sponsor</b>:    Yale University<br /><b>Not yet recruiting</b>
Health Status of Children Born After Assisted Reproductive Technologies,http://classic.clinicaltrials.gov/ct2/show/NCT06094998?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Children Born After Assisted Reproductive Technologies;   Health Status;   Child Development<br /><b>Intervention</b>:    Diagnostic Test: hemogram examination<br /><b>Sponsors</b>:    Kazakhstan's Medical University ""KSPH"";   Vyacheslav Notanovich Lokshin;   Nurgalieva Zhanar Zhenisovna;   Manzhuova Lyazzat Nurbapayevna;   Abshekenova Aigerim Temirkhanovna;   Valeria Nekhorosheva;   Kusainova Farida Azimovna<br /><b>Recruiting</b>"
Prognostic Markers for a Better Follow-up in Head and Neck Cancer.,http://classic.clinicaltrials.gov/ct2/show/NCT06094985?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Head and Neck Cancer<br /><b>Intervention</b>:    Genetic: DNA exome sequencing of tumor and blood<br /><b>Sponsor</b>:    Karolinska Institutet<br /><b>Recruiting</b>
The Effectiveness of A-CRA in Compulsory Institutional Care for Youth,http://classic.clinicaltrials.gov/ct2/show/NCT06094972?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Substance Use Disorders;   Criminal Behavior<br /><b>Interventions</b>:    Behavioral: Adolescent Community Reinforcement Approach, A-CRA;   Behavioral: TAU<br /><b>Sponsor</b>:    Karolinska Institutet<br /><b>Recruiting</b>"
Integrating Suicide Prevention Packages Into Task-shifted Mental Health Interventions in Low-resourced Contexts,http://classic.clinicaltrials.gov/ct2/show/NCT06094959?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Suicide Prevention<br /><b>Intervention</b>:    Other: Suicide Prevention Package<br /><b>Sponsors</b>:    Yale University;   Dhulikhel Hospital, Kathmandu University School of Medical Sciences;   American Foundation for Suicide Prevention<br /><b>Recruiting</b>"
Parturient Satisfaction With Epidural Analgesia by PCEA or Manual Boluses,http://classic.clinicaltrials.gov/ct2/show/NCT06094946?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Labor Pain<br /><b>Interventions</b>:    Drug: Ropivacaine Hydrocloride;   Drug: Fentanyl Citrate<br /><b>Sponsors</b>:    Women's Hospital HUS;   Helsinki University Central Hospital<br /><b>Not yet recruiting</b>
Randomized Clinical Trial of MARI,http://classic.clinicaltrials.gov/ct2/show/NCT06094933?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Posttraumatic Stress Disorder;   Anger<br /><b>Interventions</b>:    Behavioral: Mobile Anger Reduction Intervention (MARI);   Behavioral: Health Education Condition (HED)<br /><b>Sponsor</b>:    VA Office of Research and Development<br /><b>Not yet recruiting</b>
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06094920?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Diabetes Mellitus Type 2 With Proteinuria;   Diabetes Mellitus, Type 2;   Diabetes Mellitus;   Diabetes;   Diabetes Complications;   Albuminuria;   Chronic Kidney Diseases;   Chronic Kidney Disease Due to Type 2 Diabetes Mellitus;   Chronic Kidney Disease stage3;   Chronic Kidney Disease stage4;   CKD;   CKD Stage 3;   CKD Stage 4<br /><b>Interventions</b>:    Drug: Empagliflozin 10 MG;   Drug: Finerenone;   Device: Withings BPM Connect;   Device: Withings Body;   Diagnostic Test: PeeSpot Urine Collection Device;   Diagnostic Test: Hem-Col Capillary Blood Collection Device;   Behavioral: Questionnaire: participants' perspectives toward the feasibility of participation in a trial at home with digital technologies<br /><b>Sponsors</b>:    University Medical Center Groningen;   Boehringer Ingelheim<br /><b>Not yet recruiting</b>"
"Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression",http://classic.clinicaltrials.gov/ct2/show/NCT06094907?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Depressive Disorder;   Depression, Unipolar<br /><b>Intervention</b>:    Drug: N,N-Dimethyltryptamine<br /><b>Sponsor</b>:    Universidade Federal do Rio Grande do Norte<br /><b>Recruiting</b>"
Effects of Sucralose in Gut Intestinal Microbiota and Postprandial GLP-1,http://classic.clinicaltrials.gov/ct2/show/NCT06094894?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    GLP-1;   Gut Microbiota<br /><b>Interventions</b>:    Other: sucralose;   Other: placebo<br /><b>Sponsor</b>:    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran<br /><b>Recruiting</b>
"A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)",http://classic.clinicaltrials.gov/ct2/show/NCT06094881?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Immune Thrombocytopenia;   Treatment<br /><b>Intervention</b>:    Drug: Obinutuzumab Injection [Gazyva]<br /><b>Sponsor</b>:    Institute of Hematology & Blood Diseases Hospital, China<br /><b>Not yet recruiting</b>"
Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06094868?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Gastric Cancer<br /><b>Intervention</b>:    Drug: Fruquintinib<br /><b>Sponsor</b>:    Second Affiliated Hospital of Nanchang University<br /><b>Not yet recruiting</b>
Effect of Cooling on Balance Performance in Multiple Sclerosis,http://classic.clinicaltrials.gov/ct2/show/NCT06094855?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: 20 minutes of biking on a stationary recumbent bicycle with and without a cooling vest<br /><b>Sponsor</b>:    Hunter College of City University of New York<br /><b>Recruiting</b>
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06094842?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Prostate Carcinoma;   Prostate Small Cell Neuroendocrine Carcinoma;   Stage III Prostate Cancer AJCC v8;   Stage IV Prostate Cancer AJCC v8<br /><b>Interventions</b>:    Drug: Bendamustine;   Procedure: Biopsy;   Procedure: Biospecimen Collection;   Procedure: Bone Scan;   Procedure: Bridge Therapy;   Procedure: Computed Tomography;   Drug: Cyclophosphamide;   Procedure: Echocardiography;   Drug: Fludarabine;   Procedure: Leukapheresis;   Procedure: Multigated Acquisition Scan;   Biological: T-cell Receptor-engineered T-cells;   Procedure: X-Ray Imaging<br /><b>Sponsors</b>:    Fred Hutchinson Cancer Center;   Bristol-Myers Squibb<br /><b>Not yet recruiting</b>
Tobacco and Alcohol Influence on Oncogenic Drivers and Somatic Evolution in the Oral Mucosa,http://classic.clinicaltrials.gov/ct2/show/NCT06094829?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Carcinoma, Squamous Cell<br /><b>Intervention</b>:    Other: Oral cytobrush<br /><b>Sponsor</b>:    Hospices Civils de Lyon<br /><b>Not yet recruiting</b>"
Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study,http://classic.clinicaltrials.gov/ct2/show/NCT06094816?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Salt-Sensitivity of Blood Pressure<br /><b>Interventions</b>:    Drug: Furosemide (Diuretic);   Other: Hypertonic Saline Infusion<br /><b>Sponsors</b>:    University of Delaware;   National Heart, Lung, and Blood Institute (NHLBI)<br /><b>Not yet recruiting</b>"
Mindfulness-based Zentangle for Parents,http://classic.clinicaltrials.gov/ct2/show/NCT06094803?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Depressive Symptoms;   Anxiety;   Well-Being, Psychological<br /><b>Intervention</b>:    Behavioral: Mindfulness-based Zentangle Program<br /><b>Sponsor</b>:    Hong Kong Metropolitan University<br /><b>Not yet recruiting</b>"
A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects,http://classic.clinicaltrials.gov/ct2/show/NCT06094790?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Drug: CORT125134 150 mg;   Drug: CORT125134 250 mg;   Drug: CORT125134 dose to be determined<br /><b>Sponsor</b>:    Corcept Therapeutics<br /><b>Completed</b>
A Study of HY-0102 in Patients With Advanced Solid Tumors,http://classic.clinicaltrials.gov/ct2/show/NCT06094777?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Advanced Solid Tumor<br /><b>Intervention</b>:    Drug: HY-0102<br /><b>Sponsor</b>:    Shanghai YingLi Pharmaceutical Co. Ltd.<br /><b>Not yet recruiting</b>
S&B Heat Stress Pilot Protocols,http://classic.clinicaltrials.gov/ct2/show/NCT06094764?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Thermal Discomfort<br /><b>Interventions</b>:    Device: Group A;   Device: Group B<br /><b>Sponsors</b>:    The University of Texas Health Science Center, Houston;   National Institute for Occupational Safety and Health (NIOSH/CDC)<br /><b>Completed</b>"
An ACT Website for College Students With Insomnia,http://classic.clinicaltrials.gov/ct2/show/NCT06094751?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Insomnia<br /><b>Intervention</b>:    Behavioral: ACT Guide for Insomnia<br /><b>Sponsor</b>:    Utah State University<br /><b>Recruiting</b>
A Study to Evaluate the Effect of Food on the Oral Bioavailability of Relacorilant in Healthy Subjects,http://classic.clinicaltrials.gov/ct2/show/NCT06094738?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Drug: Relacorilant under fasted conditions;   Drug: Relacorilant after a high-fat meal;   Drug: Relacorilant after a low-fat meal<br /><b>Sponsor</b>:    Corcept Therapeutics<br /><b>Completed</b>
A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant,http://classic.clinicaltrials.gov/ct2/show/NCT06094725?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Hepatic Impairment<br /><b>Intervention</b>:    Drug: Relacorilant<br /><b>Sponsor</b>:    Corcept Therapeutics<br /><b>Completed</b>
A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male Subjects,http://classic.clinicaltrials.gov/ct2/show/NCT06094712?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Intervention</b>:    Drug: CORT125134<br /><b>Sponsor</b>:    Corcept Therapeutics<br /><b>Completed</b>
Improving Sleep in the Neurology In-Patient Population,http://classic.clinicaltrials.gov/ct2/show/NCT06094699?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sleep<br /><b>Interventions</b>:    Other: Sleep friendly order set;   Other: Patient sleep menu<br /><b>Sponsor</b>:    University of Pennsylvania<br /><b>Recruiting</b>
Epicardial Adipose Tissue Thickness and the Related Factors in Patients With Ankylosing Spondylitis,http://classic.clinicaltrials.gov/ct2/show/NCT06094686?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ankylosing Spondylitis<br /><b>Intervention</b>:    Diagnostic Test: epicardial adipose tissue thickness<br /><b>Sponsor</b>:    Istanbul Physical Medicine Rehabilitation Training and Research Hospital<br /><b>Completed</b>
The Relationship Between Systemic Immune Inflammation Index and Disease Activity in Patients With Ankylosing Spondylitis,http://classic.clinicaltrials.gov/ct2/show/NCT06094673?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Ankylosing Spondylitis<br /><b>Intervention</b>:    Other: No intervention<br /><b>Sponsor</b>:    Istanbul Physical Medicine Rehabilitation Training and Research Hospital<br /><b>Completed</b>
RFA or Chemical Neurolysis of the Genicular Nerves Compared to Conservative Treatment for Knee Pain Caused by OA,http://classic.clinicaltrials.gov/ct2/show/NCT06094660?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Osteo Arthritis Knee;   Knee Pain Chronic<br /><b>Interventions</b>:    Procedure: Diagnostic genicular nerve block;   Procedure: Genicular nerve block with Radiofrequency Ablation (RFA);   Procedure: Genicular nerve block with Phenol 6%<br /><b>Sponsors</b>:    Dijklander Ziekenhuis;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Bravis Hospital<br /><b>Not yet recruiting</b>
Altitudes for Caregivers,http://classic.clinicaltrials.gov/ct2/show/NCT06094647?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Care Burden;   Care Giving Burden;   Caregiver Burnout;   Caregiver Stress;   Caregiver Wellbeing;   Support, Family<br /><b>Intervention</b>:    Device: Altitudes USA<br /><b>Sponsors</b>:    University of North Carolina, Chapel Hill;   North Carolina Department of Health and Human Services<br /><b>Not yet recruiting</b>"
IGHID 12219 - A Brief Alcohol Intervention for PrEP Use Among MSM in Vietnam: A Randomized Controlled Trial (BPrEP),http://classic.clinicaltrials.gov/ct2/show/NCT06094634?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    HIV Prevention;   Unhealthy Alcohol Use<br /><b>Intervention</b>:    Behavioral: The Brief Alcohol Intervention (BAI): Behavioral<br /><b>Sponsors</b>:    University of North Carolina, Chapel Hill;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institutes of Health (NIH);   Hanoi Medical University;   Ohio State University;   Johns Hopkins University;   University of Washington<br /><b>Not yet recruiting</b>"
Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06094621?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Head and Neck Cancer<br /><b>Intervention</b>:    Other: Survey<br /><b>Sponsor</b>:    University of Michigan Rogel Cancer Center<br /><b>Not yet recruiting</b>
IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms,http://classic.clinicaltrials.gov/ct2/show/NCT06094608?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Inflammatory Bowel Diseases;   Ulcerative Colitis;   Crohn Disease<br /><b>Interventions</b>:    Device: Morning light treatment;   Behavioral: Treatment-as-usual<br /><b>Sponsors</b>:    University of Michigan;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br /><b>Not yet recruiting</b>
Mealtime Assessment Scale-p Adaptation and Validation,http://classic.clinicaltrials.gov/ct2/show/NCT06094595?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Dysphagia<br /><b>Intervention</b>:    Diagnostic Test: MAS-p administration<br /><b>Sponsors</b>:    Fondazione Don Carlo Gnocchi Onlus;   Fondazione Don Carlo Gnocchi ONLUS - Centro Bignamini, Falconara Marittima;   Meyer Children's Hospital IRCCS<br /><b>Recruiting</b>"
Knowledges and Use of Cannabidiol in Older Adults,http://classic.clinicaltrials.gov/ct2/show/NCT06094582?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Aging;   Frailty<br /><b>Intervention</b>:    Other: questionnaire<br /><b>Sponsor</b>:    University Hospital, Toulouse<br /><b>Not yet recruiting</b>"
Medical Imaging Screening for Posterior-circulation Ischemic Stroke,http://classic.clinicaltrials.gov/ct2/show/NCT06094569?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Endovascular Thrombectomy<br /><b>Intervention</b>:    Procedure: Endovascular Therapy<br /><b>Sponsor</b>:    Tianjin Huanhu Hospital<br /><b>Recruiting</b>
An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors,http://classic.clinicaltrials.gov/ct2/show/NCT06094556?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Advanced Solid Tumors<br /><b>Intervention</b>:    Drug: SHR-1826<br /><b>Sponsor</b>:    Suzhou Suncadia Biopharmaceuticals Co., Ltd.<br /><b>Not yet recruiting</b>"
Improving Overactive Bladder Treatment Access and Adherence,http://classic.clinicaltrials.gov/ct2/show/NCT06094543?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Overactive Bladder Syndrome;   Urinary Incontinence<br /><b>Intervention</b>:    Behavioral: Patient Engagement Tool<br /><b>Sponsors</b>:    Stanford University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br /><b>Not yet recruiting</b>
18F-FAPI-RGD PET/CT in Various Tumor Types,http://classic.clinicaltrials.gov/ct2/show/NCT06094530?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Neoplasms<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Sichuan Provincial People's Hospital<br /><b>Recruiting</b>
What Are Persistent Lower Back Pain Patients' Views of Sleep Health Within an Outpatient Musculoskeletal Physiotherapy Setting?,http://classic.clinicaltrials.gov/ct2/show/NCT06094517?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Persistent Lower Back Pain;   Sleep Disturbance;   Lower Back Pain;   Chronic Low-back Pain<br /><b>Intervention</b>:    Other: Interview<br /><b>Sponsors</b>:    Sheffield Hallam University;   Chesterfield Royal Hospital NHS Foundation Trust<br /><b>Not yet recruiting</b>
Spectral Lighting and Intestinal Failure,http://classic.clinicaltrials.gov/ct2/show/NCT06094504?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Intestinal Failure<br /><b>Intervention</b>:    Other: Spectral Lighting<br /><b>Sponsor</b>:    Children's Hospital Medical Center, Cincinnati<br /><b>Not yet recruiting</b>"
Virtual Diabetes Group Visits Across Health Systems,http://classic.clinicaltrials.gov/ct2/show/NCT06094491?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    T2DM (Type 2 Diabetes Mellitus);   Hypertension;   Heart Disease Chronic;   Stroke;   Hyperlipidemias;   Peripheral Vascular Diseases;   Obesity<br /><b>Intervention</b>:    Behavioral: Virtual Group Visit<br /><b>Sponsors</b>:    University of Chicago;   Advocate Health Care;   ACCESS Community Health Network;   National Institute on Minority Health and Health Disparities (NIMHD);   Midwest Clinicians' Network<br /><b>Not yet recruiting</b>
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition,http://classic.clinicaltrials.gov/ct2/show/NCT06094478?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Stroke, Acute;   Ischemic Stroke, Acute;   Hemorrhagic Stroke<br /><b>Intervention</b>:    Behavioral: HI-SPEED Protocol<br /><b>Sponsors</b>:    University of Chicago;   University of Miami;   Yale University;   University of California, Los Angeles;   University of Cincinnati;   Weill Medical College of Cornell University;   University of Utah;   Emory University;   University of Michigan;   National Institute of Neurological Disorders and Stroke (NINDS)<br /><b>Not yet recruiting</b>"
Learning Curve of Robotic Pancreatoduodenectomy,http://classic.clinicaltrials.gov/ct2/show/NCT06094465?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pancreaticoduodenectomy<br /><b>Intervention</b>:    Other: Different phase of the learning curve of RPD<br /><b>Sponsor</b>:    Peking Union Medical College Hospital<br /><b>Completed</b>
Effects of 24-week Computerized Cognitive Training in Patients With MCI and AD,http://classic.clinicaltrials.gov/ct2/show/NCT06094452?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Mild Cognitive Impairment;   Alzheimer Disease<br /><b>Interventions</b>:    Other: Computerized Cognitive Training;   Other: Treatment As Usual<br /><b>Sponsor</b>:    Chongqing Medical University<br /><b>Completed</b>
Targeted Metabolomics and Spent Embryo Culture Medium,http://classic.clinicaltrials.gov/ct2/show/NCT06094439?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Embryo Culture Media;   Metabolomics<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    gyn-medicum Göttingen<br /><b>Recruiting</b>
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors,http://classic.clinicaltrials.gov/ct2/show/NCT06094426?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    GT316,Solid Tumors,Adult<br /><b>Intervention</b>:    Biological: GT316<br /><b>Sponsor</b>:    Grit Biotechnology<br /><b>Recruiting</b>"
Effects of Multicomponent Training on Sarcopenia,http://classic.clinicaltrials.gov/ct2/show/NCT06094413?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sarcopenia<br /><b>Intervention</b>:    Behavioral: Multicomponent Training Intervention<br /><b>Sponsor</b>:    Geisinger Clinic<br /><b>Not yet recruiting</b>
Pain and Stress Detection and Relief in People With Dementia,http://classic.clinicaltrials.gov/ct2/show/NCT06094400?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Dementia;   Chronic Pain;   Perceived Stress<br /><b>Interventions</b>:    Other: Meditation;   Other: Control<br /><b>Sponsor</b>:    The Hong Kong Polytechnic University<br /><b>Not yet recruiting</b>
The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06094387?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Central Line Complication;   Thrombosis, Venous<br /><b>Intervention</b>:    Diagnostic Test: Thrombin generation assay<br /><b>Sponsor</b>:    Queen Mary Hospital, Hong Kong<br /><b>Not yet recruiting</b>"
Unveiling the Digital Phenotype of PA Behavior,http://classic.clinicaltrials.gov/ct2/show/NCT06094374?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Physical Activity - Digital Phenotyping - Activity Tracking<br /><b>Intervention</b>:    Behavioral: observation of physical activity behavior<br /><b>Sponsors</b>:    PXL University College;   Hasselt University<br /><b>Not yet recruiting</b>
"""IONTOPHORESIS vs. PHONOPHORESIS"" for Treatment of Subacromial Impingement Syndrome",http://classic.clinicaltrials.gov/ct2/show/NCT06094361?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Subacromial Impingement Syndrome<br /><b>Interventions</b>:    Procedure: Iontophoresis Intervention;   Procedure: Phonophoresis;   Procedure: Conventional Therapy<br /><b>Sponsor</b>:    Emre Şenocak<br /><b>Completed</b>
The Evaluation of Piezo and Endonasal Osteotomy Methods on Postoperative Healing Process in Septorhinoplasty,http://classic.clinicaltrials.gov/ct2/show/NCT06094348?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Nasal Deformity, Acquired;   Septum; Deviation, Congenital<br /><b>Interventions</b>:    Procedure: Endonasal osteotomy;   Device: Piezo assisted osteotomy<br /><b>Sponsor</b>:    Haseki Training and Research Hospital<br /><b>Recruiting</b>"
Effect of Virtual Reality on Balance in Autism,http://classic.clinicaltrials.gov/ct2/show/NCT06094335?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Autism<br /><b>Interventions</b>:    Device: Virtual reality rehabilitation;   Other: Traditional physical therapy<br /><b>Sponsor</b>:    Batterjee Medical College<br /><b>Completed</b>
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging,http://classic.clinicaltrials.gov/ct2/show/NCT06094322?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Prostate Cancer<br /><b>Intervention</b>:    Other: MR prostate exam<br /><b>Sponsor</b>:    Centre Hospitalier Universitaire, Amiens<br /><b>Recruiting</b>"
Effectiveness of Botulinum Toxin in Freezing of Gate in Parkinson's Disease Walking in Parkinson's Disease.,http://classic.clinicaltrials.gov/ct2/show/NCT06094309?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Freezing of Gate;   Parkinson Disease;   Botulinum Toxin<br /><b>Intervention</b>:    Drug: Botulinum toxin type A injection<br /><b>Sponsor</b>:    Centro Hospitalar de Lisboa Central<br /><b>Not yet recruiting</b>
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC),http://classic.clinicaltrials.gov/ct2/show/NCT06094296?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    NSCLC<br /><b>Interventions</b>:    Drug: BMS-986315;   Drug: Nivolumab;   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Carboplatin;   Drug: Paclitaxel<br /><b>Sponsor</b>:    Bristol-Myers Squibb<br /><b>Not yet recruiting</b>
First in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males,http://classic.clinicaltrials.gov/ct2/show/NCT06094283?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Male Contraception<br /><b>Interventions</b>:    Drug: YCT-529;   Drug: YCT-529 Placebo<br /><b>Sponsor</b>:    YourChoice Therapeutics, Inc.<br /><b>Not yet recruiting</b>"
Artificial-intelligence-based Reporting Technology for Endoscopy Monitoring and Imaging System,http://classic.clinicaltrials.gov/ct2/show/NCT06094270?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Colonoscopy<br /><b>Intervention</b>:    Device: EndoMind<br /><b>Sponsor</b>:    Wuerzburg University Hospital<br /><b>Not yet recruiting</b>
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06094257?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Sensation Disorders;   Sensation, Phantom;   Pain, Postoperative;   Pain, Chronic;   Numbness;   Sensory Disorder;   Sensory Defect;   Phantom Pain;   Phantom Sensation<br /><b>Intervention</b>:    Diagnostic Test: Sensory testing<br /><b>Sponsors</b>:    Weill Medical College of Cornell University;   Massachusetts General Hospital<br /><b>Recruiting</b>"
Statins in Patients With Spontaneous Intracerebral Hemorrhage,http://classic.clinicaltrials.gov/ct2/show/NCT06094244?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Intracerebral Hemorrhage<br /><b>Interventions</b>:    Drug: Atorvastatin;   Drug: Rosuvastatin;   Other: No drugs<br /><b>Sponsor</b>:    Pomeranian Medical University Szczecin<br /><b>Completed</b>
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study,http://classic.clinicaltrials.gov/ct2/show/NCT06094231?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Chronic Kidney Diseases;   Diabetes Mellitus;   PreDiabetes;   Overweight and Obesity<br /><b>Intervention</b>:    Behavioral: Therapeutic carbohydrate restriction combined with an SGLT-2-Inhibitor<br /><b>Sponsor</b>:    Department of Nephrology Clinic Ottakring Vienna<br /><b>Recruiting</b>
Development of a Treatment Prognosis Calculator for the Prevention of Suicide,http://classic.clinicaltrials.gov/ct2/show/NCT06094218?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Suicidal Ideation<br /><b>Interventions</b>:    Behavioral: Brief Cognitive Behavioral Therapy (BCBT);   Behavioral: Treatment as usual (TAU)<br /><b>Sponsors</b>:    Ohio State University;   United States Department of Defense<br /><b>Not yet recruiting</b>
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02),http://classic.clinicaltrials.gov/ct2/show/NCT06094205?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Anarthria;   Dysarthria;   Tetraplegia;   Spinal Cord Injuries;   Amyotrophic Lateral Sclerosis;   Brain Stem Infarctions;   Locked-in Syndrome;   Muscular Dystrophies<br /><b>Intervention</b>:    Device: BrainGate Neural Interface System<br /><b>Sponsors</b>:    Leigh R. Hochberg, MD, PhD.;   National Institute on Deafness and Other Communication Disorders (NIDCD)<br /><b>Recruiting</b>"
Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation,http://classic.clinicaltrials.gov/ct2/show/NCT06094192?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Alzheimer Disease<br /><b>Intervention</b>:    Device: High definition transcranial electrical current stimulation<br /><b>Sponsor</b>:    Boston University Charles River Campus<br /><b>Not yet recruiting</b>
"Evaluate the Safety, Tolerability of BAT6026",http://classic.clinicaltrials.gov/ct2/show/NCT06094179?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Dermatitis, Atopic<br /><b>Interventions</b>:    Drug: Monoclonal antibody BAT6026;   Drug: sodium chloride injection<br /><b>Sponsor</b>:    Bio-Thera Solutions<br /><b>Not yet recruiting</b>"
Quantitative MR Parameters in Non-myelopathic Degenerative Cervical Spinal Cord Compression: a Longitudinal Study.,http://classic.clinicaltrials.gov/ct2/show/NCT06094166?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Degenerative Cervical Spinal Myelopathy;   Cervical Spinal Cord Compression<br /><b>Intervention</b>:    Diagnostic Test: MRI<br /><b>Sponsors</b>:    Masaryk University;   Palacky University<br /><b>Recruiting</b>
"Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function",http://classic.clinicaltrials.gov/ct2/show/NCT06094153?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Healthy;   Gastrointestinal Diseases<br /><b>Interventions</b>:    Dietary Supplement: Placebo;   Dietary Supplement: HMO 1;   Dietary Supplement: HMO 2<br /><b>Sponsor</b>:    Kyowa Hakko Bio Co., Ltd.<br /><b>Recruiting</b>"
NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06094140?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pancreatic Cancer<br /><b>Interventions</b>:    Drug: Durvalumab;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Calcium folinate (leucovorin);   Drug: Fluorouracil;   Drug: Pegylated G-CSF<br /><b>Sponsors</b>:    Australasian Gastro-Intestinal Trials Group;   The University of New South Wales;   Walter and Eliza Hall Institute of Medical Research<br /><b>Recruiting</b>
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection,http://classic.clinicaltrials.gov/ct2/show/NCT06094127?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Thoracic Aortic Aneurysm;   Penetrating Aortic Ulcer<br /><b>Intervention</b>:    Device: Endovascular aortic treatment<br /><b>Sponsor</b>:    Cook Research Incorporated<br /><b>Recruiting</b>
Evaluation of VDD Leadless Pacing System During Exercise,http://classic.clinicaltrials.gov/ct2/show/NCT06094114?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Bradycardia;   Pacemaker DDD<br /><b>Intervention</b>:    Device: pacemaker follow-up<br /><b>Sponsors</b>:    Universitaire Ziekenhuizen KU Leuven;   Medtronics, Inc.<br /><b>Completed</b>"
Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision),http://classic.clinicaltrials.gov/ct2/show/NCT06094101?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Ewing Sarcoma;   Rhabdomyosarcoma;   Synovial Sarcoma<br /><b>Intervention</b>:    Biological: Peptide vaccine IPX<br /><b>Sponsors</b>:    University Hospital Tuebingen;   Deutsches Konsortium fürTranslationale Krebsforschung (DKTK);   Cooperative Ewing Sarkom Studiengruppe;   Cooperative Weichteilsarkom Study Group<br /><b>Recruiting</b>
Examining the Impact of Heated Yoga on Mindfulness and Rumination,http://classic.clinicaltrials.gov/ct2/show/NCT06094088?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Rumination;   Mindfulness<br /><b>Interventions</b>:    Behavioral: heated yoga;   Behavioral: non-heated yoga;   Behavioral: heated health education;   Behavioral: non-heated health education<br /><b>Sponsors</b>:    Massachusetts General Hospital;   Tiny Blue Dot Foundation<br /><b>Not yet recruiting</b>
Dynamic Strength Index-based Intervention in Basketball.,http://classic.clinicaltrials.gov/ct2/show/NCT06094075?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Sports;   Basketball;   Strength Training<br /><b>Interventions</b>:    Other: Resistance training based on DSI value;   Other: Normal training group<br /><b>Sponsors</b>:    University of Primorska;   Middlesex University<br /><b>Active, not recruiting</b>"
Smartphone App-assisted PPI,http://classic.clinicaltrials.gov/ct2/show/NCT06094062?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Heartburn;   Dyspepsia<br /><b>Intervention</b>:    Other: App-based treatment support<br /><b>Sponsor</b>:    University Hospital, Basel, Switzerland<br /><b>Recruiting</b>"
Acceptability of Folic Acid and Vitamin B12 Fortified Meals,http://classic.clinicaltrials.gov/ct2/show/NCT06094049?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Dietary Habits<br /><b>Interventions</b>:    Other: Preference test group;   Other: Triangle test group<br /><b>Sponsors</b>:    University Ghent;   Arba Minch University;   Institut de Recherche en Sciences de la Sante, Burkina Faso;   Addis Ababa University<br /><b>Not yet recruiting</b>"
Physical Exercise as a Sustainability Tool in Men With Dysmetabolic Hypogonadism,http://classic.clinicaltrials.gov/ct2/show/NCT06094036?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Hypogonadism, Male;   Metabolic Syndrome;   Autonomic Imbalance;   Life Style, Healthy;   Physical Inactivity<br /><b>Intervention</b>:    Behavioral: Structured and personalized program of physical exercise<br /><b>Sponsor</b>:    Istituto Auxologico Italiano<br /><b>Recruiting</b>"
Dietary Intake of Folic Acid and Vitamin B12 Among Teenage Girls - Validation of Food Frequency Questionnaire,http://classic.clinicaltrials.gov/ct2/show/NCT06094023?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Dietary Assessment<br /><b>Interventions</b>:    Other: Food Frequency Questionnaire;   Other: 24 Hour food recall<br /><b>Sponsors</b>:    University Ghent;   Arba Minch University;   Institut de Recherche en Sciences de la Sante, Burkina Faso;   Addis Ababa University<br /><b>Recruiting</b>"
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza,http://classic.clinicaltrials.gov/ct2/show/NCT06094010?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Influenza<br /><b>Intervention</b>:    Drug: Baloxavir Marboxil<br /><b>Sponsor</b>:    Hoffmann-La Roche<br /><b>Not yet recruiting</b>
Study on the Treatment of C/S of Qi Stagnation and Blood-stasis Type by Moving Cupping With Bloodletting,http://classic.clinicaltrials.gov/ct2/show/NCT06093997?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cervical Spondylosis<br /><b>Interventions</b>:    Other: Massage treatment;   Other: Cupping;   Other: Bloodletting<br /><b>Sponsor</b>:    Shanghai University of Traditional Chinese Medicine<br /><b>Not yet recruiting</b>
Cumulative Live Birth Rates in Dual Ovarian Stimulation Versus Two Antagonist Stimulations in Poor Ovarian Responders,http://classic.clinicaltrials.gov/ct2/show/NCT06093984?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Infertility<br /><b>Intervention</b>:    Procedure: duostim vs. two antagonist ovarian stimulations<br /><b>Sponsor</b>:    Shanghai First Maternity and Infant Hospital<br /><b>Not yet recruiting</b>
Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy,http://classic.clinicaltrials.gov/ct2/show/NCT06093971?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Prostate Tumor<br /><b>Interventions</b>:    Drug: remimazolam;   Drug: Propofol<br /><b>Sponsor</b>:    Yonsei University<br /><b>Not yet recruiting</b>
Paradoxical Response to Chest Wall Loading in Mechanically Ventilated Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06093958?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    ARDS;   COVID-19;   Mechanical Ventilation Pressure High;   Ventilator-Induced Lung Injury<br /><b>Intervention</b>:    Diagnostic Test: Manual loading of the chest wall<br /><b>Sponsor</b>:    HealthPartners Institute<br /><b>Withdrawn</b>
Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects,http://classic.clinicaltrials.gov/ct2/show/NCT06093945?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Malignant Tumor<br /><b>Interventions</b>:    Drug: SHR2554 tablet dosing;   Drug: Omeprazole tablet dosing<br /><b>Sponsor</b>:    Jiangsu HengRui Medicine Co., Ltd.<br /><b>Not yet recruiting</b>"
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06093932?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Hypertension,Essential<br /><b>Interventions</b>:    Drug: Songling Xuemaikang Capsules;   Behavioral: Lifestyle intervention;   Drug: Placebo<br /><b>Sponsors</b>:    Xiyuan Hospital of China Academy of Chinese Medical Sciences;   China Academy of Chinese Medical Sciences Xiyuan Hospital Shanxi Hospital;   Suzhou Hosptial of Traditional Chinese Medicine;   China Academy of Chinese Medical Sciences Xiyuan Hospital Jining Hospital;   Shandong University of Traditional Chinese Medicine<br /><b>Not yet recruiting</b>"
Study of Prevalence of Eating Disorder in Liver Transplant Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06093919?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Eating Disorders;   Eating Disorder Binge;   Liver Transplant; Complications;   Alcohol Use Disorder;   Cirrhosis Alcoholic<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Centre Hospitalier Henri Laborit<br /><b>Not yet recruiting</b>
Positive Processes and Transition to Health (PATH),http://classic.clinicaltrials.gov/ct2/show/NCT06093906?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Posttraumatic Stress Disorder;   Major Depressive Disorder<br /><b>Interventions</b>:    Behavioral: Positive Processes and Transition to Health;   Behavioral: Progressive Muscle Relaxation<br /><b>Sponsors</b>:    Case Western Reserve University;   University of Washington;   University of Delaware<br /><b>Not yet recruiting</b>
Hypotensive Anesthesia for Orthognathic Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06093893?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Hypotensive Anesthesia;   Orthognathic Surgery<br /><b>Interventions</b>:    Drug: Dexmedetomidine;   Drug: Nicardipine;   Drug: Labetalol<br /><b>Sponsor</b>:    Boston Medical Center<br /><b>Not yet recruiting</b>
"Observational, Prospective Clinical Investigation on Mini 4 Ready Intraocular Lens",http://classic.clinicaltrials.gov/ct2/show/NCT06093880?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Cataract<br /><b>Intervention</b>:    Device: monofocal intraocular lens<br /><b>Sponsor</b>:    SIFI SpA<br /><b>Not yet recruiting</b>
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation,http://classic.clinicaltrials.gov/ct2/show/NCT06093867?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health Clinical Center (CC)<br /><b>Not yet recruiting</b>"
Intraoperative Radiotherapy in Treating Spinal Metastases,http://classic.clinicaltrials.gov/ct2/show/NCT06093854?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Spinal Metastases<br /><b>Interventions</b>:    Radiation: Intraoperative radiotherapy (IORT);   Radiation: Stereotactic body radiotherapy (SBRT)<br /><b>Sponsor</b>:    Shanghai Changzheng Hospital<br /><b>Not yet recruiting</b>
Relmacabtagene Autoleucel as Second-Line Therapy in Adult Patients With Aggressive B-cell NHL,http://classic.clinicaltrials.gov/ct2/show/NCT06093841?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Lymphoma, Large B-Cell, Diffuse;   Follicular Lymphoma Grade 3B;   High-grade B-cell Lymphoma;   Mediastinal B-Cell Diffuse Large Cell Lymphoma<br /><b>Interventions</b>:    Biological: Relmacabtagene Autoleucel;   Drug: Fludarabine;   Drug: Cyclophosphamide<br /><b>Sponsor</b>:    Shanghai Ming Ju Biotechnology Co., Ltd.<br /><b>Not yet recruiting</b>"
Transcatheter Treatment of Tricuspid Valve Regurgitation,http://classic.clinicaltrials.gov/ct2/show/NCT06093828?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Symptomatic Severe Tricuspid Regurgitation<br /><b>Intervention</b>:    Device: TriFlo Tricuspid Flow Optimizer<br /><b>Sponsor</b>:    TriFlo Cardiovascular, Inc.<br /><b>Not yet recruiting</b>"
Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products,http://classic.clinicaltrials.gov/ct2/show/NCT06093815?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Injection Site Reaction<br /><b>Intervention</b>:    Device: Injection<br /><b>Sponsor</b>:    Merz North America, Inc.<br /><b>Recruiting</b>"
Endoscopic Classification and DISE-Guided Surgery in Pediatric Obstructive Sleep-Disordered Breathing.,http://classic.clinicaltrials.gov/ct2/show/NCT06093802?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Obstructive Sleep Apnea of Child<br /><b>Intervention</b>:    Diagnostic Test: Drug-induced Sleep Endoscopy findings (identified obstruction sites)<br /><b>Sponsors</b>:    Regional Hospital West Jutland;   University Hospital, Antwerp<br /><b>Not yet recruiting</b>"
The Relationship Between Personality Traits and Perioperative Anesthetic Drug Consumption,http://classic.clinicaltrials.gov/ct2/show/NCT06093789?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Anesthesia;   Infertility<br /><b>Intervention</b>:    Other: PBQ-S1<br /><b>Sponsor</b>:    Ondokuz Mayıs University<br /><b>Not yet recruiting</b>
Rib Fracture Cryoanalgesia,http://classic.clinicaltrials.gov/ct2/show/NCT06093776?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Pain Management Improvement<br /><b>Intervention</b>:    Device: ioveraº system<br /><b>Sponsors</b>:    Methodist Health System;   Pacira Pharmaceuticals, Inc<br /><b>Recruiting</b>"
Evaluating the Utility of Bone Grafts in Open Wedge Corrective Osteotomy and Plate Fixation,http://classic.clinicaltrials.gov/ct2/show/NCT06093763?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Malunion of Fracture of Radius<br /><b>Interventions</b>:    Procedure: Group without bone grafting;   Procedure: Group with bone grafting<br /><b>Sponsors</b>:    Maastricht University Medical Center;   Haga Hospital;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   VieCuri Medical Centre;   Zuyderland Medical Centre;   Elkerliek Hospital;   Erasmus Medical Center;   Amphia Hospital;   Reinier Haga Orthopedisch Centrum;   Flevoziekenhuis;   Diakonessenhuis, Utrecht;   Xpert Clinics<br /><b>Recruiting</b>"
Correlation Between State-Trait-Anxiety-Inventory and Heart Rate Variability,http://classic.clinicaltrials.gov/ct2/show/NCT06093750?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Preoperative Vegetative Stress<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Ludwig Boltzmann Institute for Traumatology - The research center in cooperation with AUVA;   UKH Salzburg;   University of Ulm;   Institute for Salutology<br /><b>Completed</b>
Strengthening Community Mental Health,http://classic.clinicaltrials.gov/ct2/show/NCT06093737?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Mental Health;   Emotional Wellbeing;   Anxiety;   Depression;   Stress;   Coping;   Perceived Stress;   Perceived Social Support<br /><b>Intervention</b>:    Behavioral: COPE: Communities Organizing for Power through Empathy<br /><b>Sponsors</b>:    Louisiana State University and A&amp;M College;   National Academies of Sciences, Engineering and Medicine;   University of Illinois at Urbana-Champaign<br /><b>Recruiting</b>"
"Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV)",http://classic.clinicaltrials.gov/ct2/show/NCT06093724?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Transgenderism<br /><b>Intervention</b>:    Diagnostic Test: Static and dynamic perineo-pelvic MRI<br /><b>Sponsor</b>:    University Hospital, Limoges<br /><b>Recruiting</b>"
Urinary Incontinence in Married Women,http://classic.clinicaltrials.gov/ct2/show/NCT06093711?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Quality of Life<br /><b>Intervention</b>:    Diagnostic Test: Description<br /><b>Sponsor</b>:    Kastamonu University<br /><b>Completed</b>
An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases,http://classic.clinicaltrials.gov/ct2/show/NCT06093698?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Recurrent or Metastatic Solid Tumors<br /><b>Intervention</b>:    Biological: Recombinant Anti-EpCAM-CD3 Antibody Injection<br /><b>Sponsor</b>:    ITabMed Co., Ltd.<br /><b>Not yet recruiting</b>"
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera,http://classic.clinicaltrials.gov/ct2/show/NCT06093672?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Polycythemia Vera<br /><b>Interventions</b>:    Drug: Givinostat Hydrochloride;   Drug: Hydroxy Urea<br /><b>Sponsor</b>:    Italfarmaco<br /><b>Not yet recruiting</b>
Nicotine Pharmacokinetic Study of Heated Tobacco and Heated Herbal Products,http://classic.clinicaltrials.gov/ct2/show/NCT06093659?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy Volunteers<br /><b>Interventions</b>:    Other: Pulze device with heated tobacco sticks (Product A);   Other: Pulze device with heated tobacco sticks (Product B);   Other: Pulze device with nicotine-infused heated herbal sticks (Product C);   Other: Pulze device with nicotine-infused heated herbal sticks (Product D);   Other: Conventional Cigarette (Product E)<br /><b>Sponsor</b>:    Imperial Brands PLC<br /><b>Recruiting</b>
Addressing Medium- to Long-term EBOLA Associated Psychological Distress and Psychosocial Problems in Central Uganda,http://classic.clinicaltrials.gov/ct2/show/NCT06093646?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Ebola Virus Disease<br /><b>Intervention</b>:    Behavioral: Ebola+D intervention<br /><b>Sponsors</b>:    MRC/UVRI and LSHTM Uganda Research Unit;   Ministry of Health, Uganda<br /><b>Recruiting</b>"
A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders,http://classic.clinicaltrials.gov/ct2/show/NCT06093633?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Sleep Disorder<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Itamar-Medical, Israel<br /><b>Recruiting</b>"
Investigating Participation Patterns Among Stage IV Melanoma Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06093594?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Stage IV Melanoma<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Power Life Sciences Inc.<br /><b>Not yet recruiting</b>
Delving Into Participation Trends in Renal Cell Carcinoma Studies,http://classic.clinicaltrials.gov/ct2/show/NCT06093568?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Renal Cell Carcinoma<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Power Life Sciences Inc.<br /><b>Not yet recruiting</b>
"A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participants",http://classic.clinicaltrials.gov/ct2/show/NCT06093542?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Heathy Participants<br /><b>Interventions</b>:    Drug: AZD7053;   Drug: Placebo<br /><b>Sponsor</b>:    AstraZeneca<br /><b>Not yet recruiting</b>
Immune Markers in Pediatric ITP,http://classic.clinicaltrials.gov/ct2/show/NCT06093529?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    ITP - Immune Thrombocytopenia<br /><b>Intervention</b>:    Diagnostic Test: complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>"
The ARUTIS Study (Anglia Ruskin University Trial of the Intuitive System),http://classic.clinicaltrials.gov/ct2/show/NCT06093516?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Visual Stress<br /><b>Intervention</b>:    Device: Tinted Lenses<br /><b>Sponsor</b>:    Anglia Ruskin University<br /><b>Recruiting</b>
Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein,http://classic.clinicaltrials.gov/ct2/show/NCT06093503?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Non-Small Cell Lung Cancer<br /><b>Interventions</b>:    Drug: Telisotuzumab Vedotin;   Drug: Osimertinib;   Drug: Cisplatin;   Drug: Carboplatin;   Drug: Pemetrexed<br /><b>Sponsor</b>:    AbbVie<br /><b>Not yet recruiting</b>
Detecting Absence Seizures Using a Hyperventilation and Eye Movement Recordings,http://classic.clinicaltrials.gov/ct2/show/NCT06093490?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Absence Epilepsy, Childhood;   Absence Seizures;   Absence Epilepsy;   Epilepsy in Children;   Staring;   Seizures<br /><b>Intervention</b>:    Device: Eysz Hyperventilation Recorder<br /><b>Sponsors</b>:    Eysz, Inc.;   National Institute of Neurological Disorders and Stroke (NINDS)<br /><b>Not yet recruiting</b>"
Studying Melatonin and Recovery in Teens,http://classic.clinicaltrials.gov/ct2/show/NCT06093477?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Juvenile; Scoliosis;   Scoliosis Idiopathic;   Scoliosis; Adolescence;   Scoliosis;Congenital;   Kyphosis;   Spondylolisthesis<br /><b>Interventions</b>:    Dietary Supplement: Melatonin;   Other: Syrup<br /><b>Sponsors</b>:    Stanford University;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)<br /><b>Not yet recruiting</b>
Beneficial Exposome Study,http://classic.clinicaltrials.gov/ct2/show/NCT06093464?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Other: Natural Compound A (masked essential oil A);   Other: Natural Compound B (masked essential oil B)<br /><b>Sponsor</b>:    Stanford University<br /><b>Not yet recruiting</b>
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder,http://classic.clinicaltrials.gov/ct2/show/NCT06093451?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Schizophrenia Agitation;   Schizo Affective Disorder;   Bipolar Disorder;   Dexmedetomidine<br /><b>Interventions</b>:    Drug: Dexmedetomidine;   Drug: Lorazepam 2 MG/ML<br /><b>Sponsors</b>:    Temple University;   BioXcel Therapeutics Inc<br /><b>Recruiting</b>
Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06093438?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Cervical Cancer;   Induction Chemotherapy;   Immunotherapy<br /><b>Intervention</b>:    Drug: Toripalimab<br /><b>Sponsor</b>:    Tianjin Medical University Cancer Institute and Hospital<br /><b>Recruiting</b>
"Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma",http://classic.clinicaltrials.gov/ct2/show/NCT06093425?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Gastric Cancer;   Gastroesophageal-junction Cancer;   Advanced Cancer<br /><b>Interventions</b>:    Drug: TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU);   Drug: Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)<br /><b>Sponsor</b>:    Suzhou Transcenta Therapeutics Co., Ltd.<br /><b>Not yet recruiting</b>"
Application of Unilateral Epidural Anesthesia in Older Patients With Hip Fracture,http://classic.clinicaltrials.gov/ct2/show/NCT06093412?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Spinal Anesthesia<br /><b>Interventions</b>:    Procedure: unilateral epidural anesthesia;   Procedure: combined lumbar and epidural anesthesia<br /><b>Sponsor</b>:    Sichuan Provincial People's Hospital<br /><b>Completed</b>
Parkinsonian Sutter,http://classic.clinicaltrials.gov/ct2/show/NCT06093399?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Parkinson's Disease Stutter<br /><b>Interventions</b>:    Device: System ON;   Device: System OFF<br /><b>Sponsor</b>:    University of British Columbia<br /><b>Not yet recruiting</b>
Promoting Intensive Transitions for Children and Youth With Medical Complexity From Pediatric to Adult Care,http://classic.clinicaltrials.gov/ct2/show/NCT06093386?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Children and Youth With Medical Complexity<br /><b>Intervention</b>:    Other: Intensive Transition Support<br /><b>Sponsors</b>:    The Hospital for Sick Children;   Canadian Institutes of Health Research (CIHR)<br /><b>Not yet recruiting</b>
The Doppler Feasibility Study,http://classic.clinicaltrials.gov/ct2/show/NCT06093373?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Heart Rate Measurements<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Sheffield Children's NHS Foundation Trust;   Sheffield Hallam University<br /><b>Recruiting</b>
Flapless Surgical Treatment of Peri-implantitis,http://classic.clinicaltrials.gov/ct2/show/NCT06093360?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Peri-Implantitis<br /><b>Intervention</b>:    Procedure: flapless surgery<br /><b>Sponsor</b>:    Universidad Complutense de Madrid<br /><b>Completed</b>
Central Apnoea Monitor Study,http://classic.clinicaltrials.gov/ct2/show/NCT06093347?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Sleep Apnea<br /><b>Intervention</b>:    <br /><b>Sponsors</b>:    Sheffield Children's NHS Foundation Trust;   Sheffield Hallam University<br /><b>Recruiting</b>
Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD,http://classic.clinicaltrials.gov/ct2/show/NCT06093334?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Acute Lymphoblastic Leukemia;   Hodgkin Disease;   Allogeneic Stem Cell Transplantation<br /><b>Interventions</b>:    Diagnostic Test: Low-field magnetic resonance imaging;   Diagnostic Test: Cardiopulmonary testing;   Diagnostic Test: Pulmonary testing;   Diagnostic Test: Blood sample<br /><b>Sponsor</b>:    University of Erlangen-Nürnberg Medical School<br /><b>Recruiting</b>
A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement,http://classic.clinicaltrials.gov/ct2/show/NCT06093321?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Nasolabial Folds<br /><b>Interventions</b>:    Device: SYB PDO Thread;   Device: MINT lift®<br /><b>Sponsor</b>:    Samyang Biopharmaceuticals Corporation<br /><b>Not yet recruiting</b>
A Study in Elderly Chinese Subjects With Underlying Diseases,http://classic.clinicaltrials.gov/ct2/show/NCT06093308?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Elderly Subjects With Underlying Diseases<br /><b>Intervention</b>:    Drug: Deuremidevir Hydrobromide Tablets<br /><b>Sponsors</b>:    Shanghai Vinnerna Biosciences Co., Ltd.;   Sponsor GmbH<br /><b>Completed</b>"
Non-invasive Brain Stimulation and Injury Risk Biomechanics,http://classic.clinicaltrials.gov/ct2/show/NCT06093295?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Concussion, Mild<br /><b>Intervention</b>:    Device: Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation)<br /><b>Sponsor</b>:    University of Georgia<br /><b>Not yet recruiting</b>"
Activity and Recreation in Communities for Health,http://classic.clinicaltrials.gov/ct2/show/NCT06093282?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Depression<br /><b>Interventions</b>:    Behavioral: ARCH;   Behavioral: Traditional Health Outreach<br /><b>Sponsors</b>:    Rush University Medical Center;   University of Chicago<br /><b>Not yet recruiting</b>
Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL),http://classic.clinicaltrials.gov/ct2/show/NCT06093269?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Hemodialysis Catheter Infection;   Infection, Bacterial<br /><b>Intervention</b>:    Biological: Blood samples<br /><b>Sponsor</b>:    University Hospital, Tours<br /><b>Not yet recruiting</b>"
Taste Changes With Fixed Orthodontic Appliances,http://classic.clinicaltrials.gov/ct2/show/NCT06093256?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Taste Perception;   Fixed Orthodontic Appliances<br /><b>Intervention</b>:    Device: Fixed orthodontic appliances<br /><b>Sponsor</b>:    Riyadh Elm University<br /><b>Not yet recruiting</b>
Women's Knowledge About Endometriosis,http://classic.clinicaltrials.gov/ct2/show/NCT06093243?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Endometriosis<br /><b>Intervention</b>:    Other: data collection<br /><b>Sponsor</b>:    Université de Reims Champagne-Ardenne<br /><b>Not yet recruiting</b>
A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function,http://classic.clinicaltrials.gov/ct2/show/NCT06093230?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Subjects With Liver Function Injury;   Normal Liver Function Subject<br /><b>Intervention</b>:    Drug: Deuremidevir Hydrobromide Tablets<br /><b>Sponsors</b>:    Shanghai Vinnerna Biosciences Co., Ltd.;   Sponsor GmbH<br /><b>Completed</b>"
Artificial Intelligence to Improve Detection and Risk Stratification of Acute Pulmonary Embolism (AID-PE),http://classic.clinicaltrials.gov/ct2/show/NCT06093217?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pulmonary Embolism<br /><b>Intervention</b>:    Device: Artificial Intelligence<br /><b>Sponsors</b>:    Royal United Hospitals Bath NHS Foundation Trust;   University of Bath;   University of Bristol;   London School of Hygiene and Tropical Medicine<br /><b>Not yet recruiting</b>
The Potential Role of Compounds Derived From Ultra-processed Foods in Pathogenesis of Eosinophilic Esophagitis,http://classic.clinicaltrials.gov/ct2/show/NCT06093204?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Esophagitis, Eosinophilic<br /><b>Intervention</b>:    Other: Dietary evaluation<br /><b>Sponsor</b>:    Federico II University<br /><b>Recruiting</b>"
Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis,http://classic.clinicaltrials.gov/ct2/show/NCT06093191?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Bronchiectasis Adult;   Pseudomonas Aeruginosa Infection<br /><b>Interventions</b>:    Drug: Tobramycin Inhalant Product;   Drug: Ciprofloxacin 750 MG;   Drug: Oral ciprofloxacin placebo;   Drug: Natural saline inhalation<br /><b>Sponsor</b>:    Shanghai Pulmonary Hospital, Shanghai, China<br /><b>Recruiting</b>"
Assessing the Feasibility of a Coach-led Digital Platform,http://classic.clinicaltrials.gov/ct2/show/NCT06093178?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Population;   Life Style, Healthy<br /><b>Intervention</b>:    Behavioral: Human coach-led digital health platform<br /><b>Sponsor</b>:    Royal College of Surgeons, Ireland<br /><b>Not yet recruiting</b>"
RE-irradiation of Diffuse MIdline Glioma paTients,http://classic.clinicaltrials.gov/ct2/show/NCT06093165?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Diffuse Midline Glioma, H3 K27M-Mutant;   Diffuse Intrinsic Pontine Glioma;   Diffuse Glioma;   Pontine Tumors;   Thalamic Tumor;   Brain Tumor, Pediatric<br /><b>Intervention</b>:    Radiation: Re-irradiation<br /><b>Sponsors</b>:    Rigshospitalet, Denmark;   Aarhus University Hospital;   Sahlgrenska University Hospital, Sweden;   Karolinska University Hospital;   Radiumhospitalet, Oslo University Hospital<br /><b>Not yet recruiting</b>"
Video Assisted Study of Salbutamol Response in Viral Wheezing,http://classic.clinicaltrials.gov/ct2/show/NCT06093152?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Wheezing<br /><b>Intervention</b>:    Drug: Salbutamol<br /><b>Sponsor</b>:    University of Oulu<br /><b>Not yet recruiting</b>
Efficacy of a Mix of Probiotics in Athletes Performance,http://classic.clinicaltrials.gov/ct2/show/NCT06093139?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Dietary Supplement: Probiotic capsule;   Dietary Supplement: Placebo<br /><b>Sponsors</b>:    Giuliani S.p.A;   FitBiomics, Inc.<br /><b>Completed</b>"
Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06093126?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Insomnia;   Dementia;   Frontotemporal Dementia<br /><b>Intervention</b>:    Drug: Lemborexant 5 MG<br /><b>Sponsor</b>:    Nova Scotia Health Authority<br /><b>Not yet recruiting</b>
Alba - a Mobile App to Provide Bereavement Support for Adolescents in Grief,http://classic.clinicaltrials.gov/ct2/show/NCT06093113?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Complicated Grief Disorder<br /><b>Interventions</b>:    Behavioral: Alba - Youth in grief;   Behavioral: Control website<br /><b>Sponsor</b>:    Uppsala University<br /><b>Not yet recruiting</b>
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim,http://classic.clinicaltrials.gov/ct2/show/NCT06093100?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Duchenne Muscular Dystrophy<br /><b>Intervention</b>:    Device: wearable technology<br /><b>Sponsor</b>:    Vanderbilt University Medical Center<br /><b>Not yet recruiting</b>
Randomized Controlled Trial of Internal Fixation Reconstruction With Stent Screw in the Treatment of Kummell's Disease,http://classic.clinicaltrials.gov/ct2/show/NCT06093087?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    BKP;   Osteoporotic Vertebral Compression Fracture;   Kummell's Disease;   Stent-screw-assisted Internal Fixation<br /><b>Interventions</b>:    Procedure: SAIF;   Procedure: BKP<br /><b>Sponsor</b>:    Second Affiliated Hospital, School of Medicine, Zhejiang University<br /><b>Not yet recruiting</b>"
Self-management Program for Patients in the Sub-acute Phase After Traumatic Injury - a Feasibility Study,http://classic.clinicaltrials.gov/ct2/show/NCT06093074?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Self-management;   Feasibility Studies;   Spinal Cord Injuries;   Brain Injuries<br /><b>Intervention</b>:    Behavioral: self-manangement program after traumatic injuries<br /><b>Sponsors</b>:    Oslo University Hospital;   Sunnaas Rehabilitation Hospital;   South-Eastern Norway Regional Health Authority<br /><b>Not yet recruiting</b>
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma,http://classic.clinicaltrials.gov/ct2/show/NCT06093061?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Nasopharyngeal Carcinoma<br /><b>Intervention</b>:    Combination Product: CCRT with Maintenance Tislelizumab and Metronomic Capecitabine<br /><b>Sponsors</b>:    National Cancer Centre, Singapore;   BeiGene;   Tan Tock Seng Hospital<br /><b>Not yet recruiting</b>"
Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome,http://classic.clinicaltrials.gov/ct2/show/NCT06093048?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Obstructive Jaundice<br /><b>Intervention</b>:    Procedure: Endoscopic retrograde cholangiopancreatography<br /><b>Sponsor</b>:    Sohag University<br /><b>Not yet recruiting</b>
"Analysis of Urinary, Vaginal and Intestinal Microbiota in Patients With Neurogenic Bladder",http://classic.clinicaltrials.gov/ct2/show/NCT06093035?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Microbial Colonization<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Fondazione Policlinico Universitario Agostino Gemelli IRCCS<br /><b>Not yet recruiting</b>
Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study,http://classic.clinicaltrials.gov/ct2/show/NCT06093022?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Breast Cancer;   Liver Metastases<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Fondazione Policlinico Universitario Agostino Gemelli IRCCS<br /><b>Recruiting</b>
The Significance of Postoperative Muscle Wasting in Pancreatic Cancer,http://classic.clinicaltrials.gov/ct2/show/NCT06093009?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Pancreatic Cancer<br /><b>Intervention</b>:    Procedure: pancreatectomy<br /><b>Sponsor</b>:    National Cheng-Kung University Hospital<br /><b>Completed</b>
Sling vs No Sling After Reverse Total Shoulder Arthroplasty: A Randomized Control Trial,http://classic.clinicaltrials.gov/ct2/show/NCT06092996?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Shoulder Disease;   Rotator Cuff Tear Arthropathy;   Shoulder Osteoarthritis<br /><b>Intervention</b>:    Other: Time of Sling Use<br /><b>Sponsor</b>:    Duke University<br /><b>Not yet recruiting</b>
"A Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of HS-10383",http://classic.clinicaltrials.gov/ct2/show/NCT06092983?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Cough<br /><b>Interventions</b>:    Drug: HS-10383;   Drug: HS-10383 Placebo<br /><b>Sponsor</b>:    Jiangsu Hansoh Pharmaceutical Co., Ltd.<br /><b>Recruiting</b>"
An Evaluation of Patient Reported Outcomes and Clinical Outcomes,http://classic.clinicaltrials.gov/ct2/show/NCT06092970?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Post-Operative Complications in Cardiac Surgery<br /><b>Interventions</b>:    Drug: RBT-1;   Drug: Placebo<br /><b>Sponsor</b>:    Renibus Therapeutics, Inc.<br /><b>Not yet recruiting</b>"
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy,http://classic.clinicaltrials.gov/ct2/show/NCT06092957?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Nasopharyngeal Carcinoma;   De-escalation Therapy<br /><b>Interventions</b>:    Drug: Cisplatin-based induction chemotherapy;   Drug: Full course of PD-1/PD-L1 blockades;   Radiation: Reduced-dose IMRT;   Radiation: Standard-dose IMRT;   Drug: Concurrent Chemotherapy<br /><b>Sponsors</b>:    Sun Yat-sen University;   First Affiliated Hospital, Sun Yat-Sen University;   Affiliated Cancer Hospital & Institute of Guangzhou Medical University;   Guangdong Provincial People's Hospital;   Second Affiliated Hospital, Sun Yat-Sen University;   The fifth Affiliated Hospital of Guangzhou Medcial University;   Zhongshan People's Hospital, Guangdong, China;   Hunan Cancer Hospital;   Tongji Hospital<br /><b>Recruiting</b>"
Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy,http://classic.clinicaltrials.gov/ct2/show/NCT06092944?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Esophagus Cancer<br /><b>Interventions</b>:    Procedure: Catheterization;   Procedure: Single nerve block;   Procedure: Continuous nerve block;   Procedure: PCIA<br /><b>Sponsor</b>:    Luo Fuchao<br /><b>Recruiting</b>
A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants,http://classic.clinicaltrials.gov/ct2/show/NCT06092931?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Healthy Participants<br /><b>Interventions</b>:    Drug: DC-806;   Drug: Midazolam;   Drug: Repaglinide;   Drug: Digoxin;   Drug: Rosuvastatin<br /><b>Sponsor</b>:    DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company<br /><b>Not yet recruiting</b>"
Generation and Validation of Predictive Models for Localized Prostate Cancer Treated With External Radiotherapy.,http://classic.clinicaltrials.gov/ct2/show/NCT06092918?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Predictive Cancer Model;   Localized Prostate Carcinoma<br /><b>Intervention</b>:    Radiation: EXTERNAL RADIOTHERAPY<br /><b>Sponsor</b>:    Consorci Sanitari de Terrassa<br /><b>Completed</b>
Endoscopic Common Bile Duct Stones Clearance During Pregnancy,http://classic.clinicaltrials.gov/ct2/show/NCT06092905?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Common Bile Duct Calculi<br /><b>Intervention</b>:    Other: Endoscopic clearance of common bile duct stones<br /><b>Sponsor</b>:    South Valley University<br /><b>Recruiting</b>
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases,http://classic.clinicaltrials.gov/ct2/show/NCT06092892?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Breast Cancer;   Axillary Nodal Disease;   Female Breast Cancer;   Axilla; Breast;   Mastectomy; Lymphedema;   Tumor, Breast<br /><b>Interventions</b>:    Procedure: Breast Surgery (BCS or mastectomy) with TAD/SNB;   Radiation: Adjuvant Radiation Therapy<br /><b>Sponsor</b>:    Alice Chung<br /><b>Not yet recruiting</b>"
Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France,http://classic.clinicaltrials.gov/ct2/show/NCT06092879?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Chronic Myeloid Leukemia<br /><b>Intervention</b>:    Other: Asciminib<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>
Digital Versus Telephone Symptom Assessment and Triage in Primary Care,http://classic.clinicaltrials.gov/ct2/show/NCT06092866?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Infections;   Injuries;   Psychiatric Disorder;   Gastro-Intestinal Disorder;   Skin Diseases<br /><b>Intervention</b>:    Behavioral: Digital triage<br /><b>Sponsor</b>:    Region Skane<br /><b>Not yet recruiting</b>
Inflammatory Stress and Periodontal Tissue Destruction,http://classic.clinicaltrials.gov/ct2/show/NCT06092853?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Oxidative Stress;   Inflammation<br /><b>Intervention</b>:    Other: Gingival crevicular fluid (GCF) and serum samples<br /><b>Sponsors</b>:    Recep Tayyip Erdogan University Training and Research Hospital;   Recep Tayyip Erdogan University<br /><b>Completed</b>
Effect of Transform Burn on Weight Loss,http://classic.clinicaltrials.gov/ct2/show/NCT06092840?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Weight Loss<br /><b>Intervention</b>:    Dietary Supplement: Transform Burn<br /><b>Sponsors</b>:    4Life Research, LLC;   Brigham Young University<br /><b>Completed</b>"
Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration,http://classic.clinicaltrials.gov/ct2/show/NCT06092827?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Diabetic Foot;   Cardiopulmonary;   Physical Inactivity<br /><b>Intervention</b>:    Behavioral: Non weight-bearing physical activity program<br /><b>Sponsors</b>:    Université du Québec à Trois-Rivières;   Fondation Santé Trois-Rivières;   Centre intégré universitaire de santé et services sociaux Mauricie et Centre-du-Québec (CIUSSS MCQ);   Université de Montréal<br /><b>Not yet recruiting</b>
tACS to Enhance Language Abilities,http://classic.clinicaltrials.gov/ct2/show/NCT06092814?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Stroke;   Aphasia, Acquired;   Aphasia<br /><b>Intervention</b>:    Device: Active transcranial alternating current stimulation (tACS)<br /><b>Sponsor</b>:    University of Pennsylvania<br /><b>Not yet recruiting</b>"
"Prediction of Coronary Artery Disease Based on Multimodal, Non-contact Information With Artificial Intelligence",http://classic.clinicaltrials.gov/ct2/show/NCT06092801?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Coronary Artery Disease<br /><b>Intervention</b>:    Other: No intervention<br /><b>Sponsor</b>:    China National Center for Cardiovascular Diseases<br /><b>Not yet recruiting</b>
"Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose",http://classic.clinicaltrials.gov/ct2/show/NCT06092788?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Healthy<br /><b>Interventions</b>:    Drug: NTP42:KVA4 Capsule;   Drug: NTP42:KVA4 Liquid<br /><b>Sponsors</b>:    ATXA Therapeutics Limited;   Hammersmith Medicines Research<br /><b>Recruiting</b>
Prevalence of Subclinical Vertebral Fractures in Rheumatoid Arthritis and Ankylosing Spondylitis,http://classic.clinicaltrials.gov/ct2/show/NCT06092775?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Vertebral Fracture<br /><b>Intervention</b>:    Device: DEXA scan,X_ray<br /><b>Sponsor</b>:    Assiut University<br /><b>Not yet recruiting</b>"
A Phase II Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis,http://classic.clinicaltrials.gov/ct2/show/NCT06092762?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Atopic Dermatitis<br /><b>Intervention</b>:    Drug: AK120<br /><b>Sponsor</b>:    Akeso<br /><b>Not yet recruiting</b>
Chronic Unilateral Lumbar Radicular Pain,http://classic.clinicaltrials.gov/ct2/show/NCT06092749?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Neuropathic Pain<br /><b>Interventions</b>:    Other: Transgrade technique (TG);   Other: Interlaminar technique (IL)<br /><b>Sponsor</b>:    Ain Shams University<br /><b>Not yet recruiting</b>
Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS),http://classic.clinicaltrials.gov/ct2/show/NCT06092736?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Microvascular Angina<br /><b>Interventions</b>:    Drug: Compound Danshen Dropping Pills;   Drug: Placebo<br /><b>Sponsor</b>:    Qilu Hospital of Shandong University<br /><b>Recruiting</b>
Effects of Probiotics Improves the Endurance and Explosiveness Exercise Performance on Healthy Human.,http://classic.clinicaltrials.gov/ct2/show/NCT06092723?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Exercise Performance<br /><b>Interventions</b>:    Dietary Supplement: Placebo;   Dietary Supplement: Probiotic 1,Lactococcus lactis subsp. lactis, LY-66;   Dietary Supplement: Probiotic 2,Lactobacillus plantarum, PL-02;   Dietary Supplement: Probiotic 3,Lactococcus lactis subsp. lactis, LY-66+Lactobacillus plantarum, PL-02<br /><b>Sponsor</b>:    Glac Biotech Co., Ltd<br /><b>Completed</b>"
Predictability of OSA With a Subjective Screening Scale (OSASSS1),http://classic.clinicaltrials.gov/ct2/show/NCT06092710?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Obstructive Sleep Apnea;   OSA<br /><b>Intervention</b>:    Diagnostic Test: neuro-sensorial subjective evaluation of the airways collapsibility<br /><b>Sponsors</b>:    Center for Sleep Medicine - Clinique André Renard;   PIRON Alain, Osteopath - physiotherapist;   LACROIX Alain, neurologist, MD, PhD;   CHAKAR Bassam, neurologist, MD, PhD;   SELAK Ivan, neurologist, MD, PhD<br /><b>Enrolling by invitation</b>"
Evaluation of 3D Printed Polyether Ether Ketone (PEEK) and Milled PEEK Indirect Restorations Compared to Hybird Resin Composite Indirect Restorations Over One Year Period of Time ( A Randomized Clinical Trial ),http://classic.clinicaltrials.gov/ct2/show/NCT06092697?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Clinical Performance<br /><b>Intervention</b>:    Other: 3D printed PEEK restorations<br /><b>Sponsor</b>:    Cairo University<br /><b>Not yet recruiting</b>
The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06092684?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Laparoscopy;   Anesthesia, Intravenous<br /><b>Interventions</b>:    Drug: BT-KTM-I;   Drug: Ketanest®S<br /><b>Sponsor</b>:    Chengdu Brilliant Pharmaceutical Co., Ltd.<br /><b>Not yet recruiting</b>"
Effect of Family-centered Perioperative Care for Anesthesia (FPCA) on Incidence of Emergency Delirium and Postoperative Maladaptive Behaviors in Children After Surgery,http://classic.clinicaltrials.gov/ct2/show/NCT06092671?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Postoperative Complications;   Child;   Anesthesia;   Family<br /><b>Intervention</b>:    Other: family-focused anesthesia strategies<br /><b>Sponsor</b>:    Second Affiliated Hospital of Wenzhou Medical University<br /><b>Not yet recruiting</b>
Cohort Study of Chronic Heart Failure,http://classic.clinicaltrials.gov/ct2/show/NCT06092658?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Condition</b>:    Analyze Etiology, Comorbidities, Clinical Characteristics<br /><b>Intervention</b>:    Other: No Intervention<br /><b>Sponsor</b>:    Xiang Xie<br /><b>Completed</b>"
Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma,http://classic.clinicaltrials.gov/ct2/show/NCT06092645?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Bile Duct Adenocarcinoma<br /><b>Intervention</b>:    Drug: surufatinib plus cadonilimab<br /><b>Sponsor</b>:    Zhejiang Cancer Hospital<br /><b>Recruiting</b>
Efficacy of Pigmented Rice on Reducing Cardiometabolic Risk Factors Among Filipino Adults,http://classic.clinicaltrials.gov/ct2/show/NCT06092632?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Conditions</b>:    Dyslipidemias;   Overweight or Obesity;   Hyperglycaemia (Non Diabetic)<br /><b>Interventions</b>:    Other: Pigmented rice;   Other: White Rice<br /><b>Sponsor</b>:    University of Santo Tomas<br /><b>Not yet recruiting</b>
Effects of Vojta Therapy on the Motor Function of Children With Neuromotor Disorders,http://classic.clinicaltrials.gov/ct2/show/NCT06092619?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT",<b>Condition</b>:    Motor Disorders<br /><b>Interventions</b>:    Other: Vojta Therapy;   Other: Conventional physiotherapy:<br /><b>Sponsor</b>:    University of Salamanca<br /><b>Not yet recruiting</b>
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients,http://classic.clinicaltrials.gov/ct2/show/NCT06092606?sfpd_d=14&sel_rss=new14,"Mon, 23 Oct 2023 12:00:00 EDT","<b>Conditions</b>:    Cancer;   Heart Failure;   Arrhythmia;   Doxorubicin Induced Cardiomyopathy;   Doxorubicin Adverse Reaction<br /><b>Interventions</b>:    Drug: Control group:DH001 placebo;   Drug: Trial group: DH001 low-dose group;   Drug: Trial group: DH001 high-dose group<br /><b>Sponsor</b>:    Monyan Pharmaceutical (Shanghai) Co., Ltd.<br /><b>Recruiting</b>"
